data_1yzs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yzs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.46 -0.57 . . . . 1.26 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 1.2 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 1.39 108.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.0 m-70 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.29 109.85 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.38 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 1.0 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.5 113.648 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 1.2 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 1.15 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 1.71 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 2.34 109.305 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 1.34 108.493 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 7.34 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 1.23 111.98 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 2.73 108.447 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 1.59 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.87 109.585 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 2.42 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 1.45 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.98 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 1.47 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 1.48 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 2.24 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.99 108.587 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.57 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.72 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 1.55 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 1.16 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.39 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 1.09 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.96 109.21 179.797 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.495 1.609 0 CA-C-O 120.618 0.174 . . . . 1.18 112.054 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 1.73 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 1.24 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 1.22 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 1.33 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.2 108.927 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 1.16 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.95 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.59 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 1.16 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' GLY . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 1.29 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.9 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 1.24 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.66 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 2.68 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 1.34 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 1.36 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 1.12 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 2.92 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.69 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 1.21 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 1.4 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.37 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 1.2 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.72 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 1.34 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 1.09 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 2.37 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.44 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.531 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 1.14 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 1.1 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.72 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.84 110.716 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 1.46 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 2.04 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.96 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 2.54 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 1.27 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 2.37 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 120' ' ' SER . 30.8 tp60 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.09 108.909 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.54 ' N ' HE21 ' A' ' 119' ' ' GLN . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.84 109.843 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 1.3 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 2.45 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 1.03 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 1.03 108.851 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.37 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 1.18 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.83 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 1.52 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 1.0 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.65 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 1.09 109.557 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.84 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.511 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 1.39 110.456 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.8 mm-40 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.322 0.582 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.0 m-70 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.444 ' H ' ' HG1' ' A' ' 68' ' ' THR . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.497 1.692 0 CA-C-O 120.796 0.248 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.521 HE21 ' C ' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.621 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.48 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.3 mm-40 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.272 0.558 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.6 m-70 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 111.585 -0.198 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.416 ' OE1' ' OH ' ' A' ' 102' ' ' TYR . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.659 HE21 ' N ' ' A' ' 120' ' ' SER . 21.0 tp60 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.659 ' N ' HE21 ' A' ' 119' ' ' GLN . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.478 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 63.7 mm-40 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.8 m-70 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 N-CA-C 113.332 0.474 . . . . 0.0 113.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.3 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 120' ' ' SER . 26.8 tp60 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.552 ' N ' HE21 ' A' ' 119' ' ' GLN . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.52 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.8 m-70 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 113.564 0.563 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.0 mm-40 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 18.1 m-70 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.2 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 68' ' ' THR . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 CA-C-O 120.848 0.27 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.612 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.5 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.1 mm-40 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.477 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.7 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 N--CA 1.493 1.486 0 CA-C-O 121.163 0.401 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 83' ' ' TRP . 31.0 tp60 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.505 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.561 ' C ' HE21 ' A' ' 137' ' ' GLN . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.515 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.7 mm-40 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 24.9 m-70 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.5 mt-30 -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 112.644 0.209 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 109' ' ' GLN . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.8 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.496 ' C ' HE21 ' A' ' 137' ' ' GLN . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 59.5 mm-40 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 27.0 m-70 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.497 ' NH1' ' OG ' ' A' ' 95' ' ' SER . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.486 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 CA-C-O 120.755 0.231 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.405 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.405 ' OE1' ' OH ' ' A' ' 102' ' ' TYR . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.566 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.56 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.56 HE21 ' C ' ' A' ' 135' ' ' ASP . 66.0 mm-40 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.234 0.54 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.4 m-70 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' NE ' ' CD1' ' A' ' 102' ' ' TYR . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.446 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.722 0.217 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 120' ' ' SER . 2.0 tm0? -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.617 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.557 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 135' ' ' ASP . 68.1 mm-40 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.401 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.7 m-70 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.494 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.784 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 90' ' ' GLY . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.494 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.529 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.62 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.559 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.559 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.5 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 17.3 m-70 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.611 HH12 ' HG ' ' A' ' 95' ' ' SER . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.445 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.673 0.197 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.611 ' HG ' HH12 ' A' ' 51' ' ' ARG . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.576 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.552 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.552 HE21 ' C ' ' A' ' 135' ' ' ASP . 71.0 mm-40 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 26.4 m-70 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.629 HE21 ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.629 ' N ' HE21 ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.514 ' C ' HE21 ' A' ' 137' ' ' GLN . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 69.0 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.1 m-70 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.527 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.493 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.494 1.509 0 CA-C-O 120.806 0.252 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.425 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.527 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.493 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.61 HE21 ' N ' ' A' ' 120' ' ' SER . 27.1 tp60 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.61 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.514 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.2 mm-40 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 32.3 m-70 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.401 HH22 ' HG ' ' A' ' 95' ' ' SER . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.588 0.162 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HG ' HH22 ' A' ' 51' ' ' ARG . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.623 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.555 ' C ' HE21 ' A' ' 137' ' ' GLN . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.522 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.8 mm-40 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' C ' ' HZ1' ' A' ' 116' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.7 m-70 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 120.865 0.277 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.541 ' HZ1' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.541 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HZ1' ' C ' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 83' ' ' TRP . 29.7 tp60 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.522 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.464 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.6 mm-40 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.1 m-70 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' OG1' ' A' ' 68' ' ' THR . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 64' ' ' SER . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 N-CA-C 113.593 0.574 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.47 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.453 ' NH2' ' O ' ' A' ' 77' ' ' PRO . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.595 HE21 ' N ' ' A' ' 120' ' ' SER . 26.0 tp60 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.595 ' N ' HE21 ' A' ' 119' ' ' GLN . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 137' ' ' GLN . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.528 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.71 0.213 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' GLY . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.66 HE21 ' N ' ' A' ' 120' ' ' SER . 24.9 tp60 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.66 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.523 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 15.3 m-70 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 3.1 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 N-CA-C 113.793 0.651 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.509 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.615 HE21 ' N ' ' A' ' 120' ' ' SER . 30.2 tp60 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.615 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.534 ' H ' ' HG1' ' A' ' 133' ' ' THR . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.5 m-70 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.497 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.2 mt-30 -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.635 0.181 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.524 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.599 HE21 ' N ' ' A' ' 120' ' ' SER . 30.3 tp60 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.599 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.55 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.55 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.476 -1.45 . . . . 30.44 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 152.88 92.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 27.48 109.13 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.78 71.29 3.36 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.259 1.972 . . . . 25.54 111.91 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.28 151.34 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 24.88 109.422 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.77 -59.68 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.502 -1.439 . . . . 19.43 109.502 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.09 160.21 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.79 2.327 . . . . 17.79 112.183 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.21 68.9 1.51 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.463 -1.455 . . . . 17.26 109.463 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.15 -20.08 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.781 2.321 . . . . 17.59 112.306 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 26' ' ' GLY . 12.6 t -161.34 -152.28 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 19.65 109.48 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.618 ' H ' ' HG ' ' A' ' 25' ' ' SER . . . -164.6 71.05 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.437 . . . . 21.2 109.506 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.66 -33.55 0.32 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 21.1 109.517 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.22 -14.82 59.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 19.31 109.459 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -54.05 142.18 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.911 . . . . 19.93 109.473 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.29 85.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.387 -1.485 . . . . 16.27 109.387 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.18 52.31 42.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.384 -1.486 . . . . 13.77 109.384 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -79.9 129.08 34.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 12.27 109.513 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.7 mp -78.94 123.87 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 10.16 109.194 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' O ' ' N ' ' A' ' 36' ' ' GLY . 34.6 t60 -65.2 153.75 40.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 8.89 109.473 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -67.91 58.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 7.19 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . 61.81 159.61 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 2.77 109.428 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -71.98 136.39 46.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -1.159 . . . . 3.16 109.459 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -143.5 98.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -0.926 . . . . 1.46 109.013 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.6 97.71 10.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 1.26 109.46 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 1.2 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 1.39 108.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.0 m-70 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.29 109.85 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.38 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 1.0 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.5 113.648 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 1.2 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 1.15 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 1.71 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 2.34 109.305 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 1.34 108.493 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 7.34 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 1.23 111.98 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 2.73 108.447 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 1.59 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.87 109.585 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 2.42 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 1.45 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.98 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 1.47 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 1.48 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 2.24 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.99 108.587 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.57 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.72 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 1.55 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 1.16 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.39 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 1.09 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt -62.11 -40.23 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.96 109.21 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -75.25 -36.5 61.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 2.59 110.175 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -77.31 -37.5 52.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.091 . . . . 1.94 109.706 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.44 104.4 1.21 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.905 . . . . 2.33 109.126 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.08 -19.48 39.31 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.359 1.373 . . . . 0.95 112.973 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.72 4.04 54.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.845 -1.159 . . . . 2.58 109.788 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 t -102.26 13.76 33.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 1.58 109.826 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.48 98.98 45.8 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.399 -0.813 . . . . 1.24 109.111 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.04 156.1 3.85 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.227 1.951 . . . . 1.18 112.054 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 1.73 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 1.24 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 1.22 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 1.33 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.2 108.927 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 1.16 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.95 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.59 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 1.16 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 90' ' ' GLY . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 1.29 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.9 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 1.24 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.66 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 2.68 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 1.34 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 1.36 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 1.12 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 2.92 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.69 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 1.21 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 1.4 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.37 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 1.2 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.72 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 1.34 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 1.09 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 2.37 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.44 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.531 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 1.14 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 1.1 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.72 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.84 110.716 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 1.46 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 2.04 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.96 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 2.54 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 1.27 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 2.37 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 120' ' ' SER . 30.8 tp60 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.09 108.909 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.54 ' N ' HE21 ' A' ' 119' ' ' GLN . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.84 109.843 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 1.3 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 2.45 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 1.03 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 1.03 108.851 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.37 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 1.18 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.83 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 1.52 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 1.0 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.65 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 1.09 109.557 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.84 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.511 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 1.39 110.456 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.8 mm-40 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.9 152.76 93.09 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.249 -1.147 . . . . 0.0 109.17 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.66 107.65 2.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.346 2.031 . . . . 0.0 111.967 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -51.21 -46.36 62.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.86 -67.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.18 110.03 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.999 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.07 178.44 0.21 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 72.21 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.816 2.344 . . . . 0.0 111.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 9.7 t -64.07 -174.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -65.21 146.64 50.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.0 144.52 4.05 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.05 79.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -1.128 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -60.51 174.28 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.89 -12.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.44 108.64 0.21 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -161.28 134.49 6.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' SER . 15.3 pt -64.19 155.74 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' SER . 18.2 m80 -67.9 56.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 33' ' ' ILE . 40.2 t -58.03 -162.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -161.14 55.01 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -161.77 77.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -1.151 . . . . 0.0 109.423 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.26 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 106.07 18.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 109.532 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.0 m-70 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.444 ' H ' ' HG1' ' A' ' 68' ' ' THR . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.5 mt -60.23 -41.36 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 58.7 mtt180 -71.87 -39.4 69.67 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.302 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -75.31 -38.79 60.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -160.48 105.18 1.34 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.184 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.92 -18.51 40.98 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.343 1.362 . . . . 0.0 112.882 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.75 5.07 52.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.866 -1.146 . . . . 0.0 109.49 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.8 t -103.34 14.84 30.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.57 98.88 30.91 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.377 -0.827 . . . . 0.0 109.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.8 156.19 3.44 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.235 1.956 . . . . 0.0 112.21 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.521 ' C ' HE21 ' A' ' 107' ' ' GLN . 0.4 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.621 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.48 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.3 mm-40 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.408 ' H2 ' ' H ' ' A' ' 18' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' H ' ' H2 ' ' A' ' 17' ' ' GLY . . . -166.13 60.41 0.62 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.71 70.25 5.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.738 2.292 . . . . 0.0 112.001 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -170.04 32.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.68 -69.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.56 68.82 6.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.722 2.282 . . . . 0.0 111.939 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.01 170.67 53.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.26 15.76 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.744 2.296 . . . . 0.0 111.986 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t -160.89 -38.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.9 -161.89 34.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.07 -32.2 0.36 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.39 -6.0 45.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.9 mt-30 -153.22 29.79 0.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.356 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.62 -83.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -162.23 -79.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -160.75 140.06 10.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.07 -21.89 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -167.32 107.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.2 p -80.32 176.76 9.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.15 85.5 0.23 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -80.6 107.94 13.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -1.152 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.0 mt -143.34 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 108.888 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.02 88.15 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.579 -0.701 . . . . 0.0 109.546 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.6 m-70 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -64.93 -40.2 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.0 mtp85 -75.49 -38.04 59.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -76.52 -38.7 54.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.424 ' OD2' ' OG ' ' A' ' 75' ' ' SER . 48.7 t0 -158.17 100.62 1.75 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 109.203 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.79 -14.34 32.75 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.31 1.34 . . . . 0.0 112.905 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.86 -25.53 23.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.976 -1.078 . . . . 0.0 110.637 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.424 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 57.6 m -82.91 20.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 0.0 109.8 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.45 98.8 52.14 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.29 -0.881 . . . . 0.0 109.101 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -54.47 171.89 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.003 1.802 . . . . 0.0 111.585 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.416 ' OE1' ' OH ' ' A' ' 102' ' ' TYR . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.659 HE21 ' N ' ' A' ' 120' ' ' SER . 21.0 tp60 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.659 ' N ' HE21 ' A' ' 119' ' ' GLN . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.478 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 63.7 mm-40 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.88 152.93 96.54 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.116 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.8 77.35 2.29 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.296 1.997 . . . . 0.0 111.922 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -58.77 -46.9 86.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.08 60.3 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.55 106.95 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.003 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -171.7 42.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.14 135.57 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.808 2.338 . . . . 0.0 112.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 p -77.55 133.41 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -52.79 119.54 10.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -61.42 -149.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.61 75.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -52.42 152.43 3.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.79 -97.46 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.36 158.57 26.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 p -175.78 149.27 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tp -161.23 132.83 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.268 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' O ' ' OG ' ' A' ' 35' ' ' SER . 9.0 t-160 -82.48 75.64 9.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 34' ' ' HIS . 18.9 m -166.12 141.04 4.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.454 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -52.94 -48.2 58.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 36' ' ' GLY . 31.5 ptt180 -51.81 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.32 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.61 97.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.237 -0.914 . . . . 0.0 109.094 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.14 112.83 25.91 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.8 m-70 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt -68.76 -39.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -75.49 -55.36 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.636 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.7 -34.19 37.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.061 . . . . 0.0 109.541 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -171.76 109.19 0.38 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.388 -0.82 . . . . 0.0 108.791 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.79 -6.7 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.324 1.349 . . . . 0.0 112.65 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -92.01 -0.83 57.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.035 . . . . 0.0 110.007 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -101.77 18.01 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.63 100.13 5.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.18 162.89 22.8 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.891 1.727 . . . . 0.0 113.332 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.473 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.3 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 120' ' ' SER . 26.8 tp60 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.552 ' N ' HE21 ' A' ' 119' ' ' GLN . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.52 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.14 152.82 5.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -1.159 . . . . 0.0 109.098 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 21' ' ' GLY . 65.7 Cg_endo -72.4 -19.95 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.358 2.039 . . . . 0.0 111.93 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 24.3 mp0 -65.07 3.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 19' ' ' PRO . . . 79.03 177.64 49.97 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.71 -89.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.745 2.297 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.62 60.51 0.33 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.91 -161.12 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.711 2.274 . . . . 0.0 111.957 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 m -77.58 166.52 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.94 65.66 3.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.07 -3.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.49 43.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -78.95 -41.11 30.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.93 -153.61 4.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.31 116.97 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 9.4 p -175.53 149.82 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.52 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -79.55 106.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.201 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.485 ' CE1' ' O ' ' A' ' 32' ' ' SER . 5.6 m80 -79.93 63.85 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 34' ' ' HIS . 19.7 m -166.18 155.3 11.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.476 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.98 29.98 58.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -170.12 143.89 2.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.2 mt -143.54 97.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 108.982 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.68 119.29 38.15 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.8 m-70 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.27 -40.96 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -75.95 -48.83 19.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.369 -0.832 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.01 -34.06 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.064 -1.022 . . . . 0.0 110.405 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' OD1' ' OD2' ' A' ' 74' ' ' ASP . 45.4 t0 -156.15 87.54 2.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 0.0 109.84 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.4 -15.78 43.06 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.544 1.496 . . . . 0.0 112.85 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD2' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -93.29 4.47 53.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.867 -1.145 . . . . 0.0 109.644 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -104.63 15.68 27.52 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.365 -0.834 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.07 101.0 8.61 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.57 166.78 26.72 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.551 1.501 . . . . 0.0 113.564 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.557 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.557 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.0 mm-40 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.87 -37.07 2.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.263 -1.139 . . . . 0.0 110.467 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.0 Cg_exo -56.12 -30.44 79.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.12 1.88 . . . . 0.0 112.112 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -56.22 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.69 178.69 9.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.2 -43.19 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.748 2.299 . . . . 0.0 111.978 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.16 34.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' C ' ' HG ' ' A' ' 25' ' ' SER . 73.0 Cg_endo -74.99 12.12 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.826 2.351 . . . . 0.0 112.016 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.51 ' HG ' ' C ' ' A' ' 24' ' ' PRO . 5.8 m -160.87 10.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.24 -14.19 82.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.91 54.4 4.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.03 -10.77 59.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 3.9 mp0 -79.48 -170.39 2.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.21 151.4 6.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.07 50.96 0.2 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -160.36 115.72 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.99 -3.74 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 0.0 109.471 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -160.37 105.36 1.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -81.37 -175.95 5.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -80.13 -95.74 0.36 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -52.23 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.1 . . . . 0.0 109.722 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.53 97.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.232 -0.917 . . . . 0.0 109.076 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.67 34.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.574 -0.704 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 18.1 m-70 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.2 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 68' ' ' THR . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt -61.21 -41.17 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -69.41 -55.29 10.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -56.1 -42.13 76.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 109.788 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -161.42 109.36 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 109.29 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.5 -22.45 38.67 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.303 1.335 . . . . 0.0 113.138 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 15.2 t70 -92.98 6.76 46.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.6 p -97.3 5.89 49.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 110.138 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.42 137.05 23.25 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 160.12 23.9 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.847 1.698 . . . . 0.0 112.182 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.612 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.5 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.1 mm-40 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.98 149.41 80.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.087 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 72.1 3.7 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.224 1.949 . . . . 0.0 111.932 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.54 178.81 1.16 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.56 -169.85 37.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.16 -66.89 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.733 2.288 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.98 60.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.48 -167.21 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.708 2.272 . . . . 0.0 112.004 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 31.5 t -169.08 -163.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -172.48 -19.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 -133.39 1.86 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -4.02 13.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -1.162 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -65.6 158.1 28.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.19 -60.57 3.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.01 73.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 m -69.17 128.12 35.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -78.02 61.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 34' ' ' HIS . 16.2 t-80 -160.32 2.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -49.79 -48.69 50.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.98 -30.5 0.39 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -79.65 114.26 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.167 . . . . 0.0 109.377 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.39 97.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.157 -0.964 . . . . 0.0 108.937 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 96.23 10.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.535 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.477 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.7 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -66.36 -41.74 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -75.02 -39.65 60.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.348 -0.845 . . . . 0.0 109.996 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -74.3 -37.39 63.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.01 -1.056 . . . . 0.0 109.718 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -160.28 102.53 1.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.218 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -18.29 37.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.32 1.347 . . . . 0.0 112.897 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.59 3.17 56.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 0.0 109.752 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -102.24 15.4 29.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.257 -0.902 . . . . 0.0 109.616 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -125.89 103.62 27.28 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.43 162.72 41.38 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.354 1.369 . . . . 0.0 112.698 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.532 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 83' ' ' TRP . 31.0 tp60 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.505 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.561 ' C ' HE21 ' A' ' 137' ' ' GLN . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.515 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.7 mm-40 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.0 60.4 0.55 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.611 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.63 -176.62 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 112.008 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.84 -7.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.42 -59.88 8.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.89 145.29 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.94 -59.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.85 -65.69 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.736 2.291 . . . . 0.0 112.235 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -77.35 -77.72 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.53 -39.89 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.38 -147.54 5.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.53 72.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -164.79 -30.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.371 -0.831 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 32' ' ' SER . . . -160.87 23.82 0.25 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.24 -33.93 1.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 30' ' ' GLY . 78.2 p -52.12 149.53 5.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -1.157 . . . . 0.0 109.517 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.1 tt -169.71 -40.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -79.8 -140.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 p -169.73 71.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.23 39.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -170.04 140.98 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -1.122 . . . . 0.0 109.388 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.61 98.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.232 -0.918 . . . . 0.0 109.086 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.98 106.57 18.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.336 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 24.9 m-70 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.5 mt-30 -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt -59.88 -43.08 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -70.44 -59.27 2.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 1.3 mp0 -50.76 -34.09 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -171.25 107.89 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.366 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.18 -14.65 31.75 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.377 1.385 . . . . 0.0 112.941 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.59 3.17 56.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.132 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.7 m -103.32 17.0 25.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.29 -0.881 . . . . 0.0 109.664 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.461 ' CG1' HH21 ' A' ' 101' ' ' ARG . 2.2 t -128.91 98.74 23.57 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.316 -0.865 . . . . 0.0 108.922 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.76 155.45 3.94 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.396 2.064 . . . . 0.0 112.644 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.461 HH21 ' CG1' ' A' ' 76' ' ' VAL . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 109' ' ' GLN . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.8 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.496 ' C ' HE21 ' A' ' 137' ' ' GLN . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 59.5 mm-40 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.33 60.27 0.45 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.172 -1.193 . . . . 0.0 109.546 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.45 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.823 2.349 . . . . 0.0 112.023 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.37 127.69 32.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 173.19 38.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 -164.39 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.788 2.325 . . . . 0.0 112.02 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.55 70.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.12 -38.49 19.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.819 2.346 . . . . 0.0 112.2 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.6 m -162.98 -26.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 109.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.88 -144.2 4.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.7 42.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.04 -13.26 59.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.473 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -71.2 64.56 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.27 62.49 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.34 -158.66 1.32 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -78.86 160.8 27.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.5 -178.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.77 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 t -71.41 105.17 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.77 158.75 29.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -170.15 144.2 2.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -1.095 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.43 97.48 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.292 -0.88 . . . . 0.0 109.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.89 100.67 12.5 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.521 -0.737 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 27.0 m-70 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.497 ' NH1' ' OG ' ' A' ' 95' ' ' SER . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.486 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.82 -39.83 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -75.21 -36.28 61.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.835 . . . . 0.0 110.185 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -76.95 -38.76 52.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.868 -1.145 . . . . 0.0 109.343 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -160.65 104.63 1.32 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.065 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.71 -20.93 39.59 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.391 1.394 . . . . 0.0 112.99 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.28 4.77 52.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.864 -1.147 . . . . 0.0 109.532 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -100.45 12.1 37.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.324 -0.86 . . . . 0.0 109.805 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.35 99.37 50.29 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.503 -0.748 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.81 156.55 3.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.327 2.018 . . . . 0.0 112.239 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.405 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.405 ' OE1' ' OH ' ' A' ' 102' ' ' TYR . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.533 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.533 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.566 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.56 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.56 HE21 ' C ' ' A' ' 135' ' ' ASP . 66.0 mm-40 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.88 70.99 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.29 94.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.04 -7.21 56.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.47 70.95 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.12 -22.7 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.11 -178.33 37.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.16 136.8 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.809 2.34 . . . . 0.0 112.224 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 p -167.57 132.7 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.5 -25.01 0.02 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.05 131.6 52.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 -51.12 9.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -162.41 134.71 5.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 131.66 10.74 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.33 -142.98 3.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -165.58 161.67 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 mt -77.73 107.22 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -80.73 -48.85 11.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -79.7 130.52 35.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.46 -20.64 0.33 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mmt-85 -81.53 113.29 19.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -1.12 . . . . 0.0 109.445 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.08 98.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.252 -0.905 . . . . 0.0 108.978 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.14 103.15 15.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.518 -0.739 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.4 m-70 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' NE ' ' CD1' ' A' ' 102' ' ' TYR . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.446 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.23 -40.53 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -76.4 -33.49 58.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 0.0 110.762 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.08 -26.49 36.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.789 -1.194 . . . . 0.0 109.8 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -171.27 91.8 0.44 Allowed Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.71 -17.44 49.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.382 1.388 . . . . 0.0 112.709 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.09 2.81 56.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.912 -1.117 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.06 15.36 29.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.83 99.96 37.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.82 155.82 2.33 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.21 1.94 . . . . 0.0 112.306 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 120' ' ' SER . 2.0 tm0? -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.617 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.557 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 135' ' ' ASP . 68.1 mm-40 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.73 -37.06 2.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.3 Cg_exo -56.09 163.5 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.145 1.897 . . . . 0.0 112.11 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -153.19 40.27 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . -169.23 70.79 0.14 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 21' ' ' GLY . 87.8 Cg_exo -46.28 -179.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.811 2.34 . . . . 0.0 112.25 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.71 -67.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.2 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.796 2.331 . . . . 0.0 111.972 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -164.26 32.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.438 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 179.89 86.31 0.07 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.83 66.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.15 -5.51 54.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -160.82 -168.78 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.8 5.52 0.1 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 32' ' ' SER . . . 57.1 83.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 31' ' ' GLY . 5.6 m -166.41 130.85 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.528 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -68.97 161.34 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.446 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.484 ' HD1' ' H ' ' A' ' 34' ' ' HIS . 27.6 p-80 -79.37 125.54 29.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -63.55 -42.53 98.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.444 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.3 162.69 26.99 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -49.55 146.83 3.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -157.31 125.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.367 -0.833 . . . . 0.0 109.223 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.02 57.15 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.7 m-70 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.494 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt -57.83 -41.8 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -75.79 -31.49 59.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 110.685 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -84.21 -34.79 23.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.844 -1.16 . . . . 0.0 110.177 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -158.58 86.68 2.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.95 -21.65 71.88 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.618 1.545 . . . . 0.0 112.969 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.86 1.27 57.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.823 -1.173 . . . . 0.0 110.067 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.2 m -105.8 17.96 22.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.216 -0.928 . . . . 0.0 109.638 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.22 100.05 52.01 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.364 -0.835 . . . . 0.0 108.866 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.2 155.67 2.87 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.292 1.995 . . . . 0.0 112.564 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 90' ' ' GLY . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.494 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.529 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.62 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.559 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.559 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.5 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.76 152.89 81.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 109.074 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.79 157.35 51.99 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.284 1.989 . . . . 0.0 112.002 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -168.06 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.17 70.53 0.23 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.23 -48.04 13.83 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.24 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.02 60.3 0.03 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.5 -171.99 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.729 2.286 . . . . 0.0 112.028 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 t -165.77 50.76 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.46 -74.75 0.7 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.62 -90.3 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -32.93 58.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.506 ' OE1' ' N ' ' A' ' 30' ' ' GLY . 1.1 tm0? -50.18 136.77 18.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 29' ' ' GLN . . . -176.16 107.31 0.23 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.27 39.53 1.44 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 30' ' ' GLY . 25.3 p -164.42 155.5 15.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.72 137.33 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -169.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.9 m -53.82 -37.92 64.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 38' ' ' ILE . . . 67.53 175.33 8.13 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -56.56 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.357 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 36' ' ' GLY . 20.1 mt -143.55 97.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.248 -0.908 . . . . 0.0 108.988 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.7 102.09 14.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.459 -0.775 . . . . 0.0 109.452 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 17.3 m-70 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.611 HH12 ' HG ' ' A' ' 95' ' ' SER . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.445 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.54 -40.97 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -72.96 -34.5 66.53 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.344 -0.848 . . . . 0.0 110.429 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.03 -38.7 24.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.165 . . . . 0.0 109.948 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.04 102.02 1.58 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.107 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 -18.3 36.52 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.312 1.341 . . . . 0.0 113.085 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -92.9 3.19 56.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.876 -1.14 . . . . 0.0 109.934 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -104.77 16.41 26.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.339 -0.851 . . . . 0.0 109.741 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 100.71 47.37 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 108.966 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.34 156.08 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.09 1.86 . . . . 0.0 111.939 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.611 ' HG ' HH12 ' A' ' 51' ' ' ARG . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.535 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.576 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.552 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.552 HE21 ' C ' ' A' ' 135' ' ' ASP . 71.0 mm-40 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.611 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.9 -36.74 2.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -1.171 . . . . 0.0 110.514 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 82.4 Cg_endo -91.17 143.15 3.14 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.395 2.063 . . . . 0.0 112.176 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 20' ' ' GLU . 24.5 mp0 -50.67 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.62 -60.04 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.69 103.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.83 178.58 46.83 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 26' ' ' GLY . 72.6 Cg_endo -75.26 -161.66 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.74 2.293 . . . . 0.0 112.057 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -74.8 25.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 24' ' ' PRO . . . -78.14 -159.94 14.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.59 75.58 1.8 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -28.12 66.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -72.77 60.68 0.51 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.6 162.41 36.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.52 -68.11 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -166.22 121.26 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.48 -163.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.529 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -167.11 36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -80.37 -144.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.21 -167.18 20.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -153.62 85.72 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.228 -1.16 . . . . 0.0 109.389 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.3 mt -143.56 97.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.168 -0.958 . . . . 0.0 109.015 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.1 107.36 19.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.503 -0.748 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 26.4 m-70 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.04 -42.28 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -76.12 -28.44 57.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.961 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -91.75 -33.31 15.06 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.807 -1.183 . . . . 0.0 110.528 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD2' ' OG ' ' A' ' 75' ' ' SER . 51.6 t0 -162.16 93.25 1.3 Allowed Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.147 -0.97 . . . . 0.0 109.667 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 -19.23 40.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.397 1.398 . . . . 0.0 112.597 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 76' ' ' VAL . 15.4 t70 -86.03 -31.81 21.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.417 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 24.9 m -66.06 9.17 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.826 -1.171 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 74' ' ' ASP . 9.2 p -144.26 101.39 4.8 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.36 162.92 22.32 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.228 1.952 . . . . 0.0 113.857 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.494 HH21 ' CG2' ' A' ' 76' ' ' VAL . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.629 HE21 ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.629 ' N ' HE21 ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.514 ' C ' HE21 ' A' ' 137' ' ' GLN . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 69.0 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.38 149.41 94.87 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.144 -1.209 . . . . 0.0 109.092 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.84 130.26 14.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.173 1.915 . . . . 0.0 111.981 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -79.98 158.88 26.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.32 179.67 45.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.52 17.59 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.705 2.27 . . . . 0.0 112.023 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.19 -71.94 0.22 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.18 154.27 46.61 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.819 2.346 . . . . 0.0 112.005 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.9 p -169.92 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.68 66.44 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.84 8.37 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -44.8 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.442 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -74.03 105.56 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 67.52 1.02 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 95.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -71.6 176.14 5.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.42 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.76 17.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -59.16 139.25 57.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.5 p -168.64 1.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.65 179.68 39.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -169.98 148.61 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -1.094 . . . . 0.0 109.465 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.37 97.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.274 -0.891 . . . . 0.0 109.082 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 91.01 6.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.382 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.1 m-70 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.527 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.493 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.09 -40.9 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.475 HH21 HE22 ' A' ' 107' ' ' GLN . 68.7 mtt180 -70.55 -42.02 71.7 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.438 -0.789 . . . . 0.0 110.306 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.14 -39.83 75.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.806 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -164.81 109.76 0.83 Allowed Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.824 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.99 -19.5 39.71 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.371 1.381 . . . . 0.0 113.079 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.57 3.02 56.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.889 -1.132 . . . . 0.0 109.854 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.5 m -98.99 11.36 39.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -0.983 . . . . 0.0 109.837 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.03 137.99 23.79 Favored Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.78 159.83 24.69 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.82 1.68 . . . . 0.0 112.292 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.425 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.527 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.493 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.61 HE21 ' N ' ' A' ' 120' ' ' SER . 27.1 tp60 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.61 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.514 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.2 mm-40 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.18 67.75 1.25 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -46.04 153.31 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.721 2.281 . . . . 0.0 112.308 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.17 -6.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.15 60.81 0.19 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 152.05 35.0 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.779 2.319 . . . . 0.0 112.034 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.69 70.04 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.32 141.91 9.69 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.78 2.32 . . . . 0.0 112.25 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -161.69 -64.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.555 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 28' ' ' ALA . . . 177.7 -48.07 0.1 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.15 10.88 1.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 30' ' ' GLY . . . -65.8 -4.69 7.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -68.67 45.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.426 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 28' ' ' ALA . . . -75.05 121.82 6.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 30' ' ' GLY . . . 55.4 169.66 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 m -63.64 115.99 5.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -1.189 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -68.84 -38.68 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 35' ' ' SER . 19.8 m-70 -57.28 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 34' ' ' HIS . 60.7 p -58.74 -160.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.3 161.65 27.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -63.4 -173.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 109.436 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.67 100.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.98 113.4 25.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.0 109.241 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 32.3 m-70 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.401 HH22 ' HG ' ' A' ' 95' ' ' SER . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt -58.78 -41.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -75.07 -30.17 60.89 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.427 -0.796 . . . . 0.0 110.847 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -87.29 -36.91 17.63 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.776 -1.202 . . . . 0.0 110.418 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -158.54 88.09 2.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.41 -16.12 45.28 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.653 1.569 . . . . 0.0 112.863 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.86 5.26 52.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.933 -1.105 . . . . 0.0 109.982 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -112.95 20.44 16.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.454 -0.779 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.53 99.24 49.97 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.321 -0.862 . . . . 0.0 109.019 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.7 155.79 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.295 1.997 . . . . 0.0 112.311 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HG ' HH22 ' A' ' 51' ' ' ARG . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.623 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.555 ' C ' HE21 ' A' ' 137' ' ' GLN . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.522 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.8 mm-40 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.74 -37.01 2.6 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 110.535 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 50.0 Cg_exo -55.99 116.24 3.03 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.106 1.871 . . . . 0.0 112.145 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -77.22 -104.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.73 178.55 53.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.32 164.16 33.3 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 111.978 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' SER . . . -160.79 70.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.09 -9.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.825 2.35 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' GLY . 14.8 m -66.13 106.96 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.38 167.45 36.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.82 -35.91 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.16 67.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -1.126 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.68 -88.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 49.92 43.83 40.15 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.19 -103.83 0.18 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -49.75 115.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 pt -80.99 2.19 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -169.66 -26.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -77.52 169.91 17.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 37.07 0.5 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -70.4 157.06 38.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.32 97.72 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.214 -0.929 . . . . 0.0 108.983 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' C ' ' HZ1' ' A' ' 116' ' ' LYS . . . -93.2 104.6 16.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.759 . . . . 0.0 109.452 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.7 m-70 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -66.46 -42.19 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -75.87 -54.74 6.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.389 -0.819 . . . . 0.0 109.99 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -56.97 -34.03 67.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.329 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.99 89.05 1.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 109.808 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.73 -16.23 47.38 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.43 1.42 . . . . 0.0 112.795 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -93.46 3.51 55.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.895 -1.128 . . . . 0.0 109.783 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -105.3 17.17 24.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.738 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.2 99.87 36.74 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.15 170.02 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.626 1.55 . . . . 0.0 111.822 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.541 ' HZ1' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.541 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.501 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HZ1' ' C ' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 83' ' ' TRP . 29.7 tp60 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.522 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.464 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.6 mm-40 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.57 152.82 5.85 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.128 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.65 14.41 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.292 1.995 . . . . 0.0 111.933 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -61.7 -161.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.08 169.94 54.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.15 -91.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.753 2.302 . . . . 0.0 111.977 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.52 -63.16 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -43.5 106.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.746 2.297 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -68.77 -9.89 53.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.34 -170.37 0.16 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 67.44 0.93 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.18 -37.71 37.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.506 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -73.08 -71.39 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.48 146.91 46.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 86.74 0.06 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -79.48 142.99 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.444 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.8 tt -79.41 -37.12 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' O ' ' N ' ' A' ' 36' ' ' GLY . 38.3 m80 -50.91 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.1 t -49.93 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . -167.33 -134.78 1.75 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -170.06 175.7 4.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.8 mt -143.47 99.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.238 -0.914 . . . . 0.0 109.003 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.56 107.47 12.46 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.1 m-70 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' OG1' ' A' ' 68' ' ' THR . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 64' ' ' SER . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 50.0 mtt-85 -75.56 -32.8 60.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -84.57 -36.24 22.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.953 -1.092 . . . . 0.0 110.103 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -152.08 85.12 4.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.36 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.83 -15.77 40.14 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.514 1.476 . . . . 0.0 112.672 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.77 1.18 57.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.916 -1.115 . . . . 0.0 109.899 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.9 16.61 25.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.11 100.54 8.71 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo -80.79 158.44 21.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.952 1.768 . . . . 0.0 113.593 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.47 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.453 ' NH2' ' O ' ' A' ' 77' ' ' PRO . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.595 HE21 ' N ' ' A' ' 120' ' ' SER . 26.0 tp60 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.595 ' N ' HE21 ' A' ' 119' ' ' GLN . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 137' ' ' GLN . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.59 60.32 0.44 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.68 80.17 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.732 2.288 . . . . 0.0 112.012 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -51.8 -25.33 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.06 172.0 42.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 152.73 39.79 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.782 2.322 . . . . 0.0 111.965 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.35 -59.88 3.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 134.07 13.77 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.71 2.274 . . . . 0.0 112.275 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.9 t -168.28 66.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.78 -51.71 0.31 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.83 167.43 23.17 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -44.8 24.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -1.097 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -162.66 2.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.75 -47.75 7.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.71 -101.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m -165.26 139.59 4.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -1.194 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -74.69 -29.58 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -56.59 95.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.507 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -165.17 83.42 0.37 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 0.0 109.401 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.22 118.92 0.83 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 11.4 mpt_? -67.2 112.81 4.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.306 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.25 97.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.45 103.8 15.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.528 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -59.83 -41.09 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.573 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -85.99 -30.0 23.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.909 -1.119 . . . . 0.0 110.045 -179.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.87 87.12 2.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.094 -1.004 . . . . 0.0 109.524 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.97 -28.93 87.05 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.74 1.627 . . . . 0.0 113.331 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 76' ' ' VAL . 2.5 p30 -82.56 -33.15 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.739 -1.226 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 m -68.7 13.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 74' ' ' ASP . 2.1 t -113.74 97.41 44.23 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.287 -0.883 . . . . 0.0 108.808 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.64 156.21 3.19 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.373 2.049 . . . . 0.0 112.34 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 97' ' ' GLY . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.66 HE21 ' N ' ' A' ' 120' ' ' SER . 24.9 tp60 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.66 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.523 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.14 152.85 82.23 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -1.133 . . . . 0.0 109.119 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.69 -176.89 2.51 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.945 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -165.81 90.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.27 60.34 4.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.55 93.96 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.784 2.323 . . . . 0.0 112.021 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.89 -69.16 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 87.92 1.31 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.766 2.31 . . . . 0.0 111.935 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.2 p -169.17 -39.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.85 -140.55 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 29' ' ' GLN . . . -161.1 -51.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.69 -4.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.149 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 27' ' ' GLY . 24.7 tp60 -65.53 150.04 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.25 7.69 88.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.52 -9.83 39.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 p -175.53 145.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -1.191 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.8 -176.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -79.1 -46.0 18.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.2 p -161.2 178.53 9.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.76 -10.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -71.6 131.87 43.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 109.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.41 97.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.111 -0.993 . . . . 0.0 108.942 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.5 92.11 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 15.3 m-70 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 3.1 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 68' ' ' THR . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.76 -42.98 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -75.46 -33.74 60.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.274 -0.891 . . . . 0.0 110.72 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -33.24 22.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.89 93.06 1.35 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.63 -20.09 48.58 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.362 1.375 . . . . 0.0 112.676 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 76' ' ' VAL . 22.7 t70 -85.33 -30.85 23.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.122 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -66.75 9.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.881 -1.137 . . . . 0.0 110.093 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 74' ' ' ASP . 9.5 p -146.67 100.89 4.0 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.99 159.83 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.251 1.967 . . . . 0.0 113.793 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.509 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.615 HE21 ' N ' ' A' ' 120' ' ' SER . 30.2 tp60 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.615 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.534 ' H ' ' HG1' ' A' ' 133' ' ' THR . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.625 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.84 -37.21 2.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.266 -1.137 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.9 Cg_exo -56.01 97.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.086 1.857 . . . . 0.0 112.151 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 21' ' ' GLY . 7.2 tm-20 -76.33 146.05 39.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' N ' ' OE2' ' A' ' 20' ' ' GLU . . . 78.86 68.24 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.22 94.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.782 2.321 . . . . 0.0 112.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.53 170.62 28.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' O ' ' OG ' ' A' ' 25' ' ' SER . 73.0 Cg_endo -75.36 -55.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.761 2.307 . . . . 0.0 111.97 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 24' ' ' PRO . 28.4 m -169.99 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.95 -64.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.21 -154.21 51.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.06 -33.97 65.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -1.131 . . . . 0.0 109.449 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.45 -66.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.337 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.6 38.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 106.73 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 m -68.85 126.18 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -1.129 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 33' ' ' ILE . 96.4 mt -50.95 -23.34 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -74.36 117.43 16.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 m -163.56 -25.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.14 -77.01 0.18 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' NH1' ' CG ' ' A' ' 119' ' ' GLN . 9.9 tpp180 -79.54 137.59 37.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.13 . . . . 0.0 109.393 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.65 98.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.23 -0.919 . . . . 0.0 109.018 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.22 113.76 27.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.5 m-70 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.497 ' OG ' ' SG ' ' A' ' 99' ' ' CYS . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.2 mt-30 -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt -59.44 -40.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.16 -35.55 61.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.16 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.86 -35.85 32.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.92 -1.113 . . . . 0.0 109.883 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -159.18 101.59 1.56 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 0.0 108.903 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -22.8 29.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.545 1.497 . . . . 0.0 113.443 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -92.67 2.28 56.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.715 -1.24 . . . . 0.0 110.084 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -99.77 10.61 41.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.195 -0.941 . . . . 0.0 110.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.86 97.72 42.64 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.332 -0.855 . . . . 0.0 108.835 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.15 155.65 4.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.336 2.024 . . . . 0.0 112.221 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.524 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' SG ' ' OG ' ' A' ' 55' ' ' SER . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.599 HE21 ' N ' ' A' ' 120' ' ' SER . 30.3 tp60 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.599 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.55 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.55 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.46 -0.57 . . . . 0.40999999999999998 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 0.35999999999999999 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 0.29999999999999999 108.849 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.25 109.85 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.3700000000000001 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 0.20999999999999999 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.17999999999999999 113.648 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 0.17999999999999999 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 0.44 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 0.92000000000000004 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' CG1' ' A' ' 44' ' ' VAL . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 1.47 109.305 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 50' ' ' ILE . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 0.29999999999999999 108.493 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 6.0599999999999996 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 0.22 111.98 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 1.98 108.447 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 0.33000000000000002 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.27 109.585 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 1.4199999999999999 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.97999999999999998 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 0.63 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 0.72999999999999998 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 1.5900000000000001 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.22 108.587 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.5699999999999998 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.71 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 0.42999999999999999 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.25 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.3900000000000001 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.26000000000000001 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.25 109.21 179.797 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.495 1.609 0 CA-C-O 120.618 0.174 . . . . 0.64000000000000001 112.054 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 0.67000000000000004 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 0.23000000000000001 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 0.16 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.17999999999999999 108.927 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.14999999999999999 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.51000000000000001 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.10000000000000001 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 0.20000000000000001 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 137' ' ' GLN . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 0.33000000000000002 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.20999999999999999 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 0.14999999999999999 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.6599999999999999 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 1.55 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 0.77000000000000002 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.79000000000000004 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 0.20000000000000001 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 1.6899999999999999 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.10000000000000001 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 0.14000000000000001 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.89000000000000001 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.29999999999999999 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 0.85999999999999999 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.0700000000000001 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.17000000000000001 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.089999999999999997 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 1.3400000000000001 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.4399999999999999 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.35999999999999999 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2000000000000002 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.1200000000000001 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.25 110.716 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 0.34999999999999998 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 0.57999999999999996 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.23999999999999999 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 1.6699999999999999 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 0.14999999999999999 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 1.4399999999999999 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.0899999999999999 108.909 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.12 109.843 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 0.23999999999999999 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 1.3400000000000001 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 0.46000000000000002 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 125' ' ' LEU . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 0.23000000000000001 108.851 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.0 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 0.34000000000000002 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.0800000000000001 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.46000000000000002 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.28999999999999998 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 0.22 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.5 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.13 109.557 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.16 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 0.19 110.456 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 88' ' ' GLN . 14.8 mm100 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54000000000000004 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.322 0.582 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.569 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' SG ' ' A' ' 99' ' ' CYS . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 69' ' ' ILE . 16.5 mt . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.497 1.692 0 CA-C-O 120.796 0.248 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 109' ' ' GLN . 0.8 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.471 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.471 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 88' ' ' GLN . 15.5 mm100 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.272 0.558 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.643 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.473 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 58' ' ' ASP . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 111.585 -0.198 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 112' ' ' THR . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 N-CA-C 113.332 0.474 . . . . 0.0 113.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' GLN . 49.5 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 99' ' ' CYS . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 58' ' ' ASP . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 113.564 0.563 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 12.3 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.477 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.477 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 112' ' ' THR . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD21 ' CG1' ' A' ' 44' ' ' VAL . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 53' ' ' LEU . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ASP . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 CA-C-O 120.848 0.27 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 57' ' ' LEU . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 112' ' ' THR . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.509 HD13 HH21 ' A' ' 51' ' ' ARG . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.509 HH21 HD13 ' A' ' 49' ' ' LEU . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 99' ' ' CYS . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 N--CA 1.493 1.486 0 CA-C-O 121.163 0.401 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.636 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 112.644 0.209 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.513 ' SG ' HD21 ' A' ' 57' ' ' LEU . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.476 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.476 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 112' ' ' THR . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 50' ' ' ILE . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.61 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.587 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 99' ' ' CYS . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 CA-C-O 120.755 0.231 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 88' ' ' GLN . 17.5 mm100 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.234 0.54 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.565 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.565 ' CG ' HD11 ' A' ' 49' ' ' LEU . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.722 0.217 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 112' ' ' THR . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.401 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 58' ' ' ASP . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.784 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 107' ' ' GLN . 12.3 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 125' ' ' LEU . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 50' ' ' ILE . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 58' ' ' ASP . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.673 0.197 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.64 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.428 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.428 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 125' ' ' LEU . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 112' ' ' THR . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 HH22 ' A' ' 51' ' ' ARG . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.501 HH22 HD13 ' A' ' 49' ' ' LEU . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.599 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' PRO . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HA ' HG22 ' A' ' 112' ' ' THR . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.755 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 49' ' ' LEU . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.546 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.586 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 58' ' ' ASP . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.494 1.509 0 CA-C-O 120.806 0.252 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.546 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 108' ' ' LEU . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.628 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' LEU . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.588 0.162 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 45' ' ' PRO . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.474 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB1' ' HZ2' ' A' ' 116' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.432 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 120.865 0.277 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.637 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 45' ' ' PRO . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.516 ' HZ2' ' HB1' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 112' ' ' THR . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 58' ' ' ASP . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 68' ' ' THR . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 N-CA-C 113.593 0.574 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.453 ' NH2' ' O ' ' A' ' 77' ' ' PRO . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 45' ' ' PRO . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 125' ' ' LEU . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.644 ' HA ' HG22 ' A' ' 112' ' ' THR . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.727 HD12 ' C ' ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' LEU . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.71 0.213 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 57' ' ' LEU . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' OE1' ' N ' ' A' ' 120' ' ' SER . 7.1 tp-100 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.402 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 122' ' ' LEU . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 49' ' ' LEU . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 112' ' ' THR . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 44' ' ' VAL . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.648 ' O ' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 99' ' ' CYS . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 N-CA-C 113.793 0.651 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 50' ' ' ILE . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' LEU . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' A' ' 99' ' ' CYS . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 58' ' ' ASP . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.635 0.181 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.512 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.512 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 125' ' ' LEU . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.476 -1.45 . . . . 29.399999999999999 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 152.88 92.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 27.34 109.13 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.78 71.29 3.36 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.259 1.972 . . . . 24.43 111.91 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.28 151.34 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 24.879999999999999 109.422 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.77 -59.68 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.502 -1.439 . . . . 19.43 109.502 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.09 160.21 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.79 2.327 . . . . 16.870000000000001 112.183 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.21 68.9 1.51 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.463 -1.455 . . . . 17.260000000000002 109.463 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.15 -20.08 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.781 2.321 . . . . 17.59 112.306 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -161.34 -152.28 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 19.600000000000001 109.48 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.6 71.05 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.437 . . . . 21.199999999999999 109.506 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.66 -33.55 0.32 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 20.460000000000001 109.517 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.22 -14.82 59.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 19.219999999999999 109.459 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -54.05 142.18 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.911 . . . . 19.93 109.473 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.29 85.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.387 -1.485 . . . . 15.539999999999999 109.387 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.18 52.31 42.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.384 -1.486 . . . . 13.539999999999999 109.384 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -79.9 129.08 34.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 12.029999999999999 109.513 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.7 mp -78.94 123.87 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 9.3699999999999992 109.194 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 34.6 t60 -65.2 153.75 40.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 8.0500000000000007 109.473 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -67.91 58.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 6.8300000000000001 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . 61.81 159.61 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 2.3300000000000001 109.428 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -71.98 136.39 46.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -1.159 . . . . 2.7799999999999998 109.459 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -143.5 98.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -0.926 . . . . 0.56000000000000005 109.013 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.6 97.71 10.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.40999999999999998 109.46 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 0.35999999999999999 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 0.29999999999999999 108.849 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.25 109.85 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.3700000000000001 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 0.20999999999999999 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.17999999999999999 113.648 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 0.17999999999999999 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 0.44 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 0.92000000000000004 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' CG1' ' A' ' 44' ' ' VAL . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 1.47 109.305 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 50' ' ' ILE . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 0.29999999999999999 108.493 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 6.0599999999999996 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 0.22 111.98 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 1.98 108.447 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 0.33000000000000002 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.27 109.585 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 1.4199999999999999 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.97999999999999998 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 0.63 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 0.72999999999999998 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 1.5900000000000001 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.22 108.587 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.5699999999999998 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.71 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 0.42999999999999999 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.25 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.3900000000000001 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.26000000000000001 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt -62.11 -40.23 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.25 109.21 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -75.25 -36.5 61.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 1.97 110.175 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -77.31 -37.5 52.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.091 . . . . 1.9399999999999999 109.706 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.44 104.4 1.21 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.905 . . . . 2.3300000000000001 109.126 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.08 -19.48 39.31 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.359 1.373 . . . . 0.32000000000000001 112.973 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.72 4.04 54.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.845 -1.159 . . . . 2.5800000000000001 109.788 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 t -102.26 13.76 33.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.77000000000000002 109.826 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.48 98.98 45.8 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.399 -0.813 . . . . 0.33000000000000002 109.111 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.04 156.1 3.85 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.227 1.951 . . . . 0.64000000000000001 112.054 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 0.67000000000000004 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 0.23000000000000001 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 0.16 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.17999999999999999 108.927 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.14999999999999999 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.51000000000000001 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.10000000000000001 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 0.20000000000000001 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 137' ' ' GLN . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 0.33000000000000002 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.20999999999999999 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 0.14999999999999999 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.6599999999999999 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 1.55 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 0.77000000000000002 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.79000000000000004 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 0.20000000000000001 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 1.6899999999999999 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.10000000000000001 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 0.14000000000000001 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.89000000000000001 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.29999999999999999 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 0.85999999999999999 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.0700000000000001 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.17000000000000001 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.089999999999999997 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 1.3400000000000001 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.4399999999999999 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.58999999999999997 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.35999999999999999 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2000000000000002 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.1200000000000001 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.25 110.716 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 0.34999999999999998 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 0.57999999999999996 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.23999999999999999 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 1.6699999999999999 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 0.14999999999999999 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 1.4399999999999999 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.0899999999999999 108.909 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.12 109.843 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 0.23999999999999999 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 1.3400000000000001 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 0.46000000000000002 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 125' ' ' LEU . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 0.23000000000000001 108.851 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.0 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 0.34000000000000002 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.0800000000000001 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.46000000000000002 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.28999999999999998 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 0.22 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.5 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.13 109.557 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.16 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 0.19 110.456 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 88' ' ' GLN . 14.8 mm100 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54000000000000004 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.9 152.76 93.09 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.249 -1.147 . . . . 0.0 109.17 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.66 107.65 2.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.346 2.031 . . . . 0.0 111.967 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -51.21 -46.36 62.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.86 -67.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.18 110.03 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.999 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.07 178.44 0.21 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 72.21 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.816 2.344 . . . . 0.0 111.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 9.7 t -64.07 -174.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -65.21 146.64 50.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.0 144.52 4.05 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.05 79.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -1.128 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -60.51 174.28 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 31' ' ' GLY . . . -169.89 -12.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 30' ' ' GLY . . . 168.44 108.64 0.21 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -161.28 134.49 6.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 15.3 pt -64.19 155.74 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' SER . 18.2 m80 -67.9 56.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' ILE . 40.2 t -58.03 -162.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -161.14 55.01 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -161.77 77.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -1.151 . . . . 0.0 109.423 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.26 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 106.07 18.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 109.532 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.569 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' SG ' ' A' ' 99' ' ' CYS . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 69' ' ' ILE . 16.5 mt -60.23 -41.36 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 58.7 mtt180 -71.87 -39.4 69.67 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.302 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -75.31 -38.79 60.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -160.48 105.18 1.34 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.184 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.92 -18.51 40.98 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.343 1.362 . . . . 0.0 112.882 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.75 5.07 52.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.866 -1.146 . . . . 0.0 109.49 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.8 t -103.34 14.84 30.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.57 98.88 30.91 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.377 -0.827 . . . . 0.0 109.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.8 156.19 3.44 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.235 1.956 . . . . 0.0 112.21 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 109' ' ' GLN . 0.8 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.471 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.471 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 88' ' ' GLN . 15.5 mm100 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.13 60.41 0.62 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.71 70.25 5.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.738 2.292 . . . . 0.0 112.001 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -170.04 32.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.68 -69.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.56 68.82 6.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.722 2.282 . . . . 0.0 111.939 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.01 170.67 53.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.26 15.76 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.744 2.296 . . . . 0.0 111.986 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t -160.89 -38.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.9 -161.89 34.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.07 -32.2 0.36 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.39 -6.0 45.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.9 mt-30 -153.22 29.79 0.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.356 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.62 -83.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -162.23 -79.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -160.75 140.06 10.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.07 -21.89 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -167.32 107.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.2 p -80.32 176.76 9.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.15 85.5 0.23 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -80.6 107.94 13.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -1.152 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.0 mt -143.34 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 108.888 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.02 88.15 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.579 -0.701 . . . . 0.0 109.546 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.643 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.473 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 58' ' ' ASP . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -64.93 -40.2 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.0 mtp85 -75.49 -38.04 59.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -76.52 -38.7 54.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -158.17 100.62 1.75 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 109.203 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.79 -14.34 32.75 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.31 1.34 . . . . 0.0 112.905 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.86 -25.53 23.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.976 -1.078 . . . . 0.0 110.637 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -82.91 20.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.45 98.8 52.14 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.29 -0.881 . . . . 0.0 109.101 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -54.47 171.89 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.003 1.802 . . . . 0.0 111.585 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.88 152.93 96.54 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.116 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.8 77.35 2.29 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.296 1.997 . . . . 0.0 111.922 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -58.77 -46.9 86.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.08 60.3 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.55 106.95 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.003 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -171.7 42.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.14 135.57 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.808 2.338 . . . . 0.0 112.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 p -77.55 133.41 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -52.79 119.54 10.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -61.42 -149.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.61 75.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -52.42 152.43 3.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.79 -97.46 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.36 158.57 26.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 p -175.78 149.27 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tp -161.23 132.83 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.268 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -82.48 75.64 9.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -166.12 141.04 4.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -52.94 -48.2 58.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 36' ' ' GLY . 31.5 ptt180 -51.81 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.32 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.61 97.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.237 -0.914 . . . . 0.0 109.094 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.14 112.83 25.91 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 112' ' ' THR . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.673 HD12 ' C ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt -68.76 -39.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -75.49 -55.36 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.636 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.7 -34.19 37.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.061 . . . . 0.0 109.541 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -171.76 109.19 0.38 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.388 -0.82 . . . . 0.0 108.791 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.79 -6.7 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.324 1.349 . . . . 0.0 112.65 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -92.01 -0.83 57.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.035 . . . . 0.0 110.007 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -101.77 18.01 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.63 100.13 5.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.18 162.89 22.8 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.891 1.727 . . . . 0.0 113.332 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' GLN . 49.5 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.14 152.82 5.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -1.159 . . . . 0.0 109.098 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLY . 65.7 Cg_endo -72.4 -19.95 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.358 2.039 . . . . 0.0 111.93 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 24.3 mp0 -65.07 3.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' PRO . . . 79.03 177.64 49.97 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.71 -89.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.745 2.297 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.62 60.51 0.33 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.91 -161.12 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.711 2.274 . . . . 0.0 111.957 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 m -77.58 166.52 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.94 65.66 3.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.07 -3.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.49 43.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -78.95 -41.11 30.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.93 -153.61 4.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.31 116.97 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 9.4 p -175.53 149.82 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.52 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.724 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.8 mp -79.55 106.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.201 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.485 ' CE1' ' O ' ' A' ' 32' ' ' SER . 5.6 m80 -79.93 63.85 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 34' ' ' HIS . 19.7 m -166.18 155.3 11.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.476 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.98 29.98 58.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -170.12 143.89 2.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.2 mt -143.54 97.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 108.982 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.68 119.29 38.15 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 99' ' ' CYS . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 58' ' ' ASP . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.27 -40.96 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -75.95 -48.83 19.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.369 -0.832 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.01 -34.06 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.064 -1.022 . . . . 0.0 110.405 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' OD1' ' OD2' ' A' ' 74' ' ' ASP . 45.4 t0 -156.15 87.54 2.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 0.0 109.84 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.4 -15.78 43.06 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.544 1.496 . . . . 0.0 112.85 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD2' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -93.29 4.47 53.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.867 -1.145 . . . . 0.0 109.644 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -104.63 15.68 27.52 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.365 -0.834 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 HH21 ' A' ' 101' ' ' ARG . 1.9 t -138.07 101.0 8.61 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.57 166.78 26.72 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.551 1.501 . . . . 0.0 113.564 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.702 HH21 HG12 ' A' ' 76' ' ' VAL . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 12.3 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.477 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.477 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.87 -37.07 2.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.263 -1.139 . . . . 0.0 110.467 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.0 Cg_exo -56.12 -30.44 79.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.12 1.88 . . . . 0.0 112.112 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -56.22 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.69 178.69 9.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.2 -43.19 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.748 2.299 . . . . 0.0 111.978 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.16 34.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.99 12.12 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.826 2.351 . . . . 0.0 112.016 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -160.87 10.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.24 -14.19 82.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.91 54.4 4.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.03 -10.77 59.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 24.9 mp0 -79.48 -170.39 2.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.21 151.4 6.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.07 50.96 0.2 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -160.36 115.72 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.99 -3.74 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 0.0 109.471 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -160.37 105.36 1.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -81.37 -175.95 5.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -80.13 -95.74 0.36 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -52.23 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.1 . . . . 0.0 109.722 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.53 97.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.232 -0.917 . . . . 0.0 109.076 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.67 34.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.574 -0.704 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 112' ' ' THR . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD21 ' CG1' ' A' ' 44' ' ' VAL . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 53' ' ' LEU . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ASP . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt -61.21 -41.17 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -69.41 -55.29 10.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -56.1 -42.13 76.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 109.788 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -161.42 109.36 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 109.29 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.5 -22.45 38.67 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.303 1.335 . . . . 0.0 113.138 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 15.2 t70 -92.98 6.76 46.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.6 p -97.3 5.89 49.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 110.138 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.42 137.05 23.25 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 160.12 23.9 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.847 1.698 . . . . 0.0 112.182 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 57' ' ' LEU . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.462 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.98 149.41 80.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.087 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 72.1 3.7 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.224 1.949 . . . . 0.0 111.932 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.54 178.81 1.16 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.56 -169.85 37.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.16 -66.89 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.733 2.288 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.98 60.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.48 -167.21 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.708 2.272 . . . . 0.0 112.004 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 31.5 t -169.08 -163.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.468 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -172.48 -19.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 -133.39 1.86 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -4.02 13.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -1.162 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -65.6 158.1 28.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.19 -60.57 3.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.01 73.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 m -69.17 128.12 35.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -78.02 61.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 34' ' ' HIS . 16.2 t-80 -160.32 2.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -49.79 -48.69 50.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.98 -30.5 0.39 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -79.65 114.26 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.167 . . . . 0.0 109.377 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.39 97.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.157 -0.964 . . . . 0.0 108.937 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 96.23 10.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.535 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 112' ' ' THR . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.509 HD13 HH21 ' A' ' 51' ' ' ARG . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.509 HH21 HD13 ' A' ' 49' ' ' LEU . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 99' ' ' CYS . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -66.36 -41.74 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -75.02 -39.65 60.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.348 -0.845 . . . . 0.0 109.996 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -74.3 -37.39 63.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.01 -1.056 . . . . 0.0 109.718 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -160.28 102.53 1.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.218 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -18.29 37.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.32 1.347 . . . . 0.0 112.897 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.59 3.17 56.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 0.0 109.752 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -102.24 15.4 29.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.257 -0.902 . . . . 0.0 109.616 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -125.89 103.62 27.28 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.43 162.72 41.38 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.354 1.369 . . . . 0.0 112.698 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.636 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.0 60.4 0.55 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.611 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.63 -176.62 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 112.008 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' A' ' 21' ' ' GLY . 8.5 pt-20 -164.84 -7.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 20' ' ' GLU . . . -53.42 -59.88 8.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.89 145.29 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.94 -59.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.85 -65.69 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.736 2.291 . . . . 0.0 112.235 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -77.35 -77.72 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.53 -39.89 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.38 -147.54 5.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.53 72.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -164.79 -30.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.371 -0.831 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.87 23.82 0.25 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.24 -33.93 1.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -52.12 149.53 5.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -1.157 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' HIS . 16.1 tt -169.71 -40.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 32.6 m80 -79.8 -140.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 p -169.73 71.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.23 39.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -170.04 140.98 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -1.122 . . . . 0.0 109.388 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.61 98.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.232 -0.918 . . . . 0.0 109.086 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.98 106.57 18.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.336 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt -59.88 -43.08 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -70.44 -59.27 2.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 1.3 mp0 -50.76 -34.09 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -171.25 107.89 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.366 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.18 -14.65 31.75 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.377 1.385 . . . . 0.0 112.941 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.59 3.17 56.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.132 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.7 m -103.32 17.0 25.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.29 -0.881 . . . . 0.0 109.664 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG12 HH21 ' A' ' 101' ' ' ARG . 2.2 t -128.91 98.74 23.57 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.316 -0.865 . . . . 0.0 108.922 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.76 155.45 3.94 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.396 2.064 . . . . 0.0 112.644 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.513 ' SG ' HD21 ' A' ' 57' ' ' LEU . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.61 HH21 HG12 ' A' ' 76' ' ' VAL . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.476 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.476 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.33 60.27 0.45 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.172 -1.193 . . . . 0.0 109.546 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.45 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.823 2.349 . . . . 0.0 112.023 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.37 127.69 32.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 173.19 38.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 -164.39 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.788 2.325 . . . . 0.0 112.02 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.55 70.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.12 -38.49 19.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.819 2.346 . . . . 0.0 112.2 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.6 m -162.98 -26.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 109.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.88 -144.2 4.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.7 42.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.04 -13.26 59.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.473 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -71.2 64.56 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.27 62.49 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.34 -158.66 1.32 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -78.86 160.8 27.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.5 -178.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.77 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 t -71.41 105.17 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.77 158.75 29.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -170.15 144.2 2.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -1.095 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.43 97.48 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.292 -0.88 . . . . 0.0 109.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.89 100.67 12.5 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.521 -0.737 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 112' ' ' THR . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 50' ' ' ILE . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.61 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.587 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 99' ' ' CYS . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.82 -39.83 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -75.21 -36.28 61.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.835 . . . . 0.0 110.185 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -76.95 -38.76 52.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.868 -1.145 . . . . 0.0 109.343 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -160.65 104.63 1.32 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.065 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.71 -20.93 39.59 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.391 1.394 . . . . 0.0 112.99 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.28 4.77 52.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.864 -1.147 . . . . 0.0 109.532 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -100.45 12.1 37.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.324 -0.86 . . . . 0.0 109.805 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.35 99.37 50.29 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.503 -0.748 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.81 156.55 3.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.327 2.018 . . . . 0.0 112.239 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 88' ' ' GLN . 17.5 mm100 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.88 70.99 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.29 94.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.04 -7.21 56.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.47 70.95 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.12 -22.7 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.11 -178.33 37.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.16 136.8 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.809 2.34 . . . . 0.0 112.224 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 p -167.57 132.7 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.5 -25.01 0.02 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.05 131.6 52.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 -51.12 9.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -162.41 134.71 5.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 131.66 10.74 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.33 -142.98 3.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -165.58 161.67 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 mt -77.73 107.22 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -80.73 -48.85 11.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -79.7 130.52 35.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.46 -20.64 0.33 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mmt-85 -81.53 113.29 19.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -1.12 . . . . 0.0 109.445 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.08 98.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.252 -0.905 . . . . 0.0 108.978 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.14 103.15 15.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.518 -0.739 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.565 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.565 ' CG ' HD11 ' A' ' 49' ' ' LEU . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.23 -40.53 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -76.4 -33.49 58.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 0.0 110.762 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.08 -26.49 36.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.789 -1.194 . . . . 0.0 109.8 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -171.27 91.8 0.44 Allowed Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.71 -17.44 49.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.382 1.388 . . . . 0.0 112.709 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.09 2.81 56.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.912 -1.117 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.06 15.36 29.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.83 99.96 37.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.82 155.82 2.33 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.21 1.94 . . . . 0.0 112.306 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.73 -37.06 2.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.3 Cg_exo -56.09 163.5 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.145 1.897 . . . . 0.0 112.11 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -153.19 40.27 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . -169.23 70.79 0.14 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 21' ' ' GLY . 87.8 Cg_exo -46.28 -179.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.811 2.34 . . . . 0.0 112.25 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.71 -67.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.2 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.796 2.331 . . . . 0.0 111.972 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -164.26 32.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.438 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 179.89 86.31 0.07 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.83 66.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.15 -5.51 54.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -160.82 -168.78 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.8 5.52 0.1 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 32' ' ' SER . . . 57.1 83.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 31' ' ' GLY . 5.6 m -166.41 130.85 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.528 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -68.97 161.34 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.446 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -79.37 125.54 29.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -63.55 -42.53 98.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.444 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.3 162.69 26.99 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 38' ' ' ILE . 22.9 ptt180 -49.55 146.83 3.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 0.0 109.502 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 37' ' ' ARG . 5.8 pt -157.31 125.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.367 -0.833 . . . . 0.0 109.223 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.02 57.15 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.7 m-70 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 112' ' ' THR . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.401 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 58' ' ' ASP . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt -57.83 -41.8 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -75.79 -31.49 59.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 110.685 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -84.21 -34.79 23.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.844 -1.16 . . . . 0.0 110.177 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -158.58 86.68 2.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.95 -21.65 71.88 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.618 1.545 . . . . 0.0 112.969 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.86 1.27 57.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.823 -1.173 . . . . 0.0 110.067 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.2 m -105.8 17.96 22.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.216 -0.928 . . . . 0.0 109.638 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.22 100.05 52.01 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.364 -0.835 . . . . 0.0 108.866 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.2 155.67 2.87 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.292 1.995 . . . . 0.0 112.564 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 107' ' ' GLN . 12.3 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 125' ' ' LEU . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.76 152.89 81.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 109.074 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.79 157.35 51.99 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.284 1.989 . . . . 0.0 112.002 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' GLY . 50.8 tt0 -168.06 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' GLU . . . -161.17 70.53 0.23 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.23 -48.04 13.83 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.24 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.02 60.3 0.03 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.5 -171.99 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.729 2.286 . . . . 0.0 112.028 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 t -165.77 50.76 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.46 -74.75 0.7 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.62 -90.3 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -32.93 58.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.506 ' OE1' ' N ' ' A' ' 30' ' ' GLY . 1.1 tm0? -50.18 136.77 18.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 29' ' ' GLN . . . -176.16 107.31 0.23 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.27 39.53 1.44 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' GLY . 25.3 p -164.42 155.5 15.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.72 137.33 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -169.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 38' ' ' ILE . 36.9 m -53.82 -37.92 64.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 38' ' ' ILE . . . 67.53 175.33 8.13 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -56.56 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.357 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 36' ' ' GLY . 20.1 mt -143.55 97.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.248 -0.908 . . . . 0.0 108.988 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.7 102.09 14.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.459 -0.775 . . . . 0.0 109.452 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 50' ' ' ILE . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 58' ' ' ASP . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.54 -40.97 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -72.96 -34.5 66.53 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.344 -0.848 . . . . 0.0 110.429 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.03 -38.7 24.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.165 . . . . 0.0 109.948 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.04 102.02 1.58 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.107 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 -18.3 36.52 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.312 1.341 . . . . 0.0 113.085 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -92.9 3.19 56.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.876 -1.14 . . . . 0.0 109.934 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -104.77 16.41 26.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.339 -0.851 . . . . 0.0 109.741 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 100.71 47.37 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 108.966 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.34 156.08 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.09 1.86 . . . . 0.0 111.939 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.64 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.428 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.428 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 125' ' ' LEU . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.611 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.9 -36.74 2.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -1.171 . . . . 0.0 110.514 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 82.4 Cg_endo -91.17 143.15 3.14 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.395 2.063 . . . . 0.0 112.176 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 24.5 mp0 -50.67 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.62 -60.04 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.69 103.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.83 178.58 46.83 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 26' ' ' GLY . 72.6 Cg_endo -75.26 -161.66 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.74 2.293 . . . . 0.0 112.057 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -74.8 25.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 24' ' ' PRO . . . -78.14 -159.94 14.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.59 75.58 1.8 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -28.12 66.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -72.77 60.68 0.51 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.6 162.41 36.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.52 -68.11 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -166.22 121.26 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.48 -163.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.529 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -167.11 36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -80.37 -144.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.21 -167.18 20.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -153.62 85.72 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.228 -1.16 . . . . 0.0 109.389 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.3 mt -143.56 97.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.168 -0.958 . . . . 0.0 109.015 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.1 107.36 19.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.503 -0.748 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 112' ' ' THR . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 HH22 ' A' ' 51' ' ' ARG . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.501 HH22 HD13 ' A' ' 49' ' ' LEU . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.599 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.04 -42.28 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -76.12 -28.44 57.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.961 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -91.75 -33.31 15.06 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.807 -1.183 . . . . 0.0 110.528 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD2' ' OG ' ' A' ' 75' ' ' SER . 51.6 t0 -162.16 93.25 1.3 Allowed Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.147 -0.97 . . . . 0.0 109.667 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 -19.23 40.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.397 1.398 . . . . 0.0 112.597 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' VAL . 15.4 t70 -86.03 -31.81 21.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.417 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 24.9 m -66.06 9.17 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.826 -1.171 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 76' ' ' VAL . 9.2 p -144.26 101.39 4.8 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.36 162.92 22.32 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.228 1.952 . . . . 0.0 113.857 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.652 HH21 HG23 ' A' ' 76' ' ' VAL . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' PRO . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.473 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.38 149.41 94.87 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.144 -1.209 . . . . 0.0 109.092 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.84 130.26 14.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.173 1.915 . . . . 0.0 111.981 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -79.98 158.88 26.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.32 179.67 45.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.52 17.59 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.705 2.27 . . . . 0.0 112.023 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.19 -71.94 0.22 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.18 154.27 46.61 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.819 2.346 . . . . 0.0 112.005 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.9 p -169.92 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.68 66.44 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' H ' ' H ' ' A' ' 28' ' ' ALA . . . 169.84 8.37 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 27' ' ' GLY . . . -73.76 -44.8 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -74.03 105.56 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 67.52 1.02 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 95.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -71.6 176.14 5.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.42 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.727 ' H ' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.76 17.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -59.16 139.25 57.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' H ' ' A' ' 36' ' ' GLY . 80.5 p -168.64 1.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 35' ' ' SER . . . -164.65 179.68 39.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -169.98 148.61 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -1.094 . . . . 0.0 109.465 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.37 97.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.274 -0.891 . . . . 0.0 109.082 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 91.01 6.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.382 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HA ' HG22 ' A' ' 112' ' ' THR . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.755 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 49' ' ' LEU . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.546 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.586 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 58' ' ' ASP . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.09 -40.9 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 HE22 ' A' ' 107' ' ' GLN . 68.7 mtt180 -70.55 -42.02 71.7 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.438 -0.789 . . . . 0.0 110.306 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.14 -39.83 75.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.806 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -164.81 109.76 0.83 Allowed Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.824 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.99 -19.5 39.71 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.371 1.381 . . . . 0.0 113.079 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.57 3.02 56.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.889 -1.132 . . . . 0.0 109.854 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.5 m -98.99 11.36 39.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -0.983 . . . . 0.0 109.837 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.03 137.99 23.79 Favored Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.78 159.83 24.69 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.82 1.68 . . . . 0.0 112.292 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.546 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.521 HE22 HH21 ' A' ' 70' ' ' ARG . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD21 ' HE ' ' A' ' 70' ' ' ARG . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.628 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' LEU . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.18 67.75 1.25 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -46.04 153.31 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.721 2.281 . . . . 0.0 112.308 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.17 -6.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.15 60.81 0.19 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 152.05 35.0 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.779 2.319 . . . . 0.0 112.034 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.69 70.04 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.32 141.91 9.69 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.78 2.32 . . . . 0.0 112.25 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -161.69 -64.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.555 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 28' ' ' ALA . . . 177.7 -48.07 0.1 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.15 10.88 1.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 30' ' ' GLY . . . -65.8 -4.69 7.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -68.67 45.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.426 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -75.05 121.82 6.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 30' ' ' GLY . . . 55.4 169.66 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 m -63.64 115.99 5.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -1.189 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 34' ' ' HIS . 9.4 tp -68.84 -38.68 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.268 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.471 ' N ' HG23 ' A' ' 33' ' ' ILE . 19.8 m-70 -57.28 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 34' ' ' HIS . 60.7 p -58.74 -160.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.3 161.65 27.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -63.4 -173.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 109.436 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.67 100.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.98 113.4 25.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.0 109.241 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt -58.78 -41.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -75.07 -30.17 60.89 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.427 -0.796 . . . . 0.0 110.847 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -87.29 -36.91 17.63 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.776 -1.202 . . . . 0.0 110.418 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -158.54 88.09 2.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.41 -16.12 45.28 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.653 1.569 . . . . 0.0 112.863 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.86 5.26 52.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.933 -1.105 . . . . 0.0 109.982 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -112.95 20.44 16.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.454 -0.779 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.53 99.24 49.97 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.321 -0.862 . . . . 0.0 109.019 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.7 155.79 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.295 1.997 . . . . 0.0 112.311 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 45' ' ' PRO . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.474 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.74 -37.01 2.6 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 110.535 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 50.0 Cg_exo -55.99 116.24 3.03 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.106 1.871 . . . . 0.0 112.145 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -77.22 -104.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.73 178.55 53.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.32 164.16 33.3 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 111.978 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' SER . . . -160.79 70.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.09 -9.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.825 2.35 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' GLY . 14.8 m -66.13 106.96 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.38 167.45 36.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.82 -35.91 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.16 67.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -1.126 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.68 -88.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 49.92 43.83 40.15 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.19 -103.83 0.18 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -49.75 115.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 pt -80.99 2.19 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -169.66 -26.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -77.52 169.91 17.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 37.07 0.5 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -70.4 157.06 38.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.32 97.72 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.214 -0.929 . . . . 0.0 108.983 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB1' ' HZ2' ' A' ' 116' ' ' LYS . . . -93.2 104.6 16.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.759 . . . . 0.0 109.452 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.432 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -66.46 -42.19 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -75.87 -54.74 6.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.389 -0.819 . . . . 0.0 109.99 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -56.97 -34.03 67.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.329 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.99 89.05 1.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 109.808 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.73 -16.23 47.38 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.43 1.42 . . . . 0.0 112.795 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -93.46 3.51 55.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.895 -1.128 . . . . 0.0 109.783 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -105.3 17.17 24.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.738 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.2 99.87 36.74 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.15 170.02 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.626 1.55 . . . . 0.0 111.822 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.637 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 45' ' ' PRO . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.516 ' HZ2' ' HB1' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.57 152.82 5.85 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.128 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.65 14.41 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.292 1.995 . . . . 0.0 111.933 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -61.7 -161.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.08 169.94 54.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.15 -91.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.753 2.302 . . . . 0.0 111.977 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HD2' ' A' ' 24' ' ' PRO . . . -159.52 -63.16 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 23' ' ' GLY . 86.6 Cg_exo -43.5 106.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.746 2.297 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -68.77 -9.89 53.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.34 -170.37 0.16 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 67.44 0.93 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.18 -37.71 37.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.506 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -73.08 -71.39 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.48 146.91 46.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 86.74 0.06 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -79.48 142.99 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.444 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' HIS . 17.8 tt -79.41 -37.12 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 38.3 m80 -50.91 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.1 t -49.93 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . -167.33 -134.78 1.75 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -170.06 175.7 4.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.8 mt -143.47 99.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.238 -0.914 . . . . 0.0 109.003 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.56 107.47 12.46 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 112' ' ' THR . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.662 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 58' ' ' ASP . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 68' ' ' THR . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.605 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 50.0 mtt-85 -75.56 -32.8 60.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -84.57 -36.24 22.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.953 -1.092 . . . . 0.0 110.103 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -152.08 85.12 4.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.36 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.83 -15.77 40.14 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.514 1.476 . . . . 0.0 112.672 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.77 1.18 57.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.916 -1.115 . . . . 0.0 109.899 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.9 16.61 25.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG12 ' NH2' ' A' ' 101' ' ' ARG . 1.5 t -138.11 100.54 8.71 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo -80.79 158.44 21.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.952 1.768 . . . . 0.0 113.593 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.479 ' NH2' HG12 ' A' ' 76' ' ' VAL . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 45' ' ' PRO . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 125' ' ' LEU . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.59 60.32 0.44 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.68 80.17 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.732 2.288 . . . . 0.0 112.012 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -51.8 -25.33 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.06 172.0 42.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 152.73 39.79 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.782 2.322 . . . . 0.0 111.965 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.35 -59.88 3.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 134.07 13.77 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.71 2.274 . . . . 0.0 112.275 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.9 t -168.28 66.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.78 -51.71 0.31 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.83 167.43 23.17 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -44.8 24.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -1.097 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -162.66 2.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.75 -47.75 7.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.71 -101.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m -165.26 139.59 4.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -1.194 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -74.69 -29.58 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -56.59 95.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.507 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -165.17 83.42 0.37 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 0.0 109.401 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.22 118.92 0.83 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 11.4 mpt_? -67.2 112.81 4.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.306 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.25 97.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.45 103.8 15.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.644 ' HA ' HG22 ' A' ' 112' ' ' THR . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' LEU . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -59.83 -41.09 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.573 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -85.99 -30.0 23.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.909 -1.119 . . . . 0.0 110.045 -179.036 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.87 87.12 2.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.094 -1.004 . . . . 0.0 109.524 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.97 -28.93 87.05 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.74 1.627 . . . . 0.0 113.331 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' VAL . 2.5 p30 -82.56 -33.15 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.739 -1.226 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 m -68.7 13.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' ASP . 2.1 t -113.74 97.41 44.23 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.287 -0.883 . . . . 0.0 108.808 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.64 156.21 3.19 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.373 2.049 . . . . 0.0 112.34 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 57' ' ' LEU . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' OE1' ' N ' ' A' ' 120' ' ' SER . 7.1 tp-100 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.402 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 122' ' ' LEU . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.14 152.85 82.23 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -1.133 . . . . 0.0 109.119 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.69 -176.89 2.51 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.945 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -165.81 90.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.27 60.34 4.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.55 93.96 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.784 2.323 . . . . 0.0 112.021 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.89 -69.16 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 87.92 1.31 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.766 2.31 . . . . 0.0 111.935 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.2 p -169.17 -39.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.85 -140.55 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.1 -51.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.69 -4.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.149 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -65.53 150.04 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.25 7.69 88.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.52 -9.83 39.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 p -175.53 145.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -1.191 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.707 ' H ' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.8 -176.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -79.1 -46.0 18.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.2 p -161.2 178.53 9.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.76 -10.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -71.6 131.87 43.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 109.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.41 97.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.111 -0.993 . . . . 0.0 108.942 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.5 92.11 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 49' ' ' LEU . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 112' ' ' THR . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 44' ' ' VAL . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.648 ' O ' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 99' ' ' CYS . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.76 -42.98 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -75.46 -33.74 60.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.274 -0.891 . . . . 0.0 110.72 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -33.24 22.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.89 93.06 1.35 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.63 -20.09 48.58 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.362 1.375 . . . . 0.0 112.676 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' VAL . 22.7 t70 -85.33 -30.85 23.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.122 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -66.75 9.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.881 -1.137 . . . . 0.0 110.093 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 76' ' ' VAL . 9.5 p -146.67 100.89 4.0 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.99 159.83 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.251 1.967 . . . . 0.0 113.793 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.64 HH21 HG23 ' A' ' 76' ' ' VAL . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.625 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.84 -37.21 2.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.266 -1.137 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.9 Cg_exo -56.01 97.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.086 1.857 . . . . 0.0 112.151 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 21' ' ' GLY . 7.2 tm-20 -76.33 146.05 39.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' N ' ' OE2' ' A' ' 20' ' ' GLU . . . 78.86 68.24 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.22 94.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.782 2.321 . . . . 0.0 112.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.53 170.62 28.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.36 -55.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.761 2.307 . . . . 0.0 111.97 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 m -169.99 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.95 -64.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.21 -154.21 51.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.06 -33.97 65.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -1.131 . . . . 0.0 109.449 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.45 -66.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.337 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.6 38.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 106.73 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 m -68.85 126.18 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -1.129 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.4 mt -50.95 -23.34 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -74.36 117.43 16.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 m -163.56 -25.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.14 -77.01 0.18 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' NH1' ' CG ' ' A' ' 119' ' ' GLN . 9.9 tpp180 -79.54 137.59 37.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.13 . . . . 0.0 109.393 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.65 98.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.23 -0.919 . . . . 0.0 109.018 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.22 113.76 27.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 50' ' ' ILE . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' LEU . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' A' ' 99' ' ' CYS . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 58' ' ' ASP . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt -59.44 -40.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.16 -35.55 61.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.16 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.86 -35.85 32.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.92 -1.113 . . . . 0.0 109.883 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -159.18 101.59 1.56 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 0.0 108.903 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -22.8 29.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.545 1.497 . . . . 0.0 113.443 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -92.67 2.28 56.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.715 -1.24 . . . . 0.0 110.084 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -99.77 10.61 41.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.195 -0.941 . . . . 0.0 110.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.86 97.72 42.64 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.332 -0.855 . . . . 0.0 108.835 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.15 155.65 4.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.336 2.024 . . . . 0.0 112.221 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.512 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.512 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.436 ' CG ' ' NH1' ' A' ' 37' ' ' ARG . 7.8 tp-100 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 125' ' ' LEU . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.46 -0.57 . . . . 0.41 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 0.36 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 0.3 108.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.0 m-70 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.25 109.85 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.37 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 0.21 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.18 113.648 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 0.18 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 0.44 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 0.92 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' CG1' ' A' ' 44' ' ' VAL . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 1.47 109.305 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 50' ' ' ILE . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 0.3 108.493 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 6.06 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 0.22 111.98 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 1.98 108.447 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 0.33 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.27 109.585 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 1.42 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.34 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.98 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 0.63 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 0.73 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 1.59 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.22 108.587 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.57 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.71 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 0.43 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.25 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.39 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.26 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.25 109.21 179.797 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 N--CA 1.495 1.609 0 CA-C-O 120.618 0.174 . . . . 0.64 112.054 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 0.67 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 0.23 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 0.16 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.18 108.927 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.15 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.51 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.1 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 0.2 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 137' ' ' GLN . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 0.33 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.21 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 0.15 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.66 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 1.55 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 0.77 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.79 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 0.2 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 1.69 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.1 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 0.14 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.89 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.3 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 0.86 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.07 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.17 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.09 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 1.34 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.44 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.59 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.36 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.12 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.25 110.716 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 0.35 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 0.58 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.24 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 1.67 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 0.15 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 1.44 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.567 HE21 ' N ' ' A' ' 120' ' ' SER . 30.8 tp60 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.09 108.909 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.567 ' N ' HE21 ' A' ' 119' ' ' GLN . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.12 109.843 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 0.24 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 1.34 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 0.46 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 125' ' ' LEU . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 0.23 108.851 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.0 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.08 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.46 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 0.22 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.5 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.13 109.557 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.16 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.548 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 0.19 110.456 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.548 HE21 ' C ' ' A' ' 135' ' ' ASP . 57.8 mm-40 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.322 0.582 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.0 m-70 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.569 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' SG ' ' A' ' 99' ' ' CYS . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 69' ' ' ILE . 16.5 mt . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.497 1.692 0 CA-C-O 120.796 0.248 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.548 ' C ' HE21 ' A' ' 107' ' ' GLN . 0.4 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.621 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.48 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.3 mm-40 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.272 0.558 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.6 m-70 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.643 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.473 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 58' ' ' ASP . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 111.585 -0.198 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 120' ' ' SER . 21.0 tp60 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.678 ' N ' HE21 ' A' ' 119' ' ' GLN . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.478 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 63.7 mm-40 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.8 m-70 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 112' ' ' THR . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 N-CA-C 113.332 0.474 . . . . 0.0 113.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.3 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.577 HE21 ' N ' ' A' ' 120' ' ' SER . 26.8 tp60 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.577 ' N ' HE21 ' A' ' 119' ' ' GLN . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.555 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 135' ' ' ASP . 60.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.8 m-70 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 99' ' ' CYS . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 58' ' ' ASP . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 113.564 0.563 . . . . 0.0 113.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.0 mm-40 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.402 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 18.1 m-70 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 112' ' ' THR . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD21 ' CG1' ' A' ' 44' ' ' VAL . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 53' ' ' LEU . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ASP . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.2 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.494 1.505 0 CA-C-O 120.848 0.27 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 57' ' ' LEU . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.612 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.536 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.536 HE21 ' C ' ' A' ' 135' ' ' ASP . 58.1 mm-40 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 112' ' ' THR . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.509 HD13 HH21 ' A' ' 51' ' ' ARG . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.509 HH21 HD13 ' A' ' 49' ' ' LEU . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.636 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 99' ' ' CYS . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.7 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 N--CA 1.493 1.486 0 CA-C-O 121.163 0.401 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.636 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.532 HE21 ' N ' ' A' ' 120' ' ' SER . 31.0 tp60 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.532 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.6 ' C ' HE21 ' A' ' 137' ' ' GLN . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.515 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.6 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.7 mm-40 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 24.9 m-70 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.5 mt-30 -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 N--CA 1.496 1.661 0 N-CA-C 112.644 0.209 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.513 ' SG ' HD21 ' A' ' 57' ' ' LEU . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' C ' HE21 ' A' ' 137' ' ' GLN . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.53 HE21 ' C ' ' A' ' 135' ' ' ASP . 59.5 mm-40 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 27.0 m-70 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 112' ' ' THR . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 50' ' ' ILE . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.61 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.587 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 99' ' ' CYS . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 0 N--CA 1.497 1.734 0 CA-C-O 120.755 0.231 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.593 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.593 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.595 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.595 HE21 ' C ' ' A' ' 135' ' ' ASP . 66.0 mm-40 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.234 0.54 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.4 m-70 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.565 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.565 ' CG ' HD11 ' A' ' 49' ' ' LEU . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo . . . . . 0 N--CA 1.496 1.66 0 CA-C-O 120.722 0.217 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 120' ' ' SER . 2.0 tm0? -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.617 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.59 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 135' ' ' ASP . 68.1 mm-40 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.401 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.7 m-70 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 112' ' ' THR . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.401 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 58' ' ' ASP . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.784 0.243 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.62 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 125' ' ' LEU . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.592 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.592 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.5 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 17.3 m-70 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 50' ' ' ILE . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 58' ' ' ASP . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo . . . . . 0 N--CA 1.496 1.628 0 CA-C-O 120.673 0.197 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.64 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.576 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 125' ' ' LEU . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.586 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.586 HE21 ' C ' ' A' ' 135' ' ' ASP . 71.0 mm-40 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 26.4 m-70 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 112' ' ' THR . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 HH22 ' A' ' 51' ' ' ARG . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.501 HH22 HD13 ' A' ' 49' ' ' LEU . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.599 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' PRO . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.648 HE21 ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.648 ' N ' HE21 ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.549 ' C ' HE21 ' A' ' 137' ' ' GLN . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.549 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.0 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.1 m-70 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HA ' HG22 ' A' ' 112' ' ' THR . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.755 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 49' ' ' LEU . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.546 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.586 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 58' ' ' ASP . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.494 1.509 0 CA-C-O 120.806 0.252 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.425 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.546 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.48 ' OE1' ' N ' ' A' ' 108' ' ' LEU . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.628 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 120' ' ' SER . 27.1 tp60 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.627 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' LEU . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.546 HE21 ' C ' ' A' ' 135' ' ' ASP . 57.2 mm-40 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 32.3 m-70 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo . . . . . 0 N--CA 1.494 1.552 0 CA-C-O 120.588 0.162 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 45' ' ' PRO . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.623 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.588 ' C ' HE21 ' A' ' 137' ' ' GLN . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.522 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.588 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.8 mm-40 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB1' ' HZ2' ' A' ' 116' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.7 m-70 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.432 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.398 0 CA-C-O 120.865 0.277 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.637 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 45' ' ' PRO . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.516 ' HZ2' ' HB1' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.55 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.55 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.464 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.6 mm-40 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.1 m-70 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 112' ' ' THR . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.662 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 58' ' ' ASP . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 68' ' ' THR . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 N-CA-C 113.593 0.574 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.47 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.453 ' NH2' ' O ' ' A' ' 77' ' ' PRO . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 45' ' ' PRO . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.62 HE21 ' N ' ' A' ' 120' ' ' SER . 26.0 tp60 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' HE21 ' A' ' 119' ' ' GLN . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 125' ' ' LEU . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 137' ' ' GLN . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.644 ' HA ' HG22 ' A' ' 112' ' ' THR . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' LEU . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.528 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 120.71 0.213 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 57' ' ' LEU . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.676 HE21 ' N ' ' A' ' 120' ' ' SER . 24.9 tp60 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.676 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 122' ' ' LEU . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.557 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.7 mm-40 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 15.3 m-70 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 49' ' ' LEU . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 112' ' ' THR . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 44' ' ' VAL . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.648 ' O ' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 99' ' ' CYS . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 3.1 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 N-CA-C 113.793 0.651 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 120' ' ' SER . 30.2 tp60 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.64 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.513 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.5 m-70 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 50' ' ' ILE . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' LEU . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' A' ' 99' ' ' CYS . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 58' ' ' ASP . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.2 mt-30 -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 CA-C-O 120.635 0.181 . . . . 0.0 112.221 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.524 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.512 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.512 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.626 HE21 ' N ' ' A' ' 120' ' ' SER . 30.3 tp60 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 125' ' ' LEU . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.583 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.583 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.476 -1.45 . . . . 29.4 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 152.88 92.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 27.34 109.13 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.78 71.29 3.36 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.259 1.972 . . . . 24.43 111.91 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.28 151.34 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 24.88 109.422 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.77 -59.68 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.502 -1.439 . . . . 19.43 109.502 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -46.09 160.21 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.79 2.327 . . . . 16.87 112.183 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.21 68.9 1.51 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.463 -1.455 . . . . 17.26 109.463 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.15 -20.08 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.781 2.321 . . . . 17.59 112.306 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 t -161.34 -152.28 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 19.6 109.48 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.6 71.05 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.506 -1.437 . . . . 21.2 109.506 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.66 -33.55 0.32 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 20.46 109.517 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.22 -14.82 59.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -1.149 . . . . 19.22 109.459 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -54.05 142.18 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.243 -0.911 . . . . 19.93 109.473 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.29 85.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.387 -1.485 . . . . 15.54 109.387 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.18 52.31 42.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.384 -1.486 . . . . 13.54 109.384 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.4 m -79.9 129.08 34.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 12.03 109.513 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.7 mp -78.94 123.87 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 9.37 109.194 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' GLY . 34.6 t60 -65.2 153.75 40.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 8.05 109.473 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -67.91 58.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 6.83 109.487 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . 61.81 159.61 0.13 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.428 -1.469 . . . . 2.33 109.428 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -71.98 136.39 46.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -1.159 . . . . 2.78 109.459 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -143.5 98.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -0.926 . . . . 0.56 109.013 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.6 97.71 10.3 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.774 . . . . 0.41 109.46 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.63 -174.18 3.98 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.223 -0.923 . . . . 0.36 109.563 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.5 t -75.76 144.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.393 -0.817 . . . . 0.3 108.849 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.0 m-70 -151.94 143.94 23.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.25 109.85 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.91 94.8 8.32 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 2.37 108.205 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -86.85 124.04 69.63 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.157 -0.965 . . . . 0.21 109.343 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.9 Cg_exo -47.78 139.65 18.76 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.972 1.781 . . . . 0.18 113.648 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -67.17 -28.7 68.32 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.379 -0.826 . . . . 0.18 108.941 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.63 -17.59 64.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.552 -0.718 . . . . 0.44 112.177 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 m -113.42 24.3 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 120.73 -1.231 . . . . 0.92 110.804 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' CG1' ' A' ' 44' ' ' VAL . 55.5 mt -91.32 133.33 35.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.806 -1.184 . . . . 1.47 109.305 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 50' ' ' ILE . 39.3 mt -100.82 129.28 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.493 -0.928 . . . . 0.3 108.493 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -134.13 85.35 39.78 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.37 -0.831 . . . . 6.06 109.937 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 37.8 Cg_endo -91.6 22.37 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 123.093 2.529 . . . . 0.22 111.98 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -139.19 108.45 7.45 Favored Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 108.447 -0.946 . . . . 1.98 108.447 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.35 160.86 29.01 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.731 1.62 . . . . 0.33 112.09 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -156.73 128.11 7.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -0.968 . . . . 1.27 109.585 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.2 p -57.49 123.68 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 1.42 109.768 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.6 mt -89.99 149.67 22.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.34 110.054 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.3 t70 -111.42 139.02 21.58 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.257 -1.016 . . . . 0.98 108.257 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.6 Cg_endo -75.83 -21.62 14.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.998 1.798 . . . . 0.63 113.126 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.85 -40.24 25.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.651 -1.281 . . . . 0.73 109.953 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -75.93 -31.26 59.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 1.59 110.193 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -70.32 -41.37 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.759 -1.213 . . . . 0.22 108.587 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -62.58 -36.59 83.19 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.57 -0.9 . . . . 2.57 108.57 179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -63.57 -47.02 83.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.281 -0.887 . . . . 1.71 108.801 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.5 mt -65.77 -47.41 75.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.365 -0.834 . . . . 0.43 109.113 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.9 t -56.89 -32.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.25 108.455 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.87 -34.58 62.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 2.39 109.21 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.29 -48.52 64.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.26 109.54 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.0 mt -62.11 -40.23 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.205 -0.934 . . . . 0.25 109.21 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -75.25 -36.5 61.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 1.97 110.175 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -77.31 -37.5 52.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.091 . . . . 1.94 109.706 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.44 104.4 1.21 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.905 . . . . 2.33 109.126 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.08 -19.48 39.31 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.359 1.373 . . . . 0.32 112.973 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.72 4.04 54.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.845 -1.159 . . . . 2.58 109.788 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 t -102.26 13.76 33.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.77 109.826 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.48 98.98 45.8 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.399 -0.813 . . . . 0.33 109.111 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.04 156.1 3.85 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.227 1.951 . . . . 0.64 112.054 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.81 172.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.484 2.123 . . . . 0.67 111.614 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -111.95 163.93 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.853 -0.795 . . . . 0.23 108.853 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -86.48 143.11 27.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 1.53 109.169 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 t -145.7 136.32 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.777 -0.823 . . . . 0.16 108.777 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.93 135.86 33.15 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.376 -0.972 . . . . 0.37 108.376 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -117.03 111.32 19.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.927 -0.768 . . . . 0.18 108.927 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mt -133.67 144.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.15 109.905 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.33 156.89 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.653 . . . . 0.51 109.504 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.68 -168.97 36.88 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.305 -1.118 . . . . 0.1 110.305 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.13 42.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.679 -0.895 . . . . 0.2 110.717 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 137' ' ' GLN . 37.9 mt-30 -130.47 40.19 3.54 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.111 -0.993 . . . . 0.33 110.802 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.82 -10.87 1.03 Allowed Glycine 0 N--CA 1.493 2.461 0 O-C-N 121.15 -0.969 . . . . 0.21 111.605 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.74 107.53 0.55 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 120.725 -1.456 . . . . 0.15 109.587 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.84 42.58 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.522 -0.987 . . . . 1.66 108.892 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.6 m-85 -132.41 123.17 26.2 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.513 -0.742 . . . . 1.55 109.015 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -105.09 123.7 48.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.887 . . . . 0.77 110.127 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -109.99 134.38 52.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.79 109.563 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.4 t -121.59 108.76 13.96 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.493 -0.754 . . . . 0.2 109.419 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.95 72.31 0.88 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.123 -1.065 . . . . 1.69 108.123 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.69 -163.64 30.45 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.183 -1.567 . . . . 0.1 109.183 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.88 17.18 0.08 OUTLIER Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.05 -1.22 . . . . 0.14 110.05 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -50.06 -43.18 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.89 109.884 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -68.35 -44.61 74.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 0.3 109.851 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -56.6 -32.17 64.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.939 -1.101 . . . . 0.86 108.898 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -64.81 -43.56 92.72 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.212 -1.033 . . . . 1.07 108.212 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.81 86.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.17 108.88 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.95 -47.65 61.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.09 109.28 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -65.54 -41.32 93.19 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.435 -0.95 . . . . 1.34 108.435 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.21 -50.04 72.39 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.546 -0.721 . . . . 2.44 109.274 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.3 tt0 -53.93 -49.84 67.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.59 109.795 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.97 4.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.36 109.761 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.1 mm100 45.2 26.67 0.26 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 3.2 110.491 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -60.59 159.65 10.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.928 -1.107 . . . . 4.12 108.714 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -80.37 -38.89 29.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.43 -0.794 . . . . 3.29 110.884 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 37.7 p -134.0 177.64 7.58 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.009 -1.057 . . . . 0.25 110.716 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.85 141.46 30.53 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.789 -0.57 . . . . 0.35 109.947 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.87 131.03 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.022 1.148 . . . . 0.58 111.01 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.45 135.6 13.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.24 109.724 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -78.72 125.08 28.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.372 -0.83 . . . . 1.67 109.133 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.25 138.11 32.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.242 -0.911 . . . . 0.15 109.505 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.47 101.89 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.875 -0.787 . . . . 1.44 108.875 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.567 HE21 ' N ' ' A' ' 120' ' ' SER . 30.8 tp60 -61.12 130.34 45.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 2.09 108.909 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.567 ' N ' HE21 ' A' ' 119' ' ' GLN . 8.6 m -141.45 179.08 7.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.923 . . . . 0.12 109.843 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -113.75 160.79 18.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.843 -0.799 . . . . 0.24 108.843 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.6 -38.71 67.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 1.34 109.909 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.3 t -54.32 -47.75 72.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.072 . . . . 0.46 109.779 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -54.75 -41.61 70.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 1.7 109.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 125' ' ' LEU . 11.0 tp -60.41 -38.99 85.78 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.956 -1.09 . . . . 0.23 108.851 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 130' ' ' GLY . 37.4 ttt180 -55.19 -37.87 67.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 2.0 109.025 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.14 -33.9 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.205 -1.035 . . . . 0.34 108.205 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.93 -48.94 6.71 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.798 . . . . 1.08 110.655 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 131' ' ' ALA . 60.8 mt -113.62 43.57 1.76 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.461 -0.774 . . . . 0.46 109.964 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.52 38.86 0.1 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.78 -53.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.866 -1.373 . . . . 0.22 109.533 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.3 p -100.4 33.73 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.15 -0.969 . . . . 1.5 109.467 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.44 117.17 59.87 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.13 109.557 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.27 -175.79 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.948 1.765 . . . . 0.16 111.604 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.548 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.7 t0 -103.03 114.37 28.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.76 -0.83 . . . . 1.27 108.76 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.2 mt -80.86 135.04 35.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.798 . . . . 0.19 110.456 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.548 HE21 ' C ' ' A' ' 135' ' ' ASP . 57.8 mm-40 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 118.04 -0.981 . . . . 0.54 109.05 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.9 152.76 93.09 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.249 -1.147 . . . . 0.0 109.17 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.66 107.65 2.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.346 2.031 . . . . 0.0 111.967 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -51.21 -46.36 62.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.86 -67.34 0.03 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.18 110.03 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.753 2.302 . . . . 0.0 111.999 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.07 178.44 0.21 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 72.21 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.816 2.344 . . . . 0.0 111.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 9.7 t -64.07 -174.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -65.21 146.64 50.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.0 144.52 4.05 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.05 79.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -1.128 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -60.51 174.28 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 31' ' ' GLY . . . -169.89 -12.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 30' ' ' GLY . . . 168.44 108.64 0.21 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -161.28 134.49 6.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' SER . 15.3 pt -64.19 155.74 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.475 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 35' ' ' SER . 18.2 m80 -67.9 56.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 33' ' ' ILE . 40.2 t -58.03 -162.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' N ' ' OG ' ' A' ' 35' ' ' SER . . . -161.14 55.01 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -161.77 77.16 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -1.151 . . . . 0.0 109.423 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.26 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.313 -0.867 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 106.07 18.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.477 -0.764 . . . . 0.0 109.532 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.7 -174.51 4.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -0.893 . . . . 0.0 109.47 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 98.3 t -83.89 144.63 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.266 -0.896 . . . . 0.0 109.008 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.0 m-70 -149.36 162.26 40.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 5.6 p30 -99.72 94.22 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -86.04 125.55 68.06 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.304 -0.872 . . . . 0.0 109.336 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.8 Cg_exo -46.84 141.24 12.02 Favored 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 121.735 1.623 . . . . 0.0 113.476 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.28 -33.69 74.81 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.349 -0.844 . . . . 0.0 109.547 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t -67.3 -20.36 65.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.555 -0.716 . . . . 0.0 112.402 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.31 19.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.594 -1.316 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.3 mt -87.59 132.48 34.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.495 -1.378 . . . . 0.0 109.268 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.66 126.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -134.13 85.68 38.84 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.569 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.5 Cg_endo -91.09 20.75 0.9 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.957 2.438 . . . . 0.0 111.838 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -134.91 107.05 10.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.22 164.62 26.64 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.677 1.585 . . . . 0.0 112.242 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.7 t -156.76 161.28 39.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.87 112.4 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 ' SG ' ' A' ' 99' ' ' CYS . 82.9 mt -82.86 149.52 27.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -0.915 . . . . 0.0 110.05 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.3 t70 -111.76 137.86 21.4 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.45 -21.08 15.39 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.904 1.736 . . . . 0.0 113.002 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.56 -43.49 18.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 0.0 110.204 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -38.65 71.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.036 -1.04 . . . . 0.0 109.875 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 65.2 t -57.93 -37.95 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.915 -1.116 . . . . 0.0 108.609 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -61.87 -47.02 86.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.419 -0.801 . . . . 0.0 108.983 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -53.29 -47.71 68.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.07 -48.39 71.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.227 -0.92 . . . . 0.0 109.209 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 t -56.91 -32.36 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 108.358 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -73.89 -35.52 64.68 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.376 -0.828 . . . . 0.0 109.168 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.93 -50.63 47.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.191 -0.943 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 69' ' ' ILE . 16.5 mt -60.23 -41.36 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.951 . . . . 0.0 108.997 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 58.7 mtt180 -71.87 -39.4 69.67 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.361 -0.837 . . . . 0.0 110.302 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -75.31 -38.79 60.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.991 -1.068 . . . . 0.0 109.725 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -160.48 105.18 1.34 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.184 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.92 -18.51 40.98 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.343 1.362 . . . . 0.0 112.882 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.75 5.07 52.46 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.866 -1.146 . . . . 0.0 109.49 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.8 t -103.34 14.84 30.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.57 98.88 30.91 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.377 -0.827 . . . . 0.0 109.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.8 156.19 3.44 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.235 1.956 . . . . 0.0 112.21 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.95 167.98 24.45 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.535 2.156 . . . . 0.0 111.642 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -102.88 166.82 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.586 -0.696 . . . . 0.0 109.287 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.12 137.32 32.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.294 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.46 137.5 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 108.858 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -88.97 139.27 30.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 108.732 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -116.46 113.04 22.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.92 140.13 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -101.33 156.33 17.51 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.81 -169.17 32.4 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.39 -5.98 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.767 -0.843 . . . . 0.0 110.862 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.2 mt-30 -129.92 38.87 3.76 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.168 -0.958 . . . . 0.0 110.666 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.5 -9.74 0.55 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.152 -0.967 . . . . 0.0 111.247 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.547 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.96 108.41 0.73 Allowed Glycine 0 N--CA 1.484 1.851 0 O-C-N 120.801 -1.411 . . . . 0.0 109.639 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.1 135.92 41.15 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.513 -0.993 . . . . 0.0 108.486 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.4 m-85 -131.37 123.77 28.92 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.441 -0.787 . . . . 0.0 108.89 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.34 118.68 37.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.384 -0.823 . . . . 0.0 110.019 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -105.48 131.55 52.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.661 -0.649 . . . . 0.0 109.582 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -119.06 108.66 14.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.548 -0.72 . . . . 0.0 109.438 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.11 72.36 0.84 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.05 -161.38 29.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.54 29.56 1.23 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.6 t -57.51 -46.46 83.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -68.81 -44.95 72.47 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.034 -1.041 . . . . 0.0 110.157 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -55.5 -32.41 62.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.9 -1.125 . . . . 0.0 108.803 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -65.26 -44.35 88.36 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.19 93.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 108.887 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.53 -47.26 84.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.31 -0.869 . . . . 0.0 108.86 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.27 -33.57 76.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.377 -0.827 . . . . 0.0 108.815 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -66.95 -41.05 87.57 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.256 -0.902 . . . . 0.0 109.22 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.548 ' C ' HE21 ' A' ' 107' ' ' GLN . 0.4 OUTLIER -63.35 -45.12 92.67 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.512 -0.743 . . . . 0.0 110.071 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 79.6 mt -64.89 2.88 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 107' ' ' GLN . 24.0 mt-30 49.58 26.37 1.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.02 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -64.29 158.07 24.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.023 -1.048 . . . . 0.0 109.063 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 1.7 mp0 -81.04 -40.36 24.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.757 . . . . 0.0 110.858 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.9 p -132.65 178.4 6.88 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -139.89 142.08 29.61 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.656 -0.653 . . . . 0.0 110.062 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.75 135.42 35.58 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 CA-C-N 119.958 1.021 . . . . 0.0 110.625 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.71 136.39 13.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -78.86 121.57 25.0 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.333 -0.855 . . . . 0.0 109.058 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.3 mt -85.45 137.16 33.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -0.972 . . . . 0.0 109.66 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.02 102.96 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -58.87 126.55 28.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.621 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.8 m -139.11 -179.36 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.385 -0.822 . . . . 0.0 109.764 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -121.27 163.54 18.41 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.614 -0.678 . . . . 0.0 109.399 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -37.13 42.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -54.16 -49.96 68.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.61 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.94 -35.63 66.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.079 -1.013 . . . . 0.0 108.701 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.3 tp -67.99 -30.92 70.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.169 -0.957 . . . . 0.0 109.647 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -65.2 -36.32 83.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.674 -1.266 . . . . 0.0 108.635 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.5 -36.92 61.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -90.06 -47.76 7.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.208 -0.933 . . . . 0.0 110.713 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -115.32 43.71 1.98 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.43 -0.794 . . . . 0.0 110.171 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.11 39.42 0.11 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.431 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -156.04 -53.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.393 . . . . 0.0 109.639 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.5 t -101.3 35.33 2.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.213 -0.929 . . . . 0.0 109.47 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.48 117.07 63.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.552 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.19 -175.66 2.75 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.861 1.707 . . . . 0.0 111.234 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.48 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 41.1 t0 -100.1 128.55 46.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 108.782 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 51.0 mt -90.09 131.57 35.88 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.53 0.681 . . . . 0.0 110.569 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 60.3 mm-40 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.036 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.13 60.41 0.62 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.71 70.25 5.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.738 2.292 . . . . 0.0 112.001 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -170.04 32.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.68 -69.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.56 68.82 6.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.722 2.282 . . . . 0.0 111.939 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.01 170.67 53.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.26 15.76 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.744 2.296 . . . . 0.0 111.986 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t -160.89 -38.89 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.48 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.9 -161.89 34.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.07 -32.2 0.36 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.39 -6.0 45.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.9 mt-30 -153.22 29.79 0.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.872 . . . . 0.0 109.356 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.62 -83.0 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . -162.23 -79.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -160.75 140.06 10.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -79.07 -21.89 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -167.32 107.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.479 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.2 p -80.32 176.76 9.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.15 85.5 0.23 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -80.6 107.94 13.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -1.152 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.0 mt -143.34 97.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 108.888 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.02 88.15 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.579 -0.701 . . . . 0.0 109.546 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.32 -173.55 3.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.328 -0.857 . . . . 0.0 109.317 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 86.1 t -75.21 144.33 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.262 -0.898 . . . . 0.0 108.786 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.6 m-70 -151.85 142.29 22.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.153 -0.967 . . . . 0.0 109.872 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.59 96.87 7.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -90.13 121.57 68.56 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.133 -0.979 . . . . 0.0 108.689 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.643 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.3 Cg_exo -46.89 142.9 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.725 1.617 . . . . 0.0 113.231 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.63 -40.38 80.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 108.836 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -35.36 27.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.521 -0.737 . . . . 0.0 111.213 -178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -98.37 26.72 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.058 -1.026 . . . . 0.0 110.564 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -96.4 140.61 30.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.754 -1.216 . . . . 0.0 108.666 179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.16 118.25 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.279 -0.888 . . . . 0.0 110.027 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.574 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 12.2 mmm180 -121.59 84.03 42.18 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.602 -0.686 . . . . 0.0 109.381 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -96.35 26.81 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.199 2.599 . . . . 0.0 111.786 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.74 104.36 5.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 0.0 109.363 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.88 159.51 31.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.544 1.496 . . . . 0.0 112.301 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -156.69 130.17 8.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 109.287 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.1 p -52.68 116.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.877 . . . . 0.0 110.048 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.473 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.06 149.99 21.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.6 t70 -108.91 134.05 20.49 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.08 -19.94 19.72 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.805 1.67 . . . . 0.0 112.913 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.95 -40.18 22.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.142 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -74.65 -42.51 58.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 109.371 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 58' ' ' ASP . 82.0 t -56.08 -36.97 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.904 -1.123 . . . . 0.0 108.76 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -67.28 -37.81 84.04 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 t -63.19 -44.27 95.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.351 -0.843 . . . . 0.0 109.304 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.16 -44.57 62.88 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.193 -0.942 . . . . 0.0 109.202 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -57.52 -31.45 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.03 -35.23 74.16 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.486 -0.759 . . . . 0.0 109.165 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -68.57 -44.99 73.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.189 -0.944 . . . . 0.0 109.287 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -64.93 -40.2 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 109.246 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.0 mtp85 -75.49 -38.04 59.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.269 -0.894 . . . . 0.0 110.08 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -76.52 -38.7 54.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -158.17 100.62 1.75 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 109.203 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.79 -14.34 32.75 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.31 1.34 . . . . 0.0 112.905 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.86 -25.53 23.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.976 -1.078 . . . . 0.0 110.637 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -82.91 20.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.45 98.8 52.14 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.29 -0.881 . . . . 0.0 109.101 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -54.47 171.89 0.37 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.003 1.802 . . . . 0.0 111.585 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.7 172.82 7.65 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.759 2.306 . . . . 0.0 111.998 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.98 167.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -88.53 138.01 31.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.153 -0.967 . . . . 0.0 109.729 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.18 131.62 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -85.5 139.19 31.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.425 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -114.58 113.45 24.41 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -134.73 141.68 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.268 -0.895 . . . . 0.0 110.267 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -102.71 156.46 17.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.682 -0.636 . . . . 0.0 109.309 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.16 -169.03 34.71 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.21 42.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.645 -0.914 . . . . 0.0 110.943 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' GLY . 64.3 mt-30 -129.13 39.59 3.75 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.055 -1.028 . . . . 0.0 110.679 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.88 -10.29 1.21 Allowed Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.125 -0.984 . . . . 0.0 111.473 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.533 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.04 106.38 0.4 Allowed Glycine 0 N--CA 1.485 1.905 0 O-C-N 120.796 -1.414 . . . . 0.0 109.732 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.61 137.0 42.0 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.535 -0.979 . . . . 0.0 108.501 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.3 m-85 -131.17 124.79 31.42 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -106.93 113.78 27.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -101.53 144.07 30.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 109.405 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.0 t -128.59 107.42 9.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.47 -0.769 . . . . 0.0 109.592 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -110.5 72.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 159.49 -163.21 33.38 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 45.07 20.07 0.23 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.574 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 9.8 t -50.49 -47.24 57.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -1.182 . . . . 0.0 110.545 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -73.0 -52.18 15.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.077 -1.014 . . . . 0.0 109.811 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -56.37 -30.29 62.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.833 -1.167 . . . . 0.0 108.98 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.22 -51.19 68.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 108.601 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.32 69.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.953 . . . . 0.0 108.808 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.75 -43.95 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.81 -43.46 79.58 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.309 -0.869 . . . . 0.0 108.876 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -64.79 -33.48 76.09 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.197 -0.939 . . . . 0.0 109.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 26.3 tt0 -69.5 -49.49 54.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.811 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.62 11.49 0.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 20.7 tt0 44.98 61.17 2.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.23 -0.919 . . . . 0.0 110.879 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.41 159.67 15.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.022 -1.049 . . . . 0.0 108.996 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.01 -43.63 16.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.6 p -131.19 177.58 7.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.999 -1.063 . . . . 0.0 110.16 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.1 tt -139.38 142.75 33.38 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.99 124.37 3.38 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 121.124 1.216 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.81 145.04 31.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.714 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.21 123.08 28.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.41 137.69 33.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.2 -0.937 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.29 103.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 120' ' ' SER . 21.0 tp60 -60.42 126.13 26.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.955 . . . . 0.0 109.302 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.678 ' N ' HE21 ' A' ' 119' ' ' GLN . 12.3 m -137.47 -178.94 5.45 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.412 -0.805 . . . . 0.0 109.43 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.3 p -119.61 163.84 16.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.7 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.56 -38.86 56.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.37 -0.831 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.8 t -54.16 -50.19 67.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.037 . . . . 0.0 110.05 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.01 -40.56 70.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.964 -1.085 . . . . 0.0 108.881 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.14 -40.27 84.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 29.2 ttt85 -56.55 -38.16 71.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.278 -0.888 . . . . 0.0 109.293 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.19 -34.57 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 108.347 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -90.42 -49.18 6.66 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.337 -0.852 . . . . 0.0 110.813 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.3 mt -113.0 42.04 1.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 109.994 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.22 39.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.08 -55.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.803 -1.41 . . . . 0.0 109.558 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.8 p -102.0 34.77 2.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.26 -0.9 . . . . 0.0 109.199 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.82 117.32 56.73 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.4 -175.51 2.73 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.827 1.684 . . . . 0.0 110.864 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.478 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 40.8 t0 -102.39 127.87 49.21 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.933 0.873 . . . . 0.0 108.738 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 56.5 mt -89.51 133.82 34.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 63.7 mm-40 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.217 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.88 152.93 96.54 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.224 -1.162 . . . . 0.0 109.116 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.8 77.35 2.29 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.296 1.997 . . . . 0.0 111.922 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -58.77 -46.9 86.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.918 . . . . 0.0 109.482 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.08 60.3 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.55 106.95 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.003 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.26 -171.7 42.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.14 135.57 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.808 2.338 . . . . 0.0 112.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 p -77.55 133.41 38.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -52.79 119.54 10.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 26' ' ' GLY . . . -61.42 -149.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.61 75.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -52.42 152.43 3.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.79 -97.46 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.36 158.57 26.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 p -175.78 149.27 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tp -161.23 132.83 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.268 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -82.48 75.64 9.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.462 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -166.12 141.04 4.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -52.94 -48.2 58.26 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 36' ' ' GLY . 31.5 ptt180 -51.81 -178.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.32 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.61 97.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.237 -0.914 . . . . 0.0 109.094 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.14 112.83 25.91 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.5 -173.32 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.254 -0.904 . . . . 0.0 109.658 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 96.1 t -75.54 144.12 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.293 -0.879 . . . . 0.0 108.765 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.8 m-70 -151.33 148.5 28.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.098 -1.001 . . . . 0.0 110.037 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -87.68 97.19 10.74 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.4 p -90.53 123.49 65.18 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.214 -0.929 . . . . 0.0 108.571 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.648 ' HA ' HG22 ' A' ' 112' ' ' THR . 62.5 Cg_exo -46.9 143.33 9.61 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.798 1.666 . . . . 0.0 113.384 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.92 -32.08 70.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.239 -0.913 . . . . 0.0 109.055 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 t -67.4 -15.34 63.63 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.496 -0.752 . . . . 0.0 112.175 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.6 m -113.64 25.98 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 120.784 -1.198 . . . . 0.0 109.963 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -98.57 133.46 42.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 0.0 108.704 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.0 134.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.112 -0.993 . . . . 0.0 111.481 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -132.77 84.32 50.34 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -93.82 26.55 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.089 2.526 . . . . 0.0 111.298 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.89 90.43 10.88 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 108.922 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.45 158.34 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.495 2.13 . . . . 0.0 112.638 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.7 p -156.79 140.28 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.2 t -80.05 110.31 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.141 -0.974 . . . . 0.0 109.404 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.6 mt -84.41 149.39 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.034 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 t70 -112.77 135.54 21.6 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.82 -23.35 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.872 1.715 . . . . 0.0 113.112 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -38.65 29.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.014 -1.053 . . . . 0.0 110.148 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -42.03 58.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.361 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 77.1 t -55.63 -37.42 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.941 -1.1 . . . . 0.0 108.75 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.26 -38.83 85.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -61.22 -47.51 85.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.045 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -66.9 -47.36 72.05 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.0 -32.27 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.39 -32.12 60.68 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.543 -0.723 . . . . 0.0 109.148 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -67.04 -41.54 86.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.468 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt -68.76 -39.93 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -75.49 -55.36 5.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.636 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.7 -34.19 37.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.061 . . . . 0.0 109.541 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -171.76 109.19 0.38 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.388 -0.82 . . . . 0.0 108.791 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.79 -6.7 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.324 1.349 . . . . 0.0 112.65 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -92.01 -0.83 57.47 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.045 -1.035 . . . . 0.0 110.007 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -101.77 18.01 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.63 100.13 5.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -80.18 162.89 22.8 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.891 1.727 . . . . 0.0 113.332 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.51 165.5 0.4 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.457 2.104 . . . . 0.0 112.072 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -107.83 171.7 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.53 139.46 30.45 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 110.08 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.26 139.76 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -92.55 136.41 33.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 108.717 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' NE1' ' OD1' ' A' ' 91' ' ' ASP . 12.5 t90 -112.96 113.6 25.72 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.95 144.23 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.65 156.52 17.73 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.76 -167.86 28.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 -5.9 29.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.814 -0.815 . . . . 0.0 111.032 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 90' ' ' GLY . 29.4 mt-30 -130.04 38.2 3.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.941 -1.099 . . . . 0.0 110.666 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.09 -11.62 0.67 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 121.159 -0.963 . . . . 0.0 111.253 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -52.16 109.09 0.78 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 120.883 -1.363 . . . . 0.0 109.903 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' OD1' ' NE1' ' A' ' 83' ' ' TRP . 7.5 m-20 -76.94 132.01 38.83 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -1.017 . . . . 0.0 108.503 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.8 m-85 -125.47 127.13 46.0 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.032 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -105.43 115.91 31.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.381 -0.824 . . . . 0.0 110.065 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -102.09 141.12 35.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.447 -0.783 . . . . 0.0 109.109 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.3 t -125.72 108.25 11.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.373 -0.829 . . . . 0.0 109.577 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -108.9 72.58 0.82 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 153.19 -161.7 29.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.52 26.92 1.14 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.8 m -58.46 -53.25 60.4 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.116 -1.226 . . . . 0.0 110.822 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -67.43 -47.15 71.06 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.093 . . . . 0.0 110.355 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -56.71 -32.18 65.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.886 -1.134 . . . . 0.0 109.33 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.4 OUTLIER -61.93 -51.01 69.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.969 -1.082 . . . . 0.0 108.423 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.77 -33.97 69.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.893 . . . . 0.0 108.959 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.63 -44.68 81.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.659 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.1 -33.51 74.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.243 -0.911 . . . . 0.0 109.099 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -66.26 -33.76 76.47 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.176 -0.952 . . . . 0.0 109.493 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 109' ' ' GLN . 45.8 tt0 -69.25 -48.23 62.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 109.956 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.5 7.8 0.2 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.3 mt-30 45.55 59.99 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 110.209 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.7 mmm-85 -98.95 150.6 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.238 -0.914 . . . . 0.0 108.877 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -79.35 -42.58 25.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.0 110.199 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 45' ' ' PRO . 24.9 p -127.02 177.69 6.48 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.095 -1.003 . . . . 0.0 110.429 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.67 143.11 36.59 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.9 122.91 2.68 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 C-N-CA 121.131 1.221 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.59 37.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.401 ' CB ' ' NZ ' ' A' ' 116' ' ' LYS . 1.4 ttmp? -79.95 122.84 27.2 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.8 mt -85.0 134.4 34.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.063 -1.023 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.1 t -125.83 102.69 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.577 HE21 ' N ' ' A' ' 120' ' ' SER . 26.8 tp60 -62.88 126.92 28.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.196 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.577 ' N ' HE21 ' A' ' 119' ' ' GLN . 13.4 m -138.37 -179.3 5.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.374 -0.829 . . . . 0.0 109.516 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -118.46 163.71 16.35 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.574 -0.704 . . . . 0.0 109.558 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -40.01 59.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.1 t -53.9 -50.29 66.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.954 -1.091 . . . . 0.0 110.014 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.32 -38.36 68.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.014 -1.054 . . . . 0.0 108.954 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.73 -39.57 92.04 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.954 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 20.4 ttm180 -56.16 -39.01 71.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.136 -0.977 . . . . 0.0 109.036 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.7 t -56.39 -35.07 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.121 -0.987 . . . . 0.0 108.432 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.4 -49.03 6.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.374 -0.829 . . . . 0.0 110.732 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 131' ' ' ALA . 98.5 mt -112.99 42.15 1.95 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.465 -0.772 . . . . 0.0 110.002 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.49 39.44 0.1 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.609 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.63 -55.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.829 -1.395 . . . . 0.0 109.659 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 25.7 m -101.31 34.37 2.59 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.224 -0.923 . . . . 0.0 109.333 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -72.01 117.25 56.42 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.937 . . . . 0.0 109.749 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.98 -175.08 2.53 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 121.868 1.712 . . . . 0.0 111.054 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.555 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.1 t0 -103.08 116.3 32.24 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 52.2 mt -80.45 135.22 36.1 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.611 -0.68 . . . . 0.0 110.412 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 135' ' ' ASP . 60.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.034 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.14 152.82 5.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -1.159 . . . . 0.0 109.098 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' GLY . 65.7 Cg_endo -72.4 -19.95 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.358 2.039 . . . . 0.0 111.93 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 24.3 mp0 -65.07 3.89 0.53 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.408 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' PRO . . . 79.03 177.64 49.97 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -72.71 -89.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.745 2.297 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.62 60.51 0.33 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.91 -161.12 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.711 2.274 . . . . 0.0 111.957 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 m -77.58 166.52 22.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.94 65.66 3.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.07 -3.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.49 43.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -78.95 -41.11 30.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.93 -153.61 4.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.31 116.97 0.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 9.4 p -175.53 149.82 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.52 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.724 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.8 mp -79.55 106.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.201 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.485 ' CE1' ' O ' ' A' ' 32' ' ' SER . 5.6 m80 -79.93 63.85 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.351 -0.843 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 34' ' ' HIS . 19.7 m -166.18 155.3 11.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.476 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.98 29.98 58.15 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -170.12 143.89 2.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.2 mt -143.54 97.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 108.982 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.68 119.29 38.15 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.88 -174.65 4.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.427 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 93.4 t -86.89 144.83 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 0.0 108.979 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.8 m-70 -149.76 149.62 30.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.232 -0.917 . . . . 0.0 110.017 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -84.82 94.32 8.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -87.65 124.62 67.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.655 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.4 Cg_exo -46.6 140.85 11.74 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.907 1.738 . . . . 0.0 113.65 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.86 -33.31 74.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -67.95 -19.62 64.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.558 -0.714 . . . . 0.0 112.401 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.1 17.17 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.586 -1.321 . . . . 0.0 110.412 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.8 mt -88.78 120.18 29.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.585 -1.322 . . . . 0.0 109.11 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -82.76 133.98 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 108.771 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' NH1' ' CD1' ' A' ' 102' ' ' TYR . 19.3 mtm180 -135.85 84.14 32.98 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 110.074 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.37 26.53 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.116 2.544 . . . . 0.0 110.873 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.23 90.68 6.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.0 164.68 27.09 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.953 1.769 . . . . 0.0 112.485 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -154.21 161.68 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 109.27 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.8 t -79.29 110.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 99' ' ' CYS . 85.8 mt -79.18 149.8 31.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.827 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.8 t70 -110.91 134.31 21.02 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -73.81 -20.76 19.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.778 1.652 . . . . 0.0 112.966 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.41 22.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 110.178 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -75.13 -36.76 61.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.574 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 58' ' ' ASP . 60.1 t -60.29 -40.52 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.926 -1.109 . . . . 0.0 108.618 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -61.57 -47.87 83.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.424 ' O ' ' OG1' ' A' ' 68' ' ' THR . 67.7 m -53.11 -47.7 68.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 109.14 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.2 -49.57 69.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 109.164 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.03 -34.13 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.913 -1.117 . . . . 0.0 108.074 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.53 -31.77 60.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.469 -0.769 . . . . 0.0 109.072 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 64' ' ' SER . 1.1 m -67.95 -42.65 80.63 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.427 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.27 -40.96 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.661 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -75.95 -48.83 19.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.369 -0.832 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.01 -34.06 75.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.064 -1.022 . . . . 0.0 110.405 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' OD1' ' OD2' ' A' ' 74' ' ' ASP . 45.4 t0 -156.15 87.54 2.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.031 -1.043 . . . . 0.0 109.84 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.4 -15.78 43.06 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.544 1.496 . . . . 0.0 112.85 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD2' ' OD1' ' A' ' 72' ' ' ASP . 2.9 p30 -93.29 4.47 53.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.867 -1.145 . . . . 0.0 109.644 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -104.63 15.68 27.52 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.365 -0.834 . . . . 0.0 109.707 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG12 HH21 ' A' ' 101' ' ' ARG . 1.9 t -138.07 101.0 8.61 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.57 166.78 26.72 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.551 1.501 . . . . 0.0 113.564 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.79 168.18 1.24 Allowed 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 122.699 2.266 . . . . 0.0 112.468 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 pt -109.75 171.7 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -89.93 138.63 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.039 . . . . 0.0 109.881 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.1 t -145.07 138.65 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.21 141.99 28.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.245 -0.91 . . . . 0.0 108.851 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -119.41 113.38 20.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.639 -0.663 . . . . 0.0 109.278 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.8 144.27 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.315 -0.865 . . . . 0.0 109.96 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -103.3 157.1 17.25 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.62 -0.675 . . . . 0.0 109.358 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.27 -172.39 36.88 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.81 -6.37 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.822 -0.811 . . . . 0.0 110.906 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -127.23 26.7 6.0 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.143 -0.973 . . . . 0.0 110.478 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 -12.83 23.62 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.849 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.69 108.78 0.58 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.08 135.37 39.89 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.537 -0.979 . . . . 0.0 108.892 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.85 135.62 46.83 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.52 -0.737 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.31 119.31 36.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.39 -0.819 . . . . 0.0 109.94 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -101.01 137.8 38.91 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.461 -0.774 . . . . 0.0 109.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -123.7 108.18 12.27 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.501 -0.75 . . . . 0.0 109.335 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -109.26 72.54 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.74 -155.88 26.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.84 17.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 97' ' ' GLY . 10.0 t -54.29 -48.34 71.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -1.116 . . . . 0.0 110.4 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -70.98 -49.32 46.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.007 -1.058 . . . . 0.0 109.913 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.702 HH21 HG12 ' A' ' 76' ' ' VAL . 12.4 mtp-105 -56.77 -31.67 64.86 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.698 -1.251 . . . . 0.0 109.156 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.55 ' CD1' ' NH1' ' A' ' 51' ' ' ARG . 19.6 t80 -61.28 -44.98 96.35 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.44 71.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.06 -49.88 32.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -64.13 -33.85 76.71 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -63.17 -41.86 99.29 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 109' ' ' GLN . 66.3 tt0 -68.86 -43.26 75.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.507 -0.745 . . . . 0.0 109.936 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.14 11.69 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 42.07 33.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -0.798 . . . . 0.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -71.25 152.03 43.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.01 -1.056 . . . . 0.0 108.723 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.56 -42.34 22.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.268 -0.895 . . . . 0.0 110.283 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.2 p -130.89 177.96 7.02 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.64 141.78 23.69 Favored Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.615 -0.678 . . . . 0.0 109.851 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.75 131.16 25.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.974 1.116 . . . . 0.0 110.866 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.5 135.16 19.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.041 -1.037 . . . . 0.0 109.867 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -77.98 115.95 18.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 108.867 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.85 136.93 36.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 0.0 109.704 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -128.89 102.49 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -58.44 128.73 38.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.787 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 7.0 m -138.66 179.32 6.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.295 -0.878 . . . . 0.0 109.728 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.6 p -116.84 160.58 20.63 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.99 -38.48 67.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 109.857 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.8 t -53.47 -46.48 69.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.841 -1.162 . . . . 0.0 109.186 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.41 -41.26 72.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.946 . . . . 0.0 108.988 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.75 -32.94 74.16 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.006 -1.059 . . . . 0.0 109.368 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 130' ' ' GLY . 12.7 mmm180 -63.78 -33.71 76.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.743 -1.223 . . . . 0.0 108.913 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.37 -36.01 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -89.99 -49.37 6.64 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.39 -0.819 . . . . 0.0 110.277 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' ALA . 69.8 mt -112.5 43.94 1.55 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -0.759 . . . . 0.0 109.446 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.17 38.3 0.07 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.03 -53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.771 -1.429 . . . . 0.0 109.642 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -99.71 33.07 2.63 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.126 -0.984 . . . . 0.0 109.695 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.98 117.91 63.93 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.58 -175.51 2.72 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.997 1.798 . . . . 0.0 111.566 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 137' ' ' GLN . 44.8 t0 -104.11 127.92 51.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.786 . . . . 0.0 109.015 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.1 mt -93.52 137.28 32.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.491 0.662 . . . . 0.0 110.4 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.0 mm-40 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.981 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.87 -37.07 2.55 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.263 -1.139 . . . . 0.0 110.467 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.0 Cg_exo -56.12 -30.44 79.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.12 1.88 . . . . 0.0 112.112 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -56.22 -90.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.69 178.69 9.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.2 -43.19 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.748 2.299 . . . . 0.0 111.978 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.16 34.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.99 12.12 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.826 2.351 . . . . 0.0 112.016 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -160.87 10.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.24 -14.19 82.56 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.91 54.4 4.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.03 -10.77 59.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 3.9 mp0 -79.48 -170.39 2.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.21 151.4 6.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -170.07 50.96 0.2 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -160.36 115.72 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.164 -1.198 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -85.99 -3.74 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 0.0 109.471 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -160.37 105.36 1.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -81.37 -175.95 5.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.925 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ARG . . . -80.13 -95.74 0.36 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -52.23 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.1 . . . . 0.0 109.722 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mt -142.53 97.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.232 -0.917 . . . . 0.0 109.076 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.67 34.89 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.574 -0.704 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.25 -173.9 4.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 109.526 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.402 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 51.2 t -80.31 142.6 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 108.817 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 18.1 m-70 -147.06 163.27 36.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.147 -0.971 . . . . 0.0 110.044 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 9.0 p30 -102.55 96.58 7.0 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.484 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.2 p -88.46 125.14 64.46 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.364 -0.835 . . . . 0.0 109.222 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 112' ' ' THR . 53.3 Cg_exo -47.73 141.74 15.36 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.696 1.597 . . . . 0.0 113.395 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.79 -29.44 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.161 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.4 p -69.71 -14.06 62.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.664 -0.647 . . . . 0.0 112.309 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.12 26.41 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.793 -1.192 . . . . 0.0 110.701 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD21 ' CG1' ' A' ' 44' ' ' VAL . 48.5 mt -92.87 132.61 36.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.863 -1.148 . . . . 0.0 108.738 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mt -100.36 125.8 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.426 -0.796 . . . . 0.0 109.003 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 14.9 mtp180 -134.68 86.27 34.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.437 -0.789 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' O ' HD12 ' A' ' 53' ' ' LEU . 26.6 Cg_endo -92.9 23.46 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.363 2.709 . . . . 0.0 112.469 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -130.89 134.56 26.12 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.21 158.51 37.41 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.185 1.923 . . . . 0.0 112.172 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -157.67 131.25 7.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.9 t -81.83 111.41 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.275 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.7 mt -85.4 149.63 25.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.314 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.66 138.95 22.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.4 Cg_endo -73.93 -24.63 15.05 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.914 1.743 . . . . 0.0 113.268 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -44.24 18.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.9 -1.125 . . . . 0.0 110.629 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -35.46 74.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.978 -1.076 . . . . 0.0 109.619 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 58' ' ' ASP . 38.5 t -58.26 -51.24 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.2 mt-30 -59.02 -37.99 78.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.19 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.59 -48.06 78.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.56 -45.74 82.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -55.06 -30.95 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 t70 -65.37 -46.88 78.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.481 -0.762 . . . . 0.0 109.5 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -45.68 88.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.6 mt -61.21 -41.17 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 109.155 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -69.41 -55.29 10.75 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.243 -0.911 . . . . 0.0 109.258 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -56.1 -42.13 76.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 109.788 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -161.42 109.36 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 109.29 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.5 -22.45 38.67 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.303 1.335 . . . . 0.0 113.138 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 15.2 t70 -92.98 6.76 46.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.6 p -97.3 5.89 49.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.224 -0.922 . . . . 0.0 110.138 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.42 137.05 23.25 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 160.12 23.9 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.847 1.698 . . . . 0.0 112.182 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.84 165.2 33.44 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.398 2.065 . . . . 0.0 111.659 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 pt -102.18 163.87 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -84.33 135.05 34.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.087 -1.008 . . . . 0.0 109.112 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -143.7 137.69 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 108.888 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 138.82 31.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.312 -0.867 . . . . 0.0 108.978 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -116.64 113.6 22.91 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mt -133.33 142.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.391 -0.818 . . . . 0.0 110.047 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 2.9 tttp -100.02 156.12 17.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.0 109.365 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 -164.66 27.23 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.22 -6.96 46.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.942 . . . . 0.0 111.109 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.5 mt-30 -129.03 39.05 3.84 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.039 -1.038 . . . . 0.0 110.673 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.83 -11.82 0.59 Allowed Glycine 0 N--CA 1.494 2.503 0 O-C-N 121.064 -1.022 . . . . 0.0 111.262 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 88' ' ' GLN . . . -52.18 113.39 2.55 Favored Glycine 0 N--CA 1.485 1.917 0 O-C-N 120.881 -1.364 . . . . 0.0 110.042 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 21.7 m-20 -80.15 131.81 35.79 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 108.742 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 93.2 m-85 -122.1 120.92 35.68 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -100.81 123.69 45.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 110.058 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -111.29 129.33 56.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.717 -0.614 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.1 t -117.52 107.67 14.57 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -106.62 71.98 0.88 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' O ' ' NH2' ' A' ' 51' ' ' ARG . . . 149.06 -161.78 28.8 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.02 29.03 1.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 57' ' ' LEU . 6.0 t -61.08 -41.24 96.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -1.157 . . . . 0.0 110.55 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -67.26 -45.93 75.2 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.788 -1.195 . . . . 0.0 109.982 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.1 mtt85 -56.21 -32.44 64.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.923 -1.111 . . . . 0.0 109.002 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 18.6 t80 -63.77 -44.04 94.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.3 93.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.79 -48.24 75.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.408 -0.808 . . . . 0.0 109.084 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -66.01 -33.74 76.51 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -71.09 -32.79 69.5 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.301 -0.874 . . . . 0.0 108.982 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -70.31 -36.59 74.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.453 -0.779 . . . . 0.0 109.726 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.3 mt -81.8 13.58 3.15 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.185 -0.947 . . . . 0.0 109.744 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 41.6 38.82 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.503 -0.748 . . . . 0.0 110.879 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -72.54 159.06 34.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 108.914 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -81.74 -42.49 19.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' PRO . 43.7 p -133.06 177.6 7.54 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.018 -1.051 . . . . 0.0 110.318 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 tt -139.35 142.03 31.01 Favored Pre-proline 0 N--CA 1.503 2.216 0 O-C-N 121.779 -0.576 . . . . 0.0 109.81 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.59 135.75 31.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.957 1.105 . . . . 0.0 110.591 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.67 133.68 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 109.874 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -72.1 120.76 18.16 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.55 136.48 33.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.963 -1.085 . . . . 0.0 109.546 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.11 102.83 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.5 tm0? -61.03 126.08 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 108.996 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.612 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 12.6 m -137.17 179.74 6.21 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.294 -0.879 . . . . 0.0 109.618 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.2 p -116.34 164.94 13.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.665 -0.647 . . . . 0.0 109.553 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -42.72 68.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 t -53.54 -47.97 69.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.986 -1.071 . . . . 0.0 109.899 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -54.99 -40.54 70.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.115 -0.991 . . . . 0.0 108.996 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.29 -38.93 88.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 108.894 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.5 ttt180 -56.06 -38.5 70.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.168 -0.957 . . . . 0.0 108.982 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.46 -34.79 47.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.118 -0.989 . . . . 0.0 108.387 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.43 -49.1 6.71 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.276 -0.89 . . . . 0.0 110.728 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 131' ' ' ALA . 88.0 mt -113.75 43.31 1.83 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.407 -0.808 . . . . 0.0 109.893 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.14 39.86 0.09 OUTLIER Glycine 0 N--CA 1.489 2.181 0 C-N-CA 120.184 -1.008 . . . . 0.0 110.626 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -154.95 -54.93 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.813 -1.404 . . . . 0.0 109.64 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.2 t -101.56 34.72 2.51 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.202 -0.937 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.2 117.38 61.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.553 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.54 -175.04 2.49 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 121.956 1.771 . . . . 0.0 111.26 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.536 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -101.5 119.27 38.51 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 50.8 mt -81.34 132.56 35.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.573 -0.704 . . . . 0.0 110.655 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.536 HE21 ' C ' ' A' ' 135' ' ' ASP . 58.1 mm-40 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.959 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.98 149.41 80.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.087 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 72.1 3.7 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.224 1.949 . . . . 0.0 111.932 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.54 178.81 1.16 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.56 -169.85 37.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.16 -66.89 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.733 2.288 . . . . 0.0 112.23 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 174.98 60.25 0.05 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.48 -167.21 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.708 2.272 . . . . 0.0 112.004 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' N ' ' A' ' 26' ' ' GLY . 31.5 t -169.08 -163.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.468 ' N ' ' OG ' ' A' ' 25' ' ' SER . . . -172.48 -19.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.92 -133.39 1.86 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.42 -4.02 13.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -1.162 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -65.6 158.1 28.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.19 -60.57 3.89 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.34 13.01 73.44 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 m -69.17 128.12 35.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.463 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.0 pt -78.02 61.63 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CG ' ' O ' ' A' ' 34' ' ' HIS . 16.2 t-80 -160.32 2.09 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.5 p -49.79 -48.69 50.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.98 -30.5 0.39 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -79.65 114.26 18.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.167 . . . . 0.0 109.377 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.4 mt -143.39 97.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.157 -0.964 . . . . 0.0 108.937 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.41 96.23 10.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.535 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.24 -173.76 4.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.373 -0.829 . . . . 0.0 109.412 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 57.6 t -75.92 143.45 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 0.0 108.912 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -150.7 146.42 26.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.097 -1.002 . . . . 0.0 110.116 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -86.57 95.45 9.75 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -89.52 122.98 67.81 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 108.923 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.636 ' HA ' HG22 ' A' ' 112' ' ' THR . 72.9 Cg_exo -48.1 139.77 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.833 1.689 . . . . 0.0 113.391 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -28.62 68.7 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.715 0.769 . . . . 0.0 109.219 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 p -64.77 -25.71 68.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.676 -0.64 . . . . 0.0 112.035 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 m -106.46 24.31 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.839 -1.163 . . . . 0.0 111.321 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.509 HD13 HH21 ' A' ' 51' ' ' ARG . 56.5 mt -89.69 130.82 35.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.711 -1.243 . . . . 0.0 108.798 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -98.47 127.06 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.509 HH21 HD13 ' A' ' 49' ' ' LEU . 53.4 mtt-85 -133.91 85.19 41.48 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -96.12 28.84 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.381 2.721 . . . . 0.0 111.698 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.39 89.86 9.24 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.34 161.28 1.2 Allowed 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.489 2.126 . . . . 0.0 112.426 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.636 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 12.4 p -156.92 145.24 19.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.361 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.4 t -78.97 110.35 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.203 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 99' ' ' CYS . 79.7 mt -83.9 149.49 26.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 4.6 t70 -112.26 137.62 21.58 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 85.7 Cg_endo -75.33 -19.05 17.55 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.797 1.665 . . . . 0.0 113.088 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -83.06 -43.36 16.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.912 -1.117 . . . . 0.0 110.254 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.61 -37.48 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.12 -0.987 . . . . 0.0 109.403 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 40.4 t -55.9 -47.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.008 -1.058 . . . . 0.0 108.885 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 2.7 mt-30 -64.03 -37.16 86.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 108.978 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -57.72 -47.99 80.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.399 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.24 -45.07 86.12 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.134 -0.979 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.72 -34.35 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -70.69 -31.94 69.0 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.384 -0.822 . . . . 0.0 108.852 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -45.3 66.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -66.36 -41.74 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.227 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -75.02 -39.65 60.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.348 -0.845 . . . . 0.0 109.996 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -74.3 -37.39 63.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.01 -1.056 . . . . 0.0 109.718 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -160.28 102.53 1.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 109.218 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -18.29 37.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.32 1.347 . . . . 0.0 112.897 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -92.59 3.17 56.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 0.0 109.752 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 t -102.24 15.4 29.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.257 -0.902 . . . . 0.0 109.616 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -125.89 103.62 27.28 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.43 162.72 41.38 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.354 1.369 . . . . 0.0 112.698 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.72 167.57 20.79 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.747 2.298 . . . . 0.0 112.015 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 pt -108.77 166.71 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -84.36 134.07 34.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 t -138.72 136.86 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.02 137.63 32.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 108.589 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.0 t90 -117.44 112.87 21.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.4 mt -133.92 145.64 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.348 -0.845 . . . . 0.0 110.135 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -105.08 156.25 18.24 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.497 0.665 . . . . 0.0 109.33 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.09 -176.57 40.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.57 -5.7 16.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.764 -0.845 . . . . 0.0 111.044 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -126.64 25.03 6.51 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.54 -13.05 36.97 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.005 -1.06 . . . . 0.0 110.994 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.57 109.44 0.81 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -77.66 136.07 38.16 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.598 -0.942 . . . . 0.0 108.97 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.5 m-85 -133.52 133.25 41.93 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.53 -0.731 . . . . 0.0 109.52 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.78 125.48 54.04 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -110.93 129.83 55.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.589 -0.694 . . . . 0.0 109.817 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.9 t -117.33 107.74 14.75 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -105.24 71.98 0.97 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.75 -157.31 27.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.07 14.85 0.1 OUTLIER Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.131 -1.217 . . . . 0.0 110.098 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.636 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 7.0 t -52.24 -43.12 64.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 110.282 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -68.89 -46.34 68.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.023 -1.048 . . . . 0.0 109.968 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -56.6 -32.49 65.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.804 -1.185 . . . . 0.0 108.844 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.55 -45.71 91.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.029 -1.044 . . . . 0.0 108.198 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.41 89.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 108.882 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.53 -49.93 61.05 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.367 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -63.26 -35.22 79.63 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.9 -46.31 89.76 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.462 -0.774 . . . . 0.0 108.947 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 109' ' ' GLN . 5.8 tt0 -55.87 -51.43 67.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 109.769 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' ARG . 76.0 mt -65.49 5.71 0.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 109.799 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 107' ' ' GLN . 14.7 mm100 45.24 21.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 108' ' ' LEU . 11.5 mmt85 -53.17 151.41 5.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.931 -1.106 . . . . 0.0 108.614 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -77.16 -41.53 41.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.349 -0.844 . . . . 0.0 110.548 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.636 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.1 p -129.98 177.22 7.44 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.105 -0.997 . . . . 0.0 110.81 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.0 tt -139.56 143.29 34.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.51 123.22 3.31 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 120.983 1.122 . . . . 0.0 111.174 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.94 33.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 110.001 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -76.07 119.51 20.1 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -83.47 138.65 33.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.977 -1.077 . . . . 0.0 109.76 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -128.58 103.4 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.532 HE21 ' N ' ' A' ' 120' ' ' SER . 31.0 tp60 -61.81 128.81 38.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 108.999 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.532 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.2 m -138.12 -178.73 5.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.302 -0.874 . . . . 0.0 109.47 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.6 p -117.49 175.53 5.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.58 -0.7 . . . . 0.0 110.002 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -48.28 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.696 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 t -54.39 -47.24 72.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.01 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.25 -41.23 68.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.853 -1.154 . . . . 0.0 109.081 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.28 -39.38 86.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.933 -1.104 . . . . 0.0 108.661 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 47.3 ttp180 -55.03 -38.05 67.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.24 -0.913 . . . . 0.0 109.093 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -56.95 -34.25 44.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.949 -1.094 . . . . 0.0 108.086 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.26 -49.88 6.3 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.334 -0.854 . . . . 0.0 110.953 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.9 mt -111.25 40.89 1.96 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.37 -0.831 . . . . 0.0 110.137 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.42 41.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.199 -1.0 . . . . 0.0 110.912 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.76 -60.61 0.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.755 -1.438 . . . . 0.0 109.625 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.5 t -101.77 34.66 2.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.093 -1.004 . . . . 0.0 109.215 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.27 119.21 66.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 109.94 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.48 -173.69 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.975 1.783 . . . . 0.0 110.891 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.6 ' C ' HE21 ' A' ' 137' ' ' GLN . 39.4 t0 -110.81 92.66 4.13 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.515 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.775 0.798 . . . . 0.0 111.026 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.6 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.7 mm-40 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.856 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.0 60.4 0.55 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.33 -1.1 . . . . 0.0 109.611 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.63 -176.62 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 112.008 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' A' ' 21' ' ' GLY . 8.5 pt-20 -164.84 -7.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.415 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 20' ' ' GLU . . . -53.42 -59.88 8.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.89 145.29 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.94 -59.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.85 -65.69 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.736 2.291 . . . . 0.0 112.235 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -77.35 -77.72 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.53 -39.89 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.38 -147.54 5.05 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.53 72.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 0.0 109.442 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -164.79 -30.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.371 -0.831 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.87 23.82 0.25 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.24 -33.93 1.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -52.12 149.53 5.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -1.157 . . . . 0.0 109.517 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 34' ' ' HIS . 16.1 tt -169.71 -40.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.513 ' N ' HG23 ' A' ' 33' ' ' ILE . 32.6 m80 -79.8 -140.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.487 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 p -169.73 71.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.23 39.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -170.04 140.98 2.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -1.122 . . . . 0.0 109.388 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.61 98.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.232 -0.918 . . . . 0.0 109.086 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.98 106.57 18.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.336 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.8 -174.55 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 85.4 t -80.19 143.93 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.195 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 24.9 m-70 -151.9 144.85 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.325 -0.859 . . . . 0.0 109.72 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -86.35 93.49 9.11 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.6 p -80.57 125.9 79.61 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.233 -0.917 . . . . 0.0 109.171 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 82.6 Cg_exo -48.14 135.06 24.73 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.627 1.551 . . . . 0.0 112.937 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -32.2 73.27 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.895 0.855 . . . . 0.0 108.918 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -59.86 -27.92 67.09 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.886 -0.509 . . . . 0.0 111.662 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.58 24.06 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.013 -1.054 . . . . 0.0 110.798 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.36 134.5 41.28 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.5 mt -105.72 136.72 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.175 -0.953 . . . . 0.0 110.953 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.621 ' NH1' ' CD2' ' A' ' 102' ' ' TYR . 10.9 mtm180 -135.19 86.16 31.68 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.436 -0.79 . . . . 0.0 109.981 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.5 21.33 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.588 2.192 . . . . 0.0 111.592 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mt -142.32 90.35 8.16 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.9 163.03 26.25 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.098 1.865 . . . . 0.0 112.021 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -153.03 139.5 18.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.182 -0.948 . . . . 0.0 109.552 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.7 p -49.13 124.59 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 109.918 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.4 mt -99.3 149.7 22.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 0.0 109.927 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -109.35 136.32 20.2 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 86.8 Cg_endo -75.17 -19.05 17.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.859 1.706 . . . . 0.0 112.973 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -82.79 -43.09 17.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.808 -1.182 . . . . 0.0 110.287 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -73.1 -35.0 66.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.968 . . . . 0.0 109.472 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 47.3 t -60.09 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.092 . . . . 0.0 108.973 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.5 mt-30 -58.18 -38.06 75.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 108.907 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.8 m -59.1 -47.25 85.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -66.83 -44.84 80.05 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.96 -30.83 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 11.5 t70 -68.89 -45.89 69.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.14 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -59.95 -47.76 84.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.69 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 mt -59.88 -43.08 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 109.266 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -70.44 -59.27 2.95 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 1.3 mp0 -50.76 -34.09 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -171.25 107.89 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.366 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.18 -14.65 31.75 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.377 1.385 . . . . 0.0 112.941 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.59 3.17 56.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.132 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.7 m -103.32 17.0 25.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.29 -0.881 . . . . 0.0 109.664 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG12 HH21 ' A' ' 101' ' ' ARG . 2.2 t -128.91 98.74 23.57 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.316 -0.865 . . . . 0.0 108.922 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.76 155.45 3.94 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.396 2.064 . . . . 0.0 112.644 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.24 172.83 15.26 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.785 2.323 . . . . 0.0 111.795 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 pt -113.75 165.9 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 21.4 t0 -87.37 145.6 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.5 t -145.85 137.81 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.2 mp -86.38 136.55 33.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -117.44 112.88 21.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.98 144.47 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.334 -0.854 . . . . 0.0 109.975 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.3 tttp -104.56 155.91 18.42 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.593 0.711 . . . . 0.0 109.845 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.9 -175.24 41.15 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.78 20.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.676 -0.896 . . . . 0.0 110.852 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -130.14 37.75 3.86 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.124 -0.985 . . . . 0.0 110.663 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.69 -12.85 2.56 Favored Glycine 0 N--CA 1.493 2.491 0 O-C-N 121.1 -1.0 . . . . 0.0 111.532 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.92 104.7 0.12 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.68 135.95 40.41 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.624 -0.927 . . . . 0.0 108.774 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.1 m-85 -130.41 129.53 43.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.542 -0.723 . . . . 0.0 109.656 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.5 124.31 51.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.461 -0.774 . . . . 0.0 109.631 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -114.69 130.07 56.77 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.719 -0.613 . . . . 0.0 109.375 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 t -117.54 108.81 15.94 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.19 72.13 0.98 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.11 -157.85 28.9 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.34 29.64 2.62 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.513 ' SG ' HD21 ' A' ' 57' ' ' LEU . 10.2 t -57.67 -50.19 74.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.053 -1.263 . . . . 0.0 110.604 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -74.09 -47.29 37.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.908 -1.12 . . . . 0.0 110.098 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.61 HH21 HG12 ' A' ' 76' ' ' VAL . 17.5 mtp-105 -56.39 -30.62 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.751 -1.218 . . . . 0.0 108.597 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD2' ' NH1' ' A' ' 51' ' ' ARG . 28.0 t80 -63.11 -48.98 76.23 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -33.69 68.76 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.789 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.59 -49.85 36.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -0.793 . . . . 0.0 109.573 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -64.69 -36.82 85.53 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.149 -0.969 . . . . 0.0 108.511 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.5 -33.61 75.43 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 108.868 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.29 -41.4 73.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 109.651 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 110' ' ' ARG . 91.2 mt -74.96 10.35 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.8 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 45.57 21.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.484 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' LEU . 5.2 mmp_? -53.23 155.75 2.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.946 -1.096 . . . . 0.0 108.589 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -79.68 -41.28 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 110.396 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.3 p -131.74 176.8 8.02 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.113 -0.992 . . . . 0.0 110.129 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.57 141.04 29.74 Favored Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 121.602 -0.686 . . . . 0.0 109.479 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.47 131.15 22.46 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 119.977 1.028 . . . . 0.0 110.967 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.32 10.88 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.603 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -75.58 116.44 16.31 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.8 mt -77.1 138.74 39.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.031 -1.043 . . . . 0.0 109.185 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.1 102.08 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.626 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.85 129.79 43.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 8.0 m -140.87 -179.06 5.84 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.295 -0.878 . . . . 0.0 109.724 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.1 p -122.0 163.9 18.56 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.599 -0.688 . . . . 0.0 109.426 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.1 -39.65 56.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.3 m -54.07 -49.71 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.828 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -55.8 -36.44 67.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.126 -0.983 . . . . 0.0 108.83 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.25 -30.25 69.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.084 -1.01 . . . . 0.0 109.443 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.9 ttp180 -64.53 -38.61 91.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.688 -1.257 . . . . 0.0 108.827 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.2 -38.43 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 108.508 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -89.63 -48.16 7.47 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 0.0 110.732 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.2 mt -112.12 41.78 1.9 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.365 -0.834 . . . . 0.0 109.924 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.89 39.27 0.1 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.55 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.07 -55.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.802 -1.411 . . . . 0.0 109.713 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -101.03 36.57 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.179 -0.951 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.82 116.98 61.72 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.66 -175.81 2.87 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.772 1.648 . . . . 0.0 111.254 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' C ' HE21 ' A' ' 137' ' ' GLN . 33.8 t0 -100.96 116.04 31.88 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 47.6 mt -79.64 131.44 35.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 110.513 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.53 HE21 ' C ' ' A' ' 135' ' ' ASP . 59.5 mm-40 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.044 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.33 60.27 0.45 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.172 -1.193 . . . . 0.0 109.546 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.45 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.823 2.349 . . . . 0.0 112.023 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.37 127.69 32.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.76 173.19 38.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 -164.39 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.788 2.325 . . . . 0.0 112.02 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.55 70.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.12 -38.49 19.41 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.819 2.346 . . . . 0.0 112.2 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.6 m -162.98 -26.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.841 . . . . 0.0 109.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.88 -144.2 4.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.7 42.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.04 -13.26 59.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.473 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -71.2 64.56 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.27 62.49 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.34 -158.66 1.32 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -78.86 160.8 27.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -1.133 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.5 -178.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -61.77 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 t -71.41 105.17 3.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.77 158.75 29.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -170.15 144.2 2.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.339 -1.095 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.43 97.48 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.292 -0.88 . . . . 0.0 109.176 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.89 100.67 12.5 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.521 -0.737 . . . . 0.0 109.404 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.75 -173.64 3.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.282 -0.886 . . . . 0.0 109.363 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 45.9 t -82.69 143.23 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.237 -0.915 . . . . 0.0 108.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 27.0 m-70 -149.23 155.47 40.65 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.033 -1.042 . . . . 0.0 110.133 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.8 p30 -93.47 94.92 8.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.39 123.22 68.75 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.337 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 112' ' ' THR . 76.3 Cg_exo -47.92 140.01 18.99 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.802 1.668 . . . . 0.0 113.212 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.03 -31.42 72.29 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 108.914 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.54 -24.13 67.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.664 -0.648 . . . . 0.0 111.661 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.6 23.04 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.822 -1.174 . . . . 0.0 110.461 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -98.49 134.41 41.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 50' ' ' ILE . 35.6 mt -103.07 136.41 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.14 -0.975 . . . . 0.0 110.829 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.61 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.4 mtp85 -134.5 84.92 38.8 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.456 -0.778 . . . . 0.0 109.686 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.59 25.46 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.914 2.41 . . . . 0.0 111.737 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 tt -141.38 105.01 5.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.32 -0.863 . . . . 0.0 109.154 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 164.68 28.11 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.638 1.559 . . . . 0.0 112.383 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.587 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 10.0 p -156.7 161.27 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.393 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -83.59 111.29 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 99' ' ' CYS . 81.4 mt -85.23 149.62 25.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.165 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.1 t70 -111.47 135.94 21.03 Favored Pre-proline 0 N--CA 1.493 1.71 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.18 -18.49 18.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.79 1.66 . . . . 0.0 113.032 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.97 16.63 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.918 -1.114 . . . . 0.0 110.149 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -38.63 68.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.074 -1.016 . . . . 0.0 109.793 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 58' ' ' ASP . 74.1 t -57.91 -37.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.598 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -62.9 -47.98 80.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.078 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -47.22 74.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.384 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -66.58 -45.57 78.85 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.48 -31.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -72.29 -37.11 69.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.38 -0.825 . . . . 0.0 109.414 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -64.96 -46.42 81.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.82 -39.83 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.203 -0.936 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -75.21 -36.28 61.39 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.835 . . . . 0.0 110.185 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -76.95 -38.76 52.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.868 -1.145 . . . . 0.0 109.343 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -160.65 104.63 1.32 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.065 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.71 -20.93 39.59 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.391 1.394 . . . . 0.0 112.99 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -92.28 4.77 52.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.864 -1.147 . . . . 0.0 109.532 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -100.45 12.1 37.98 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.324 -0.86 . . . . 0.0 109.805 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.35 99.37 50.29 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.503 -0.748 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.81 156.55 3.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.327 2.018 . . . . 0.0 112.239 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.11 170.36 19.2 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.53 2.153 . . . . 0.0 111.777 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.09 164.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -82.02 121.15 26.17 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.051 -1.031 . . . . 0.0 109.653 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.81 135.4 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.91 136.56 32.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.279 -0.888 . . . . 0.0 108.645 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.4 t90 -114.73 111.62 21.56 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.93 145.68 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.424 -0.797 . . . . 0.0 110.149 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -104.87 156.48 17.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.513 0.673 . . . . 0.0 109.445 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.26 -176.18 42.01 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.64 -5.4 15.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.788 -0.83 . . . . 0.0 111.008 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 137' ' ' GLN . 20.4 mt-30 -129.15 26.35 5.46 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.206 -0.934 . . . . 0.0 110.705 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 82.25 -13.59 38.62 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.028 -1.045 . . . . 0.0 111.305 178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.29 108.49 0.58 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -76.99 136.04 38.7 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.526 -0.984 . . . . 0.0 109.076 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -132.99 136.8 46.26 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.464 -0.772 . . . . 0.0 109.431 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -115.07 122.43 46.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.96 144.29 32.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.578 -0.701 . . . . 0.0 109.6 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.497 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 30.6 t -128.41 107.74 9.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -109.13 72.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 152.63 -156.51 26.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.12 16.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 6.2 t -50.25 -42.86 52.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -1.185 . . . . 0.0 110.154 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -73.53 -49.72 25.07 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.029 -1.044 . . . . 0.0 110.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -56.11 -31.76 63.58 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.754 -1.216 . . . . 0.0 108.702 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -61.13 -51.67 68.08 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.144 -0.972 . . . . 0.0 108.646 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.41 -31.74 66.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 108.865 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.83 -47.17 40.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -65.96 -41.99 90.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.191 -0.943 . . . . 0.0 108.486 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.7 -32.57 74.3 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.38 -0.825 . . . . 0.0 109.405 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' GLN . 51.7 tt0 -72.89 -49.52 29.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 110.115 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.82 11.77 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 0.0 110.158 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 107' ' ' GLN . 34.7 mt-30 45.9 47.14 12.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -82.09 154.76 25.42 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.03 -1.044 . . . . 0.0 108.761 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -81.17 -40.84 23.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.799 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.5 p -133.85 177.4 7.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.987 -1.071 . . . . 0.0 110.631 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 tt -140.11 142.91 31.89 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.32 122.92 2.92 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 121.025 1.15 . . . . 0.0 111.081 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 146.14 34.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 109.83 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -77.56 124.86 28.47 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.27 136.04 33.32 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.064 -1.023 . . . . 0.0 109.227 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.44 103.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.593 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.61 128.51 36.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 108.975 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.593 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.5 m -139.59 -179.51 5.95 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.282 -0.886 . . . . 0.0 109.481 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.81 160.99 21.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.632 -0.667 . . . . 0.0 109.342 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.27 -23.17 3.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -69.19 -50.58 46.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.917 -1.115 . . . . 0.0 109.961 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -55.83 -34.28 65.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.908 -1.12 . . . . 0.0 108.703 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.3 tp -63.91 -40.58 96.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.302 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 16.0 ttt180 -56.09 -39.02 71.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.044 -1.035 . . . . 0.0 108.573 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.53 -36.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.113 -0.992 . . . . 0.0 108.426 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -89.98 -49.54 6.54 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.215 -0.928 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 97.0 mt -112.48 42.87 1.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.402 -0.811 . . . . 0.0 109.961 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.78 39.15 0.1 Allowed Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.72 -58.33 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.384 . . . . 0.0 109.43 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.3 t -99.22 39.3 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.124 -0.985 . . . . 0.0 109.163 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.59 119.39 77.26 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.825 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.24 -173.37 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.911 1.74 . . . . 0.0 111.138 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.595 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.8 t0 -110.06 93.02 4.28 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.6 mt -60.79 137.61 58.19 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.713 0.768 . . . . 0.0 110.953 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.595 HE21 ' C ' ' A' ' 135' ' ' ASP . 66.0 mm-40 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.077 -0.963 . . . . 0.0 108.761 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.88 70.99 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.29 94.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.814 2.343 . . . . 0.0 112.248 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.04 -7.21 56.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.88 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.47 70.95 0.22 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -46.12 -22.7 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.683 2.255 . . . . 0.0 112.341 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.11 -178.33 37.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.16 136.8 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.809 2.34 . . . . 0.0 112.224 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 p -167.57 132.7 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.5 -25.01 0.02 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.05 131.6 52.04 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.77 -51.12 9.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -1.136 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -162.41 134.71 5.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.35 -0.844 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 131.66 10.74 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.33 -142.98 3.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.9 p -165.58 161.67 18.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -1.113 . . . . 0.0 109.464 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 mt -77.73 107.22 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -80.73 -48.85 11.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -79.7 130.52 35.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.46 -20.64 0.33 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mmt-85 -81.53 113.29 19.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -1.12 . . . . 0.0 109.445 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.0 mt -143.08 98.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.252 -0.905 . . . . 0.0 108.978 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.14 103.15 15.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.518 -0.739 . . . . 0.0 109.587 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.71 -174.15 3.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.44 -0.788 . . . . 0.0 109.297 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.438 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 40.4 t -86.34 144.16 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 0.0 108.877 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 37.4 m-70 -149.81 155.09 39.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.978 -1.076 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.6 p30 -92.47 93.35 8.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.3 p -87.33 124.13 68.65 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.327 -0.858 . . . . 0.0 109.125 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.7 Cg_exo -46.74 141.36 11.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.738 1.625 . . . . 0.0 113.303 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.56 -36.1 80.3 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.302 -0.874 . . . . 0.0 109.263 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.95 -25.94 67.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.694 -0.629 . . . . 0.0 111.671 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.05 17.5 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.798 -1.189 . . . . 0.0 110.142 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.565 HD11 ' CG ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -98.83 131.11 45.2 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.4 135.77 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.064 -1.022 . . . . 0.0 110.726 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.565 ' CG ' HD11 ' A' ' 49' ' ' LEU . 71.8 mtt-85 -132.52 83.13 55.07 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.518 -0.739 . . . . 0.0 109.273 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' LEU . 38.8 Cg_endo -92.11 20.48 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.934 2.422 . . . . 0.0 112.129 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -140.27 91.64 9.8 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.02 164.97 26.78 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.912 1.741 . . . . 0.0 112.101 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.0 m -156.11 137.93 14.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.938 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.6 p -49.22 125.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 109.986 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.7 mt -99.01 149.93 22.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.8 t70 -109.24 138.41 20.46 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.1 Cg_endo -74.29 -24.77 14.08 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.898 1.732 . . . . 0.0 113.378 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.5 -42.34 22.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.737 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -71.34 -33.44 69.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.795 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.3 t -63.61 -51.37 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.862 -1.149 . . . . 0.0 109.288 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.99 -36.5 67.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 108.924 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 p -61.7 -47.29 85.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.333 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.1 -42.18 85.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 t -57.05 -32.29 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 108.815 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -70.77 -38.8 73.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.373 -0.83 . . . . 0.0 109.411 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 m -65.1 -48.56 73.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.563 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.4 mt -60.23 -40.53 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.204 -0.935 . . . . 0.0 109.172 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -76.4 -33.49 58.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 0.0 110.762 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.08 -26.49 36.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.789 -1.194 . . . . 0.0 109.8 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -171.27 91.8 0.44 Allowed Pre-proline 0 C--N 1.302 -1.489 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.71 -17.44 49.72 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.382 1.388 . . . . 0.0 112.709 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -93.09 2.81 56.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.912 -1.117 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.06 15.36 29.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.248 -0.908 . . . . 0.0 109.758 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.83 99.96 37.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.82 155.82 2.33 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.21 1.94 . . . . 0.0 112.306 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.47 167.94 24.95 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.478 2.118 . . . . 0.0 111.809 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.9 pt -104.54 161.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -79.65 136.93 36.93 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.005 -1.059 . . . . 0.0 109.007 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.42 133.42 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.8 134.09 33.95 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -114.31 112.42 23.06 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mt -136.72 142.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -100.5 156.77 17.09 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.75 37.67 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.96 -6.41 41.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.695 -0.885 . . . . 0.0 111.011 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -126.36 25.72 6.53 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.105 -0.997 . . . . 0.0 110.588 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.98 -10.73 38.94 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.078 -1.014 . . . . 0.0 111.113 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 92' ' ' TYR . . . -55.21 109.57 1.38 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.53 137.75 44.59 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.481 -1.011 . . . . 0.0 108.965 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' GLY . 97.2 m-85 -131.3 122.96 27.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.606 -0.684 . . . . 0.0 109.28 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -106.16 115.82 30.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.51 -0.744 . . . . 0.0 109.954 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.62 153.14 19.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.425 -0.797 . . . . 0.0 109.149 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -135.7 109.72 8.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.226 -0.922 . . . . 0.0 109.756 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -114.77 73.41 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.19 -165.97 34.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.21 30.61 2.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 4.4 m -52.09 -48.84 64.53 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -1.146 . . . . 0.0 110.409 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -72.08 -46.21 57.69 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.109 -0.994 . . . . 0.0 110.383 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.3 mtt180 -55.71 -31.58 62.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.769 -1.207 . . . . 0.0 108.659 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.448 ' CD1' ' NE ' ' A' ' 51' ' ' ARG . 36.6 t80 -63.54 -47.75 80.31 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.95 69.06 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.16 -0.963 . . . . 0.0 108.687 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.33 -48.53 49.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -63.77 -43.64 95.81 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.021 -1.049 . . . . 0.0 108.634 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -59.04 -46.4 88.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.389 -0.819 . . . . 0.0 109.442 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 109' ' ' GLN . 52.5 tt0 -60.3 -47.54 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.39 5.53 0.27 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 109.882 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' A' ' 107' ' ' GLN . 15.5 mm100 47.83 20.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -52.57 154.21 2.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.011 -1.056 . . . . 0.0 108.646 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -79.07 -42.55 26.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 0.0 110.16 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 45' ' ' PRO . 31.3 p -128.73 178.27 6.46 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.137 -0.977 . . . . 0.0 110.524 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.2 tt -138.95 143.79 38.66 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -84.65 122.71 2.75 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 120.94 1.094 . . . . 0.0 110.929 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.3 145.85 33.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.118 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -79.58 125.73 29.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.0 mt -85.94 141.55 29.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.22 -0.925 . . . . 0.0 109.366 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.05 101.68 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.555 -0.716 . . . . 0.0 109.281 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 120' ' ' SER . 2.0 tm0? -58.54 133.52 55.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 108.909 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.617 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.0 m -147.51 179.11 7.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.124 -0.985 . . . . 0.0 110.342 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.3 p -125.22 164.83 19.44 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.7 mt -51.74 -31.67 27.48 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.917 -1.114 . . . . 0.0 110.193 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.7 t -53.35 -49.23 67.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.793 -1.192 . . . . 0.0 109.577 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -68.67 -40.84 79.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.094 -1.004 . . . . 0.0 109.804 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.807 -1.183 . . . . 0.0 109.467 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 130' ' ' GLY . 84.3 mtt180 -62.38 -37.0 84.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.127 -0.983 . . . . 0.0 109.243 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.9 t -52.71 -34.04 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -91.35 -47.99 7.16 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.586 -0.696 . . . . 0.0 110.252 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.9 mt -110.02 41.94 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.767 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.31 38.21 0.09 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -155.6 -55.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.734 -1.45 . . . . 0.0 109.87 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.3 t -98.15 32.37 2.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.174 -0.954 . . . . 0.0 109.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.2 m -67.0 119.31 63.2 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.928 . . . . 0.0 109.79 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.33 -173.39 1.63 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.528 2.152 . . . . 0.0 111.785 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.59 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.6 t0 -111.23 95.24 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -63.84 141.43 58.77 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.469 -0.77 . . . . 0.0 110.881 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 135' ' ' ASP . 68.1 mm-40 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.942 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.73 -37.06 2.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.3 Cg_exo -56.09 163.5 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.145 1.897 . . . . 0.0 112.11 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -153.19 40.27 0.53 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . -169.23 70.79 0.14 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 21' ' ' GLY . 87.8 Cg_exo -46.28 -179.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.811 2.34 . . . . 0.0 112.25 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.71 -67.16 0.02 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.2 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.796 2.331 . . . . 0.0 111.972 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -164.26 32.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.438 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 179.89 86.31 0.07 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.83 66.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.15 -5.51 54.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 109.441 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -160.82 -168.78 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.8 5.52 0.1 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 32' ' ' SER . . . 57.1 83.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 31' ' ' GLY . 5.6 m -166.41 130.85 2.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.528 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -68.97 161.34 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.446 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -79.37 125.54 29.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -63.55 -42.53 98.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.444 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.3 162.69 26.99 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 38' ' ' ILE . 22.9 ptt180 -49.55 146.83 3.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -1.135 . . . . 0.0 109.502 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 37' ' ' ARG . 5.8 pt -157.31 125.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.367 -0.833 . . . . 0.0 109.223 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.02 57.15 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.59 -173.38 2.25 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.632 -0.667 . . . . 0.0 109.456 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.3 t -81.68 142.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.854 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.7 m-70 -147.25 153.96 40.42 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.123 -0.986 . . . . 0.0 109.984 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -92.15 94.08 9.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.2 p -88.13 123.98 67.6 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.31 -0.869 . . . . 0.0 109.254 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.64 ' HA ' HG22 ' A' ' 112' ' ' THR . 78.5 Cg_exo -47.59 139.63 17.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.908 1.739 . . . . 0.0 113.589 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -67.71 -27.49 66.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.302 -0.874 . . . . 0.0 108.888 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 t -67.49 -18.82 65.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.492 -0.755 . . . . 0.0 111.943 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.84 23.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.719 -1.238 . . . . 0.0 110.691 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 49' ' ' LEU . 41.9 mt -90.48 129.51 36.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.807 -1.183 . . . . 0.0 108.988 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.2 mt -95.67 123.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' NH2' ' CB ' ' A' ' 102' ' ' TYR . 8.4 mmm180 -127.18 84.87 62.33 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.569 -0.707 . . . . 0.0 110.055 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -92.24 23.13 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.909 2.406 . . . . 0.0 111.714 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.16 90.13 5.41 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 108.737 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.3 165.16 23.7 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.079 1.853 . . . . 0.0 112.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.401 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 4.0 p -156.58 138.86 14.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.175 -0.953 . . . . 0.0 109.354 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.39 145.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.703 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.08 149.78 35.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.788 0.804 . . . . 0.0 109.934 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.9 t70 -112.57 140.11 23.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.542 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.1 Cg_endo -75.43 -21.52 15.0 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.005 1.803 . . . . 0.0 113.118 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.32 -38.52 30.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.727 -1.233 . . . . 0.0 109.778 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 mmtt -76.79 -31.65 57.12 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.196 -0.94 . . . . 0.0 110.111 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 58' ' ' ASP . 80.2 t -72.52 -40.5 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.754 -1.216 . . . . 0.0 108.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -64.14 -35.68 81.56 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 t -66.34 -45.22 80.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 108.812 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.1 mt -67.43 -44.78 77.9 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.378 -0.826 . . . . 0.0 109.134 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.4 t -57.6 -30.77 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -67.95 -43.98 77.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.525 -0.735 . . . . 0.0 109.173 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -61.38 -50.81 71.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.8 mt -57.83 -41.8 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.903 . . . . 0.0 109.206 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -75.79 -31.49 59.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 110.685 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -84.21 -34.79 23.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.844 -1.16 . . . . 0.0 110.177 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -158.58 86.68 2.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.95 -21.65 71.88 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.618 1.545 . . . . 0.0 112.969 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.86 1.27 57.38 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.823 -1.173 . . . . 0.0 110.067 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.2 m -105.8 17.96 22.89 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.216 -0.928 . . . . 0.0 109.638 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.22 100.05 52.01 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.364 -0.835 . . . . 0.0 108.866 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.2 155.67 2.87 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.292 1.995 . . . . 0.0 112.564 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.21 170.0 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.663 2.242 . . . . 0.0 111.908 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -107.33 163.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.11 135.34 34.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.123 -0.985 . . . . 0.0 109.068 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.32 135.66 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.36 136.34 32.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -114.37 111.57 21.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.3 mt -134.3 140.67 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.403 -0.811 . . . . 0.0 110.098 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -101.66 156.39 17.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.92 -167.8 37.68 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.1 -6.35 41.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.956 . . . . 0.0 110.844 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -130.32 39.61 3.63 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.056 -1.028 . . . . 0.0 111.016 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.61 -10.58 1.43 Allowed Glycine 0 N--CA 1.494 2.563 0 O-C-N 121.145 -0.972 . . . . 0.0 111.642 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.37 107.85 0.67 Allowed Glycine 0 N--CA 1.485 1.933 0 O-C-N 120.744 -1.445 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.69 136.31 41.85 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.547 -0.973 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.2 m-85 -132.51 124.89 29.36 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.48 121.92 45.25 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 0.0 110.222 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -105.74 143.11 34.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.649 -0.657 . . . . 0.0 109.401 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.9 t -129.39 108.72 10.51 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.478 -0.764 . . . . 0.0 109.439 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -110.16 72.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.8 -160.94 30.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.98 32.43 2.34 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 13.3 t -58.2 -51.56 69.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -1.105 . . . . 0.0 110.461 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -69.75 -47.02 64.52 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.002 -1.061 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -55.53 -31.18 61.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.841 -1.162 . . . . 0.0 109.272 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' CB ' ' NH2' ' A' ' 51' ' ' ARG . 18.4 t80 -64.44 -44.85 89.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.46 80.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.477 -0.764 . . . . 0.0 109.238 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.22 -47.75 83.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -67.4 -34.0 76.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -0.902 . . . . 0.0 108.759 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.54 -34.66 78.4 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.302 -0.874 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 109' ' ' GLN . 55.7 tt0 -71.24 -48.32 51.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' ARG . 30.3 mt -68.64 13.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.6 pt20 41.83 22.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.713 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' LEU . 7.8 mmm-85 -51.02 155.13 1.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.006 -1.059 . . . . 0.0 108.816 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.38 -42.93 19.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.465 -0.772 . . . . 0.0 110.191 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 45' ' ' PRO . 36.0 p -132.24 177.12 7.82 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.086 -1.009 . . . . 0.0 110.513 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.9 tt -139.44 143.22 34.94 Favored Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.58 121.74 3.01 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.845 1.03 . . . . 0.0 110.897 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.15 142.58 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.409 -0.807 . . . . 0.0 110.005 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -74.4 128.93 36.78 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -91.78 136.23 33.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.055 -1.028 . . . . 0.0 109.506 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.52 103.98 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.62 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -62.5 126.83 28.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.073 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 11.6 m -138.69 -179.83 6.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -118.08 162.13 18.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 109.46 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -41.17 61.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.688 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -54.67 -49.31 70.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.164 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -54.3 -40.51 67.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.091 -1.006 . . . . 0.0 109.057 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 125' ' ' LEU . 13.2 tp -61.55 -38.48 87.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.897 -1.127 . . . . 0.0 108.726 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 130' ' ' GLY . 30.5 ttm180 -55.27 -38.9 69.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.208 -0.933 . . . . 0.0 108.919 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.6 t -55.71 -35.88 40.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -90.0 -49.94 6.31 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.377 -0.827 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 87.1 mt -109.27 40.11 1.92 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.888 . . . . 0.0 109.975 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.08 39.45 0.09 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.774 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.66 -57.24 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.776 -1.426 . . . . 0.0 109.455 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.6 p -101.98 35.1 2.46 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.901 . . . . 0.0 109.133 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -69.14 119.82 72.58 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.63 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.38 -173.99 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 122.196 1.93 . . . . 0.0 111.298 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.592 ' C ' HE21 ' A' ' 137' ' ' GLN . 40.4 t0 -110.6 94.44 5.0 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 92.8 mt -62.4 140.7 58.56 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.592 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.5 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.247 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.76 152.89 81.04 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.207 -1.173 . . . . 0.0 109.074 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.79 157.35 51.99 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.284 1.989 . . . . 0.0 112.002 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 21' ' ' GLY . 50.8 tt0 -168.06 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 20' ' ' GLU . . . -161.17 70.53 0.23 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.23 -48.04 13.83 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.784 2.323 . . . . 0.0 112.24 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.02 60.3 0.03 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.5 -171.99 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.729 2.286 . . . . 0.0 112.028 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 t -165.77 50.76 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.46 -74.75 0.7 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.62 -90.3 0.09 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -32.93 58.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -1.142 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.506 ' OE1' ' N ' ' A' ' 30' ' ' GLY . 1.1 tm0? -50.18 136.77 18.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' N ' ' OE1' ' A' ' 29' ' ' GLN . . . -176.16 107.31 0.23 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.27 39.53 1.44 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 30' ' ' GLY . 25.3 p -164.42 155.5 15.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.72 137.33 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -169.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.159 -0.963 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 38' ' ' ILE . 36.9 m -53.82 -37.92 64.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 38' ' ' ILE . . . 67.53 175.33 8.13 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -56.56 88.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -1.113 . . . . 0.0 109.357 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 36' ' ' GLY . 20.1 mt -143.55 97.53 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.248 -0.908 . . . . 0.0 108.988 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.7 102.09 14.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.459 -0.775 . . . . 0.0 109.452 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.63 -173.73 4.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 47.0 t -78.64 143.55 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.275 -0.891 . . . . 0.0 108.877 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 17.3 m-70 -149.7 163.32 38.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.056 -1.028 . . . . 0.0 109.98 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -103.09 96.32 6.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.5 p -89.35 125.29 62.23 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.347 -0.845 . . . . 0.0 109.304 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.649 ' HA ' HG22 ' A' ' 112' ' ' THR . 81.4 Cg_exo -47.79 142.06 15.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.698 1.598 . . . . 0.0 113.569 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -68.55 -32.64 72.72 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.671 0.748 . . . . 0.0 109.153 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -27.65 69.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 0.0 111.756 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.89 25.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.734 -1.229 . . . . 0.0 111.178 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.66 132.51 34.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.741 -1.225 . . . . 0.0 109.102 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 50' ' ' ILE . 28.2 mt -103.17 125.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' NH2' ' O ' ' A' ' 97' ' ' GLY . 50.7 mtp85 -134.63 85.69 36.03 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.325 -0.859 . . . . 0.0 110.202 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -92.43 23.91 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.031 2.488 . . . . 0.0 111.375 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -138.01 104.07 8.13 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.26 162.35 31.32 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.681 1.587 . . . . 0.0 112.393 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -155.58 158.5 38.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.822 . . . . 0.0 109.353 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.4 t -84.85 114.92 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD21 ' SG ' ' A' ' 99' ' ' CYS . 80.4 mt -85.25 149.79 25.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 110.012 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.6 t70 -112.42 137.2 21.52 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.9 Cg_endo -74.45 -21.94 16.67 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.823 1.682 . . . . 0.0 113.345 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -38.95 24.91 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.742 -1.224 . . . . 0.0 110.117 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -75.65 -31.04 59.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.053 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 58' ' ' ASP . 66.5 t -69.52 -45.72 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.208 . . . . 0.0 108.467 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.44 -38.84 75.07 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 t -61.56 -47.66 84.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.154 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.75 -44.56 85.53 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.72 -31.89 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 108.437 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.86 -42.83 76.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.07 -51.67 65.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.519 -0.738 . . . . 0.0 109.732 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.54 -40.97 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.076 -1.015 . . . . 0.0 109.093 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -72.96 -34.5 66.53 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.344 -0.848 . . . . 0.0 110.429 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -82.03 -38.7 24.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.837 -1.165 . . . . 0.0 109.948 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.04 102.02 1.58 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.107 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 -18.3 36.52 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.312 1.341 . . . . 0.0 113.085 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -92.9 3.19 56.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.876 -1.14 . . . . 0.0 109.934 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -104.77 16.41 26.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.339 -0.851 . . . . 0.0 109.741 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.32 100.71 47.37 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 108.966 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.34 156.08 2.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.09 1.86 . . . . 0.0 111.939 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.5 169.01 21.95 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.392 2.061 . . . . 0.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -103.34 160.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -81.43 128.5 33.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.021 -1.049 . . . . 0.0 109.345 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.01 137.16 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.466 -0.771 . . . . 0.0 108.979 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.17 139.78 30.13 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -118.08 104.13 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.599 -0.688 . . . . 0.0 109.314 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.71 143.71 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.48 -0.762 . . . . 0.0 110.41 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -103.37 156.32 17.83 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.32 -170.32 37.79 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.0 -5.16 24.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.621 -0.929 . . . . 0.0 110.819 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' GLY . 31.1 mt-30 -129.71 38.1 3.88 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.984 . . . . 0.0 110.796 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 -10.27 0.9 Allowed Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.124 -0.985 . . . . 0.0 111.502 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.26 109.05 0.89 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.87 135.59 41.54 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.521 -0.988 . . . . 0.0 109.044 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -133.32 128.95 36.83 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -109.6 123.13 48.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -108.91 134.02 52.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 109.648 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.6 t -119.38 107.53 13.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.01 72.11 0.93 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.57 -156.28 26.7 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.9 15.27 0.1 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 t -50.73 -41.68 56.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -1.127 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -73.04 -47.69 42.68 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.076 -1.015 . . . . 0.0 110.239 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -56.06 -32.02 63.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.781 -1.2 . . . . 0.0 108.677 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -65.47 -44.87 85.82 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.123 -0.986 . . . . 0.0 108.352 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.17 -32.38 66.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.5 -47.64 19.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 109.755 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.5 -43.38 90.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.892 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 107' ' ' GLN . 2.3 tm0? -63.86 -32.57 74.13 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.194 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 109' ' ' GLN . 49.8 tt0 -73.21 -47.65 41.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 110.106 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.2 mt -64.01 7.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.08 -1.013 . . . . 0.0 110.215 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 107' ' ' GLN . 4.9 tp-100 47.62 60.01 3.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.064 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -96.96 161.6 13.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.92 . . . . 0.0 109.057 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.64 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.4 tt0 -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 45' ' ' PRO . 25.4 p -132.81 177.44 7.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.905 -1.122 . . . . 0.0 110.063 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.0 tt -138.85 141.82 31.71 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.586 -0.696 . . . . 0.0 109.988 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -70.87 134.45 25.67 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 120.844 1.029 . . . . 0.0 110.578 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.15 137.71 15.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.802 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -75.82 121.0 21.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.509 -0.744 . . . . 0.0 109.025 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.6 mt -85.89 134.87 33.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.106 -0.996 . . . . 0.0 109.341 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.27 102.67 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.576 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -56.21 127.93 33.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 108.944 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.576 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 5.7 m -137.26 -178.58 5.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.416 -0.802 . . . . 0.0 109.524 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -125.41 176.27 6.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -42.6 98.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.451 -0.781 . . . . 0.0 109.781 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.5 t -59.26 -47.36 85.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.982 -1.074 . . . . 0.0 110.449 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -54.08 -40.05 66.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.985 -1.072 . . . . 0.0 109.074 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 125' ' ' LEU . 15.3 tp -62.43 -39.14 92.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 108.814 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' GLY . 38.3 ttt180 -55.66 -38.27 69.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.161 -0.962 . . . . 0.0 108.943 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.33 -34.35 45.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -90.13 -49.62 6.46 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.315 -0.866 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -112.93 42.24 1.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.346 -0.846 . . . . 0.0 109.94 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.66 40.3 0.08 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 120.217 -0.992 . . . . 0.0 110.813 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.89 -59.72 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.766 -1.432 . . . . 0.0 109.63 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.3 m -100.69 35.05 2.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.091 -1.005 . . . . 0.0 109.293 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -70.95 119.65 74.55 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.182 -0.949 . . . . 0.0 109.859 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.77 -173.7 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.916 1.744 . . . . 0.0 111.05 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.586 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.4 t0 -110.49 94.64 5.11 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 96.1 mt -61.5 141.29 57.81 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.718 0.77 . . . . 0.0 110.9 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.586 HE21 ' C ' ' A' ' 135' ' ' ASP . 71.0 mm-40 . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.074 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.611 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.9 -36.74 2.42 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.21 -1.171 . . . . 0.0 110.514 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 82.4 Cg_endo -91.17 143.15 3.14 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.395 2.063 . . . . 0.0 112.176 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 24.5 mp0 -50.67 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.62 -60.04 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -45.69 103.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.83 178.58 46.83 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 26' ' ' GLY . 72.6 Cg_endo -75.26 -161.66 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.74 2.293 . . . . 0.0 112.057 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -74.8 25.95 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 24' ' ' PRO . . . -78.14 -159.94 14.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.59 75.58 1.8 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.02 -28.12 66.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -72.77 60.68 0.51 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.6 162.41 36.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.52 -68.11 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -166.22 121.26 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.48 -163.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.902 . . . . 0.0 109.529 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -167.11 36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -80.37 -144.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.21 -167.18 20.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -153.62 85.72 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.228 -1.16 . . . . 0.0 109.389 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.3 mt -143.56 97.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.168 -0.958 . . . . 0.0 109.015 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.1 107.36 19.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.503 -0.748 . . . . 0.0 109.457 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.24 -175.1 5.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 99.5 t -83.04 144.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.202 -0.937 . . . . 0.0 109.065 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 26.4 m-70 -148.8 158.4 44.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.3 -0.875 . . . . 0.0 109.67 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 11.5 p30 -94.93 94.84 8.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.1 p -88.71 124.26 66.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HA ' HG22 ' A' ' 112' ' ' THR . 85.9 Cg_exo -47.41 140.81 15.15 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.953 1.769 . . . . 0.0 113.945 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.07 -26.99 66.12 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.464 -0.772 . . . . 0.0 109.138 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 t -72.25 -16.0 61.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.431 -0.793 . . . . 0.0 112.51 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.2 m -111.05 23.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.614 -1.304 . . . . 0.0 110.788 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 HH22 ' A' ' 51' ' ' ARG . 75.7 mt -92.43 124.87 36.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.801 -1.187 . . . . 0.0 109.091 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -90.17 130.14 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.201 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.501 HH22 HD13 ' A' ' 49' ' ' LEU . 62.7 mtt85 -134.49 83.77 42.11 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.465 -0.772 . . . . 0.0 109.501 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.599 ' O ' HD12 ' A' ' 53' ' ' LEU . 39.1 Cg_endo -92.65 22.51 0.61 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.304 2.669 . . . . 0.0 111.823 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.02 108.58 9.77 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.42 160.61 32.11 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.628 1.552 . . . . 0.0 112.234 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -156.54 152.51 27.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 0.0 109.345 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.9 t -82.36 110.39 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.568 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.2 mt -79.01 149.82 32.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.642 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 60' ' ' ALA . 5.0 t70 -110.27 136.51 20.52 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.99 -23.25 16.32 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.936 1.758 . . . . 0.0 113.017 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -80.89 -41.3 23.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.008 -1.057 . . . . 0.0 110.32 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -73.34 -37.51 66.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.029 -1.044 . . . . 0.0 109.744 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 56.5 t -59.14 -39.18 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.898 -1.126 . . . . 0.0 108.708 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -63.89 -40.3 96.2 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.296 -0.877 . . . . 0.0 109.006 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 68' ' ' THR . 5.4 t -58.67 -47.7 83.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.107 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.45 -48.45 72.68 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.361 -0.837 . . . . 0.0 109.269 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 t -56.37 -32.01 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.61 -0.681 . . . . 0.0 109.17 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 64' ' ' SER . 0.9 OUTLIER -60.08 -50.58 73.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.623 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.04 -42.28 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.93 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -76.12 -28.44 57.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.961 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -91.75 -33.31 15.06 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.807 -1.183 . . . . 0.0 110.528 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' OD2' ' OG ' ' A' ' 75' ' ' SER . 51.6 t0 -162.16 93.25 1.3 Allowed Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.147 -0.97 . . . . 0.0 109.667 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.18 -19.23 40.77 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.397 1.398 . . . . 0.0 112.597 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' VAL . 15.4 t70 -86.03 -31.81 21.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.918 -1.114 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.417 ' OG ' ' OD2' ' A' ' 72' ' ' ASP . 24.9 m -66.06 9.17 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.826 -1.171 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.2 p -144.26 101.39 4.8 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.36 162.92 22.32 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.228 1.952 . . . . 0.0 113.857 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -47.04 170.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.766 2.31 . . . . 0.0 112.121 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.53 170.86 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -92.54 140.17 29.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.991 -1.068 . . . . 0.0 109.579 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.46 136.6 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.282 -0.886 . . . . 0.0 108.803 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt -85.98 134.61 33.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -111.2 113.67 26.34 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -131.83 146.13 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.307 -0.871 . . . . 0.0 109.971 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 91' ' ' ASP . 5.8 tttp -105.96 156.89 17.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.48 0.657 . . . . 0.0 109.648 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.19 -168.09 35.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.04 -6.3 41.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.6 -0.941 . . . . 0.0 110.839 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -130.04 39.04 3.73 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.056 -1.028 . . . . 0.0 110.893 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 68.14 -9.72 1.5 Allowed Glycine 0 N--CA 1.493 2.472 0 O-C-N 121.23 -0.919 . . . . 0.0 111.844 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -55.34 110.73 1.93 Allowed Glycine 0 N--CA 1.488 2.133 0 O-C-N 120.665 -1.491 . . . . 0.0 109.68 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 85' ' ' LYS . 5.0 m-20 -75.74 137.06 40.35 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.492 -1.005 . . . . 0.0 109.369 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.13 126.26 33.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -104.96 116.42 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.39 128.51 52.26 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 t -118.53 107.74 14.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.377 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -105.02 71.97 0.98 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 154.04 -159.14 28.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.16 16.82 0.09 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' N ' ' O ' ' A' ' 97' ' ' GLY . 11.6 t -53.32 -46.81 69.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -1.184 . . . . 0.0 110.44 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -67.12 -45.26 77.69 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.045 -1.034 . . . . 0.0 109.943 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.652 HH21 HG23 ' A' ' 76' ' ' VAL . 49.1 mtt180 -56.8 -32.53 65.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.008 -1.057 . . . . 0.0 109.109 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -63.35 -45.74 89.79 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.927 -1.108 . . . . 0.0 108.397 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.86 83.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.041 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.86 -49.49 57.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.124 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -63.34 -33.89 76.5 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -64.94 -44.33 89.79 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.445 -0.784 . . . . 0.0 109.035 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.04 -33.34 71.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.018 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.96 0.25 4.73 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 56.25 31.51 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.697 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -78.78 149.07 32.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.879 -1.138 . . . . 0.0 108.712 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -79.14 -44.09 22.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.428 -0.795 . . . . 0.0 109.988 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 45' ' ' PRO . 21.7 p -125.78 177.46 6.27 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.049 -1.032 . . . . 0.0 110.069 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.38 143.36 38.36 Favored Pre-proline 0 N--CA 1.5 2.057 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.84 128.21 3.77 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 121.011 1.14 . . . . 0.0 111.216 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.98 146.31 31.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.328 -0.858 . . . . 0.0 109.622 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -80.05 106.44 12.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.8 mt -68.13 139.82 56.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.065 . . . . 0.0 108.966 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.06 101.65 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.648 HE21 ' N ' ' A' ' 120' ' ' SER . 1.7 tm0? -58.25 132.63 54.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.434 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.648 ' N ' HE21 ' A' ' 119' ' ' GLN . 4.7 m -141.33 -178.92 5.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -0.868 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.9 p -119.44 160.2 22.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.695 . . . . 0.0 109.224 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.5 tp -53.77 -39.67 65.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.9 t -53.94 -46.98 71.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -55.69 -42.34 75.05 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.183 -0.948 . . . . 0.0 109.076 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.72 -39.31 84.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.969 -1.082 . . . . 0.0 108.995 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 130' ' ' GLY . 0.4 OUTLIER -55.7 -37.86 68.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 108.649 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.4 t -57.97 -34.75 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.62 -49.56 6.41 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 0.0 110.775 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -110.27 41.53 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 0.0 109.769 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -62.27 39.48 0.06 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -158.0 -55.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.659 -1.495 . . . . 0.0 109.92 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -99.88 36.01 1.91 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.104 -0.997 . . . . 0.0 109.707 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -73.1 121.99 86.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 109.8 -179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.86 -173.55 1.81 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.365 2.043 . . . . 0.0 111.581 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.549 ' C ' HE21 ' A' ' 137' ' ' GLN . 22.2 t0 -109.56 94.18 4.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.8 mt -64.56 142.77 58.31 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.702 0.763 . . . . 0.0 110.824 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.549 HE21 ' C ' ' A' ' 135' ' ' ASP . 69.0 mm-40 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.168 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.38 149.41 94.87 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.144 -1.209 . . . . 0.0 109.092 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.84 130.26 14.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.173 1.915 . . . . 0.0 111.981 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -79.98 158.88 26.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.32 179.67 45.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.52 17.59 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.705 2.27 . . . . 0.0 112.023 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.19 -71.94 0.22 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.18 154.27 46.61 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.819 2.346 . . . . 0.0 112.005 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.9 p -169.92 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.68 66.44 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' H ' ' H ' ' A' ' 28' ' ' ALA . . . 169.84 8.37 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' H ' ' H ' ' A' ' 27' ' ' GLY . . . -73.76 -44.8 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -74.03 105.56 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.66 67.52 1.02 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.97 95.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.1 m -71.6 176.14 5.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.42 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.76 17.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -59.16 139.25 57.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' H ' ' A' ' 36' ' ' GLY . 80.5 p -168.64 1.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 35' ' ' SER . . . -164.65 179.68 39.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -169.98 148.61 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -1.094 . . . . 0.0 109.465 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.37 97.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.274 -0.891 . . . . 0.0 109.082 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.81 91.01 6.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.556 -0.715 . . . . 0.0 109.382 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.56 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.322 -0.861 . . . . 0.0 109.436 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 97.5 t -74.77 143.14 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.1 m-70 -151.42 135.72 16.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.328 -0.857 . . . . 0.0 109.705 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -77.94 96.89 5.15 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.8 p -89.78 122.95 67.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.268 -0.895 . . . . 0.0 109.32 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.628 ' HA ' HG22 ' A' ' 112' ' ' THR . 75.1 Cg_exo -48.01 138.94 21.08 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 121.887 1.725 . . . . 0.0 113.379 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.43 -26.83 68.14 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.382 -0.824 . . . . 0.0 109.062 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.6 p -70.12 -18.86 63.25 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.822 -0.549 . . . . 0.0 112.429 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 m -111.64 -11.75 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 O-C-N 120.774 -1.204 . . . . 0.0 111.074 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.755 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -77.93 136.71 38.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.486 -1.384 . . . . 0.0 108.411 179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 49' ' ' LEU . 8.0 mt -101.58 137.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.6 -0.687 . . . . 0.0 111.674 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.546 HH12 ' C ' ' A' ' 98' ' ' GLY . 6.9 mmt180 -131.28 83.73 58.84 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -92.96 23.54 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.891 2.394 . . . . 0.0 112.398 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.3 102.32 8.95 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.318 -0.864 . . . . 0.0 109.305 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.37 162.61 27.95 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.628 1.552 . . . . 0.0 112.295 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.586 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 6.6 p -156.51 131.43 9.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 109.272 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.7 p -49.58 121.11 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.711 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD21 ' SG ' ' A' ' 99' ' ' CYS . 77.7 mt -94.51 149.69 20.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.887 . . . . 0.0 109.946 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 10.3 t70 -111.11 135.69 20.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.02 -18.81 18.39 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.796 1.664 . . . . 0.0 112.961 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.37 -41.65 17.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.0 110.177 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -73.71 -37.98 64.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 58' ' ' ASP . 64.4 t -58.92 -37.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 108.644 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -62.54 -47.49 83.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.409 -0.807 . . . . 0.0 108.95 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -53.34 -47.12 69.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.387 -0.821 . . . . 0.0 109.299 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.82 -48.1 69.98 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.283 -0.886 . . . . 0.0 109.283 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 t -57.01 -31.81 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.08 -42.71 89.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.503 -0.748 . . . . 0.0 109.171 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -65.13 -48.47 73.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.336 -0.852 . . . . 0.0 109.699 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.09 -40.9 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.074 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 HE22 ' A' ' 107' ' ' GLN . 68.7 mtt180 -70.55 -42.02 71.7 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.438 -0.789 . . . . 0.0 110.306 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.14 -39.83 75.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.963 -1.086 . . . . 0.0 109.806 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -164.81 109.76 0.83 Allowed Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 108.824 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.99 -19.5 39.71 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.371 1.381 . . . . 0.0 113.079 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -92.57 3.02 56.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.889 -1.132 . . . . 0.0 109.854 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.5 m -98.99 11.36 39.22 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -0.983 . . . . 0.0 109.837 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.03 137.99 23.79 Favored Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.78 159.83 24.69 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.82 1.68 . . . . 0.0 112.292 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.63 171.93 17.28 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.524 2.149 . . . . 0.0 111.848 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 pt -112.85 167.52 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 135.41 33.35 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.286 -0.884 . . . . 0.0 109.372 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.29 131.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.36 135.63 33.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.425 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.6 t90 -116.75 112.34 21.04 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.0 144.56 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -102.99 155.95 18.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 109.577 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.72 -176.42 39.85 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.6 -6.56 20.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.726 -0.867 . . . . 0.0 110.924 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -125.23 24.46 7.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 0.0 110.412 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.86 -11.17 42.72 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.159 -1.019 . . . . 0.0 111.028 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -53.55 107.96 0.71 Allowed Glycine 0 N--CA 1.487 2.074 0 O-C-N 120.821 -1.399 . . . . 0.0 109.991 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.32 136.62 42.56 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.591 -0.946 . . . . 0.0 108.853 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -130.26 118.64 21.66 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.349 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -102.27 115.4 30.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.481 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -100.83 151.82 21.26 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.538 -0.726 . . . . 0.0 109.531 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.2 t -134.33 108.82 8.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.501 -0.75 . . . . 0.0 109.16 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -111.52 72.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 51' ' ' ARG . . . 155.85 -157.14 27.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.546 ' C ' HH12 ' A' ' 51' ' ' ARG . . . 44.99 19.02 0.15 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HG ' ' HG ' ' A' ' 55' ' ' SER . 11.0 t -52.25 -48.15 65.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -1.188 . . . . 0.0 110.474 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -70.74 -47.45 59.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.996 -1.065 . . . . 0.0 109.816 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -57.52 -30.96 65.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.794 -1.191 . . . . 0.0 108.972 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.42 -44.83 95.49 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.59 69.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 108.594 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.21 -46.66 32.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.41 -0.806 . . . . 0.0 109.24 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -67.84 -41.71 82.56 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.184 -0.948 . . . . 0.0 108.576 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.65 -37.55 84.43 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.257 -0.902 . . . . 0.0 108.703 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.521 HE22 HH21 ' A' ' 70' ' ' ARG . 2.9 tm0? -65.19 -53.44 44.71 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.488 -0.757 . . . . 0.0 110.234 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD21 ' HE ' ' A' ' 70' ' ' ARG . 26.3 mt -64.03 5.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 107' ' ' GLN . 3.9 tp-100 45.36 49.06 10.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.19 -0.943 . . . . 0.0 110.163 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -83.18 159.17 22.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.025 . . . . 0.0 108.87 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 15.1 mp0 -80.46 -39.62 27.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 110.888 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.628 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.0 p -133.3 176.98 8.04 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.003 -1.06 . . . . 0.0 110.58 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.5 tt -141.05 141.66 24.71 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.708 -0.62 . . . . 0.0 109.675 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -68.24 132.97 27.21 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.026 1.151 . . . . 0.0 110.837 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.14 138.11 16.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.116 -0.99 . . . . 0.0 109.833 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -82.31 119.19 23.81 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 46.1 mt -80.48 138.56 36.58 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.307 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.71 101.99 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 120' ' ' SER . 27.1 tp60 -59.98 130.77 48.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.969 . . . . 0.0 108.753 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.627 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -141.74 -179.66 6.32 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 0.0 109.864 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.5 p -119.91 162.82 18.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.24 -25.48 5.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.96 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.1 m -66.61 -50.61 62.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.134 . . . . 0.0 110.186 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.65 -35.01 67.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.841 -1.162 . . . . 0.0 108.757 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' LEU . 12.8 tp -62.8 -40.72 98.21 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' GLY . 18.8 ttt-85 -57.02 -38.78 73.63 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.059 . . . . 0.0 108.783 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.87 -35.73 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.036 -1.04 . . . . 0.0 108.532 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -90.41 -49.11 6.71 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.227 -0.921 . . . . 0.0 110.911 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 95.9 mt -113.18 42.82 1.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.8 39.32 0.1 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.539 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.16 -58.65 0.13 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.805 -1.409 . . . . 0.0 109.49 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.2 p -99.67 37.49 1.59 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.233 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.59 117.35 61.52 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.315 -0.865 . . . . 0.0 109.915 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.38 -175.0 2.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 121.815 1.677 . . . . 0.0 110.947 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' C ' HE21 ' A' ' 137' ' ' GLN . 36.2 t0 -104.04 117.82 35.2 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 44.2 mt -79.99 132.47 36.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.509 -0.745 . . . . 0.0 110.481 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.546 HE21 ' C ' ' A' ' 135' ' ' ASP . 57.2 mm-40 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.058 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -165.18 67.75 1.25 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -46.04 153.31 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.721 2.281 . . . . 0.0 112.308 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.17 -6.41 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.15 60.81 0.19 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 152.05 35.0 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.779 2.319 . . . . 0.0 112.034 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.69 70.04 0.95 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.32 141.91 9.69 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.78 2.32 . . . . 0.0 112.25 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.5 m -161.69 -64.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.555 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' C ' ' N ' ' A' ' 28' ' ' ALA . . . 177.7 -48.07 0.1 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.15 10.88 1.3 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 30' ' ' GLY . . . -65.8 -4.69 7.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -68.67 45.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.426 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 28' ' ' ALA . . . -75.05 121.82 6.71 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 30' ' ' GLY . . . 55.4 169.66 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 m -63.64 115.99 5.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -1.189 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 34' ' ' HIS . 9.4 tp -68.84 -38.68 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.268 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.471 ' N ' HG23 ' A' ' 33' ' ' ILE . 19.8 m-70 -57.28 -171.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 34' ' ' HIS . 60.7 p -58.74 -160.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.452 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.3 161.65 27.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -63.4 -173.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -1.169 . . . . 0.0 109.436 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.67 100.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.98 113.4 25.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.0 109.241 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.59 -174.41 4.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.265 -0.897 . . . . 0.0 109.674 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 61.1 t -84.52 145.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 32.3 m-70 -150.03 161.85 41.53 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.139 -0.976 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.2 p30 -99.52 93.39 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.7 p -87.33 126.52 62.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 109.368 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.3 Cg_exo -47.45 139.79 16.76 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.78 1.653 . . . . 0.0 113.29 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -67.26 -30.79 70.77 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.389 -0.819 . . . . 0.0 109.54 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.5 p -63.97 -27.12 68.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.726 -0.609 . . . . 0.0 112.161 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 25.09 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.758 -1.213 . . . . 0.0 111.43 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.9 mt -93.64 120.46 33.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.721 -1.237 . . . . 0.0 109.416 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -87.1 131.43 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 108.753 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -135.64 84.55 33.12 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.428 -0.795 . . . . 0.0 109.935 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -91.98 23.36 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 123.133 2.556 . . . . 0.0 111.838 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.46 89.56 8.34 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 162.88 8.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.289 1.993 . . . . 0.0 111.799 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 m -156.83 127.08 6.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.139 -0.976 . . . . 0.0 109.649 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.7 120.24 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.321 -0.862 . . . . 0.0 109.811 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 99' ' ' CYS . 75.9 mt -92.88 149.85 20.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.23 -0.919 . . . . 0.0 109.957 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.5 t70 -109.61 136.32 20.3 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -20.63 18.72 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.802 1.668 . . . . 0.0 112.994 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.35 -42.3 18.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 110.366 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -73.58 -35.48 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.13 -0.981 . . . . 0.0 109.749 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ASP . 75.7 t -62.72 -39.29 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.826 -1.172 . . . . 0.0 108.738 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.869 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -57.55 -47.5 81.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 109.063 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.91 -47.92 76.04 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.221 -0.924 . . . . 0.0 109.046 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.1 -31.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.8 -40.67 63.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 108.854 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -63.03 -52.26 63.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.7 mt -58.78 -41.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.132 -0.98 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -75.07 -30.17 60.89 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.427 -0.796 . . . . 0.0 110.847 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -87.29 -36.91 17.63 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.776 -1.202 . . . . 0.0 110.418 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -158.54 88.09 2.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.41 -16.12 45.28 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.653 1.569 . . . . 0.0 112.863 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -93.86 5.26 52.24 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.933 -1.105 . . . . 0.0 109.982 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.9 t -112.95 20.44 16.39 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.454 -0.779 . . . . 0.0 110.009 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.53 99.24 49.97 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.321 -0.862 . . . . 0.0 109.019 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.7 155.79 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.295 1.997 . . . . 0.0 112.311 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.49 172.8 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.699 2.266 . . . . 0.0 111.621 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -112.67 164.7 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 137.51 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.645 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.5 137.06 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.04 136.79 32.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 108.677 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -115.96 111.45 20.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -133.44 144.13 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.39 -0.819 . . . . 0.0 109.971 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 91' ' ' ASP . 6.9 tttp -103.6 156.41 17.81 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.41 -170.91 37.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 -6.36 34.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.913 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' GLY . 25.0 mt-30 -129.2 38.18 3.94 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.975 -1.078 . . . . 0.0 110.515 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.66 -12.69 0.97 Allowed Glycine 0 N--CA 1.493 2.444 0 O-C-N 121.158 -0.964 . . . . 0.0 111.308 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.525 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -49.94 106.97 0.27 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.47 135.42 40.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.64 -0.917 . . . . 0.0 109.088 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.3 m-85 -132.28 135.63 46.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.497 -0.752 . . . . 0.0 109.275 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -114.61 121.07 42.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.999 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.42 141.45 35.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.459 -0.775 . . . . 0.0 109.073 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.1 t -127.37 109.68 12.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.421 -0.8 . . . . 0.0 109.665 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.35 72.68 0.79 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 147.65 -157.3 27.32 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.98 17.77 0.1 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.4 t -53.2 -42.45 66.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.163 -1.198 . . . . 0.0 110.496 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -70.86 -47.71 57.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.997 -1.064 . . . . 0.0 109.954 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.715 -1.241 . . . . 0.0 108.427 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -64.27 -41.82 96.75 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.72 92.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.344 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.97 84.85 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.271 -0.893 . . . . 0.0 108.739 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -63.91 -38.89 92.77 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.55 -35.58 79.92 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -66.75 -38.87 87.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.25 2.4 11.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.036 -1.04 . . . . 0.0 109.822 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 48.59 31.75 3.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.2 mmt-85 -67.8 160.48 28.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.022 -1.049 . . . . 0.0 108.744 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.63 -41.37 27.15 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.506 -0.746 . . . . 0.0 110.598 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 45' ' ' PRO . 29.3 p -128.49 178.64 6.16 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.05 -1.031 . . . . 0.0 111.195 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.9 44.06 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.08 129.95 5.46 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 121.258 1.305 . . . . 0.0 111.241 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 144.97 25.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.893 . . . . 0.0 110.216 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -81.67 118.8 23.11 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.01 137.62 36.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.126 -0.984 . . . . 0.0 109.63 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.22 101.89 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.623 ' NE2' ' N ' ' A' ' 120' ' ' SER . 1.6 tm0? -60.05 128.48 37.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.623 ' N ' ' NE2' ' A' ' 119' ' ' GLN . 9.1 m -139.5 -178.77 5.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 109.183 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 174.84 6.06 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.075 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -47.72 84.95 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.564 -0.71 . . . . 0.0 109.624 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.4 t -55.74 -47.03 77.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.136 -0.977 . . . . 0.0 110.308 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -54.1 -41.16 67.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.884 -1.135 . . . . 0.0 108.987 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 15.3 tp -61.24 -39.32 89.88 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.984 -1.073 . . . . 0.0 108.669 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 130' ' ' GLY . 41.8 ttt-85 -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -0.946 . . . . 0.0 108.993 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -55.71 -36.03 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -89.98 -50.0 6.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.483 -0.761 . . . . 0.0 110.949 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -108.01 39.09 2.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 0.0 109.869 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.73 39.99 0.09 OUTLIER Glycine 0 N--CA 1.488 2.148 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -150.3 -59.59 0.19 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.791 -1.417 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -101.86 35.83 2.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.0 108.999 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -68.45 118.99 65.15 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.846 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.23 -173.93 1.92 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.232 1.954 . . . . 0.0 111.107 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.588 ' C ' HE21 ' A' ' 137' ' ' GLN . 21.5 t0 -111.7 95.51 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.522 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 95.9 mt -61.66 141.56 57.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.759 0.79 . . . . 0.0 110.849 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.588 HE21 ' C ' ' A' ' 135' ' ' ASP . 70.8 mm-40 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.088 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.74 -37.01 2.6 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 110.535 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 50.0 Cg_exo -55.99 116.24 3.03 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.106 1.871 . . . . 0.0 112.145 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -77.22 -104.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.496 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.73 178.55 53.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.32 164.16 33.3 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 111.978 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' SER . . . -160.79 70.47 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.09 -9.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.825 2.35 . . . . 0.0 112.25 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' GLY . 14.8 m -66.13 106.96 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.38 167.45 36.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.82 -35.91 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.16 67.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -1.126 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -71.68 -88.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 49.92 43.83 40.15 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.19 -103.83 0.18 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -49.75 115.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.5 pt -80.99 2.19 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -169.66 -26.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -77.52 169.91 17.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 37.07 0.5 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -70.4 157.06 38.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -1.159 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.32 97.72 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.214 -0.929 . . . . 0.0 108.983 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB1' ' HZ2' ' A' ' 116' ' ' LYS . . . -93.2 104.6 16.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.759 . . . . 0.0 109.452 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.36 -173.8 4.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 94.2 t -75.86 144.56 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.264 -0.897 . . . . 0.0 108.834 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 12.7 m-70 -150.92 158.89 44.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.15 -0.969 . . . . 0.0 109.912 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 15.5 p30 -98.05 97.8 9.21 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 49' ' ' LEU . 4.1 p -91.82 124.59 59.97 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.314 -0.866 . . . . 0.0 109.045 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' HA ' HG22 ' A' ' 112' ' ' THR . 87.2 Cg_exo -46.91 141.33 12.11 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 121.937 1.758 . . . . 0.0 113.682 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -68.55 -32.15 71.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.387 -0.82 . . . . 0.0 109.523 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -68.17 -19.41 64.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 112.393 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.1 p -106.12 19.24 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.616 -1.303 . . . . 0.0 110.608 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.432 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -86.59 134.09 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.501 -1.375 . . . . 0.0 109.068 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mt -99.9 124.47 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 mtm-85 -133.9 85.38 41.02 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.428 -0.795 . . . . 0.0 109.888 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -93.58 24.37 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.296 2.664 . . . . 0.0 112.043 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tt -130.89 102.78 16.0 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.488 -0.758 . . . . 0.0 109.572 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.23 158.87 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.948 1.766 . . . . 0.0 112.313 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.8 m -157.26 128.91 7.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.579 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.81 115.45 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.132 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.5 mt -88.69 149.52 23.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.555 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 8.7 t70 -113.08 138.97 22.48 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.31 -22.51 14.21 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.763 1.642 . . . . 0.0 113.225 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.09 -41.55 20.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.76 -1.212 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -72.23 -33.54 67.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 0.0 109.829 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 54.7 t -62.13 -51.22 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.94 -1.1 . . . . 0.0 109.077 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -55.69 -39.18 70.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 108.974 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 p -58.44 -47.84 82.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.1 mt -66.86 -44.22 81.53 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.189 -0.944 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -55.92 -31.82 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 108.182 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -74.79 -33.61 62.27 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.301 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -66.86 -42.11 86.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.954 -1.091 . . . . 0.0 109.283 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mt -66.46 -42.19 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.364 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -75.87 -54.74 6.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.389 -0.819 . . . . 0.0 109.99 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -56.97 -34.03 67.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.113 -0.992 . . . . 0.0 110.329 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -162.99 89.05 1.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 109.808 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.73 -16.23 47.38 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.43 1.42 . . . . 0.0 112.795 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -93.46 3.51 55.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.895 -1.128 . . . . 0.0 109.783 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 t -105.3 17.17 24.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.261 -0.899 . . . . 0.0 109.738 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.2 99.87 36.74 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.15 170.02 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.626 1.55 . . . . 0.0 111.822 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.67 163.54 31.52 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.507 2.138 . . . . 0.0 112.078 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.26 168.61 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.73 139.26 32.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.093 . . . . 0.0 109.739 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.4 t -144.27 136.98 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mp -91.06 139.81 30.41 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.299 -0.875 . . . . 0.0 108.731 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 10.7 t90 -118.69 113.43 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.11 145.08 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.208 -0.932 . . . . 0.0 110.031 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HZ3' ' CG ' ' A' ' 91' ' ' ASP . 1.3 tttp -100.41 157.23 16.78 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.59 -0.694 . . . . 0.0 109.681 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.43 -169.46 29.09 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.671 -0.971 . . . . 0.0 110.671 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.48 -7.23 41.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.698 -0.883 . . . . 0.0 110.902 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -125.72 26.56 6.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.147 -0.971 . . . . 0.0 110.13 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.99 -11.27 11.76 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . . . -52.87 116.85 5.9 Favored Glycine 0 N--CA 1.485 1.909 0 O-C-N 120.91 -1.347 . . . . 0.0 109.78 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 17.5 m-20 -79.65 134.12 36.42 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.416 -1.05 . . . . 0.0 109.177 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CE1' ' O ' ' A' ' 90' ' ' GLY . 95.5 m-85 -124.92 123.67 40.41 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.78 123.22 46.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.329 -0.857 . . . . 0.0 110.271 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.95 130.45 54.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.681 -0.637 . . . . 0.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.9 t -117.87 106.88 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -106.83 72.02 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.4 -157.97 27.49 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 45.24 27.31 1.68 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.167 -1.196 . . . . 0.0 110.196 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.3 m -58.91 -50.49 73.82 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.142 -1.21 . . . . 0.0 110.749 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -68.01 -44.78 75.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.888 -1.132 . . . . 0.0 110.373 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -55.6 -32.14 62.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.815 -1.178 . . . . 0.0 108.82 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.9 t80 -64.42 -43.0 95.72 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.48 -38.41 87.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 0.0 108.651 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -47.31 67.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.322 -0.861 . . . . 0.0 109.218 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.01 -44.52 84.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.441 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -61.39 -43.99 97.91 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 109' ' ' GLN . 10.7 tm0? -58.83 -47.96 82.99 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.582 -0.699 . . . . 0.0 110.286 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.41 9.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.985 -1.072 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 107' ' ' GLN . 0.3 OUTLIER 46.94 52.16 11.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -86.09 157.16 20.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.197 -0.939 . . . . 0.0 108.803 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.637 ' HG2' HG23 ' A' ' 112' ' ' THR . 5.6 tt0 -83.06 -44.47 15.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 110.168 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.651 HG22 ' HA ' ' A' ' 45' ' ' PRO . 23.1 p -131.84 177.23 7.69 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.864 -1.147 . . . . 0.0 110.38 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.4 tt -138.38 143.76 39.99 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.98 121.67 2.84 Favored 'Trans proline' 0 N--CA 1.484 0.912 0 C-N-CA 121.011 1.141 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.09 37.72 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 109.929 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.516 ' HZ2' ' HB1' ' A' ' 39' ' ' ALA . 4.3 tmtt? -77.05 124.98 28.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.94 141.13 28.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.118 -0.988 . . . . 0.0 109.997 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.26 103.38 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.55 HE21 ' N ' ' A' ' 120' ' ' SER . 29.7 tp60 -62.23 129.62 41.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 108.695 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.55 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.1 m -139.27 179.42 6.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.274 -0.891 . . . . 0.0 109.961 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -113.66 161.95 16.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.71 -38.33 69.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.093 -1.004 . . . . 0.0 110.102 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.8 m -54.17 -49.21 69.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.878 -1.139 . . . . 0.0 109.797 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.68 -40.29 72.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.053 -1.03 . . . . 0.0 109.471 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -58.96 -40.46 84.78 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.837 -1.164 . . . . 0.0 109.271 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 130' ' ' GLY . 90.0 mtt180 -59.57 -36.34 76.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.099 -1.001 . . . . 0.0 109.355 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.3 t -53.39 -33.5 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.675 -1.266 . . . . 0.0 107.629 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.61 -48.02 7.33 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.51 -0.744 . . . . 0.0 110.215 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . 85.0 mt -115.07 46.14 1.49 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.487 -0.758 . . . . 0.0 109.812 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.09 38.5 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.73 -55.26 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.814 -1.403 . . . . 0.0 109.955 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.7 p -98.47 35.48 1.79 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.016 -1.052 . . . . 0.0 109.642 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -75.04 117.86 66.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.161 -0.962 . . . . 0.0 109.692 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.03 -175.0 2.45 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.043 1.829 . . . . 0.0 111.415 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.464 ' CG ' ' NE2' ' A' ' 137' ' ' GLN . 44.9 t0 -104.24 128.7 52.02 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.3 mt -92.79 136.76 32.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.548 0.689 . . . . 0.0 110.378 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 57.6 mm-40 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.876 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.57 152.82 5.85 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.128 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.65 14.41 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.292 1.995 . . . . 0.0 111.933 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -61.7 -161.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.425 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.08 169.94 54.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.15 -91.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.753 2.302 . . . . 0.0 111.977 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HD2' ' A' ' 24' ' ' PRO . . . -159.52 -63.16 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 23' ' ' GLY . 86.6 Cg_exo -43.5 106.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.746 2.297 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -68.77 -9.89 53.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.34 -170.37 0.16 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.3 67.44 0.93 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.18 -37.71 37.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.506 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -73.08 -71.39 0.31 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.48 146.91 46.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 86.74 0.06 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.9 m -79.48 142.99 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.444 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 34' ' ' HIS . 17.8 tt -79.41 -37.12 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.432 ' N ' HG23 ' A' ' 33' ' ' ILE . 38.3 m80 -50.91 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.1 t -49.93 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 34' ' ' HIS . . . -167.33 -134.78 1.75 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -170.06 175.7 4.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 109.441 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.8 mt -143.47 99.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.238 -0.914 . . . . 0.0 109.003 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.56 107.47 12.46 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.06 -174.54 4.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.236 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 91.5 t -83.91 144.82 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.019 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 29.1 m-70 -149.28 158.99 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.236 -0.915 . . . . 0.0 109.641 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 10.7 p30 -94.98 95.89 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -88.84 123.16 68.3 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.275 -0.89 . . . . 0.0 109.225 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 112' ' ' THR . 77.9 Cg_exo -47.22 141.96 12.66 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.791 1.661 . . . . 0.0 113.423 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.95 -34.07 74.75 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.371 -0.831 . . . . 0.0 108.94 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -27.95 64.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 111.497 -178.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.06 24.38 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 120.771 -1.206 . . . . 0.0 110.265 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.662 ' C ' HD12 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -93.76 130.95 39.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.905 -1.122 . . . . 0.0 108.966 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.52 132.51 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.256 -0.902 . . . . 0.0 110.664 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 95' ' ' SER . 0.6 OUTLIER -131.81 83.23 57.95 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.692 -0.63 . . . . 0.0 109.35 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -97.29 28.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 123.172 2.581 . . . . 0.0 111.439 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 tt -141.52 90.06 9.04 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.309 -0.869 . . . . 0.0 109.13 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.36 157.52 2.04 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.468 2.112 . . . . 0.0 112.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.6 p -156.91 140.8 16.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.324 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.34 109.93 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.139 -0.976 . . . . 0.0 109.23 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.1 mt -87.19 149.21 24.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 110.053 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.5 t70 -111.41 135.89 21.0 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.93 -18.66 18.73 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.807 1.671 . . . . 0.0 112.997 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.16 -41.99 17.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.982 -1.074 . . . . 0.0 110.191 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -73.39 -41.12 63.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.146 -0.971 . . . . 0.0 109.452 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 58' ' ' ASP . 79.6 t -55.65 -37.32 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.108 . . . . 0.0 108.714 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -65.95 -41.29 91.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t -57.72 -47.37 82.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 mt -67.46 -48.89 65.87 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.211 -0.931 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.16 -32.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.65 -35.35 60.45 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 68' ' ' THR . 2.1 m -64.23 -49.26 72.61 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.472 -0.767 . . . . 0.0 109.419 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 109.621 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.605 ' HE ' ' CD2' ' A' ' 108' ' ' LEU . 50.0 mtt-85 -75.56 -32.8 60.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -84.57 -36.24 22.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.953 -1.092 . . . . 0.0 110.103 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -152.08 85.12 4.74 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.36 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.83 -15.77 40.14 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.514 1.476 . . . . 0.0 112.672 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.77 1.18 57.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.916 -1.115 . . . . 0.0 109.899 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -103.9 16.61 25.92 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG12 ' NH2' ' A' ' 101' ' ' ARG . 1.5 t -138.11 100.54 8.71 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.453 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 87.7 Cg_endo -80.79 158.44 21.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.952 1.768 . . . . 0.0 113.593 -177.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -45.96 173.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.756 2.304 . . . . 0.0 112.38 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -116.95 171.29 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 36.0 t0 -89.86 142.36 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 6.0 t -145.96 139.69 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.284 -0.885 . . . . 0.0 108.723 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mp -89.59 133.22 34.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.152 -0.968 . . . . 0.0 108.584 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.47 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 11.0 t90 -111.25 111.55 22.69 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.21 144.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 110.036 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.43 155.51 18.44 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.337 0.589 . . . . 0.0 109.777 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -94.63 -174.85 38.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 -6.38 18.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.698 -0.884 . . . . 0.0 110.758 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -129.73 36.86 4.03 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.125 -0.985 . . . . 0.0 110.838 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.81 -13.71 3.0 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.082 -1.011 . . . . 0.0 111.533 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.466 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.5 108.89 0.67 Allowed Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.782 -1.423 . . . . 0.0 109.776 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.11 132.37 36.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.515 -0.991 . . . . 0.0 109.342 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.8 m-85 -125.86 135.13 51.59 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.524 -0.735 . . . . 0.0 109.018 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -112.57 117.11 31.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.941 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -104.9 133.69 49.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.461 -0.774 . . . . 0.0 109.496 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.523 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 26.0 t -117.92 108.37 15.21 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.453 -0.779 . . . . 0.0 109.403 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -108.49 72.67 0.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 157.09 -164.77 32.98 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . 44.28 23.07 0.42 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 97' ' ' GLY . 3.3 m -49.88 -51.2 42.33 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.379 -1.071 . . . . 0.0 110.382 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -69.59 -46.45 66.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.479 ' NH2' HG12 ' A' ' 76' ' ' VAL . 84.7 mtp180 -58.57 -31.03 67.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.86 -1.15 . . . . 0.0 109.236 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.25 -50.8 70.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.23 -37.53 75.04 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.892 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.29 89.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.402 -0.811 . . . . 0.0 109.401 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.29 -43.81 96.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 108.661 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -65.52 -31.14 72.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -72.23 -31.6 65.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.71 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' CD2' ' HE ' ' A' ' 70' ' ' ARG . 92.0 mt -81.0 2.64 26.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.135 -0.978 . . . . 0.0 109.693 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 56.39 46.26 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.971 . . . . 0.0 110.239 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -87.33 152.94 21.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.028 -1.045 . . . . 0.0 108.848 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.06 -42.73 23.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.339 -0.85 . . . . 0.0 110.275 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 45' ' ' PRO . 30.9 p -130.03 177.64 7.14 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.119 -0.988 . . . . 0.0 110.202 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.57 143.07 33.98 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.0 131.63 5.2 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.002 1.135 . . . . 0.0 110.965 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.06 143.78 24.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.9 . . . . 0.0 109.786 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -77.97 119.61 21.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 108.96 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.1 137.25 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.971 . . . . 0.0 109.281 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.61 101.66 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.62 HE21 ' N ' ' A' ' 120' ' ' SER . 26.0 tp60 -61.52 129.71 42.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.971 . . . . 0.0 109.315 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.62 ' N ' HE21 ' A' ' 119' ' ' GLN . 10.1 m -141.48 -178.94 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -120.94 163.61 17.98 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.536 -0.727 . . . . 0.0 109.428 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.92 -34.29 27.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.225 -0.922 . . . . 0.0 109.638 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.0 t -58.59 -50.13 74.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.002 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -55.66 -36.23 66.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.999 -1.063 . . . . 0.0 108.836 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 125' ' ' LEU . 14.0 tp -61.85 -40.57 95.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.082 -1.011 . . . . 0.0 108.706 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLY . 26.9 ttm180 -56.4 -39.13 72.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.264 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.38 -35.14 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.528 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -90.19 -48.97 6.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.197 -0.94 . . . . 0.0 110.702 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 131' ' ' ALA . 92.9 mt -114.51 42.99 2.0 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -65.0 38.37 0.11 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -151.92 -58.55 0.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.871 -1.37 . . . . 0.0 109.22 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -101.3 35.08 2.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.09 138.01 97.28 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -95.24 -176.76 0.4 Allowed 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.149 1.9 . . . . 0.0 111.849 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 137' ' ' GLN . 27.0 t0 -106.44 125.39 50.94 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 30.2 mt -97.55 134.29 40.97 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.648 0.737 . . . . 0.0 110.476 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 58.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.072 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.59 60.32 0.44 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.264 -1.139 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.68 80.17 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.732 2.288 . . . . 0.0 112.012 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -51.8 -25.33 7.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.06 172.0 42.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.29 152.73 39.79 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.782 2.322 . . . . 0.0 111.965 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.35 -59.88 3.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 134.07 13.77 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.71 2.274 . . . . 0.0 112.275 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.9 t -168.28 66.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.78 -51.71 0.31 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.83 167.43 23.17 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.39 -44.8 24.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -1.097 . . . . 0.0 109.532 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -162.66 2.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.75 -47.75 7.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.71 -101.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 m -165.26 139.59 4.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -1.194 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.0 mm -74.69 -29.58 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -56.59 95.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.507 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.9 p -165.17 83.42 0.37 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 0.0 109.401 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.22 118.92 0.83 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 37' ' ' ARG . 11.4 mpt_? -67.2 112.81 4.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -1.148 . . . . 0.0 109.306 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.5 mt -143.25 97.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.45 103.8 15.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.434 -0.791 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.76 -173.85 4.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.914 . . . . 0.0 109.572 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 87.5 t -75.71 144.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.877 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 13.4 m-70 -151.63 148.11 27.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.3 -0.875 . . . . 0.0 109.653 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.64 96.75 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.0 p -88.46 124.16 66.68 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.157 -0.965 . . . . 0.0 108.972 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.644 ' HA ' HG22 ' A' ' 112' ' ' THR . 84.4 Cg_exo -46.04 142.63 8.12 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.86 1.707 . . . . 0.0 113.491 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.46 -35.35 73.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 108.816 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 t -66.1 -12.74 57.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.393 -0.817 . . . . 0.0 112.146 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.33 26.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.787 -1.196 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 49' ' ' LEU . 1.3 pp -96.75 143.16 27.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 108.481 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.9 mt -115.5 135.36 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.458 -0.776 . . . . 0.0 110.973 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' NE ' ' CD2' ' A' ' 102' ' ' TYR . 79.9 mtt-85 -134.04 85.49 39.88 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 109.567 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' O ' HD12 ' A' ' 53' ' ' LEU . 29.8 Cg_endo -92.45 22.5 0.62 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.087 2.525 . . . . 0.0 112.02 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -130.98 143.17 48.31 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -75.54 155.55 40.48 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.118 1.878 . . . . 0.0 111.95 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' CB ' ' SG ' ' A' ' 99' ' ' CYS . 20.3 m -157.89 128.64 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.687 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.3 t -90.08 110.24 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 109.188 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 99' ' ' CYS . 83.4 mt -85.17 149.64 25.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.2 t70 -112.46 137.99 21.8 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.528 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 97.9 Cg_endo -75.36 -21.82 14.82 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.772 1.648 . . . . 0.0 113.293 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.74 -40.59 22.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.784 -1.197 . . . . 0.0 110.486 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.77 -34.88 64.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 0.0 109.816 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 58' ' ' ASP . 53.0 t -60.66 -47.38 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.925 -1.109 . . . . 0.0 109.247 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.3 mt-30 -60.71 -39.93 90.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 108.972 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.2 t -59.48 -47.53 85.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.42 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.94 -44.13 85.97 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.93 -31.06 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' O ' ' OE1' ' A' ' 71' ' ' GLU . 10.6 t70 -67.26 -45.29 77.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.638 -0.664 . . . . 0.0 109.25 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -60.91 -47.9 84.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.485 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.3 mt -59.83 -41.09 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.896 . . . . 0.0 109.209 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -75.83 -33.87 60.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 110.573 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -85.99 -30.0 23.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.909 -1.119 . . . . 0.0 110.045 -179.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -158.87 87.12 2.25 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.094 -1.004 . . . . 0.0 109.524 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.97 -28.93 87.05 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.74 1.627 . . . . 0.0 113.331 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 76' ' ' VAL . 2.5 p30 -82.56 -33.15 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.739 -1.226 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 m -68.7 13.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' ASP . 2.1 t -113.74 97.41 44.23 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 121.287 -0.883 . . . . 0.0 108.808 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.64 156.21 3.19 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.373 2.049 . . . . 0.0 112.34 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.31 172.78 13.41 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.598 2.199 . . . . 0.0 111.603 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 pt -109.66 162.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.585 -0.697 . . . . 0.0 109.208 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.95 136.67 33.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.224 -0.923 . . . . 0.0 109.481 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.49 134.19 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.64 139.31 30.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.915 . . . . 0.0 108.688 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -116.76 112.53 21.3 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.2 mt -136.19 141.91 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.298 -0.876 . . . . 0.0 110.231 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -100.88 157.08 16.99 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.14 -169.51 36.31 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.69 -7.68 49.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.876 . . . . 0.0 111.086 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.49 25.59 6.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.116 -0.99 . . . . 0.0 110.653 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.61 -10.74 43.37 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.014 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.532 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -54.46 109.51 1.23 Allowed Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.88 -1.364 . . . . 0.0 109.888 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.28 137.29 42.83 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.508 -0.995 . . . . 0.0 108.713 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 98.0 m-85 -131.56 123.85 28.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.492 -0.755 . . . . 0.0 109.028 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -105.46 117.8 34.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -98.5 151.61 20.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.759 -0.588 . . . . 0.0 109.553 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 t -135.66 107.85 7.24 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.36 -0.838 . . . . 0.0 109.372 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -111.66 72.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 149.56 -158.73 27.78 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.54 20.5 0.21 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 57' ' ' LEU . 4.8 t -56.53 -44.3 80.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -1.093 . . . . 0.0 110.929 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -74.96 -52.42 11.2 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.786 -1.196 . . . . 0.0 110.403 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -55.29 -31.11 61.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.804 -1.185 . . . . 0.0 108.48 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.538 ' CD2' ' NE ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -61.46 -51.18 69.75 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.65 73.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.938 . . . . 0.0 108.922 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.93 87.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.35 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -69.2 -40.91 77.74 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.247 -0.908 . . . . 0.0 108.985 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.95 -31.7 72.44 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.095 -1.003 . . . . 0.0 108.895 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -68.64 -36.62 78.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.1 mt -82.87 9.22 10.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 47.22 59.96 3.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.163 -0.96 . . . . 0.0 110.14 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -97.97 160.07 14.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.229 -0.919 . . . . 0.0 109.08 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -83.87 -42.59 16.21 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.644 HG22 ' HA ' ' A' ' 45' ' ' PRO . 35.4 p -132.62 177.76 7.37 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.97 -1.081 . . . . 0.0 110.555 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.2 tt -139.56 141.82 29.7 Favored Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.687 -0.633 . . . . 0.0 109.86 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.9 133.27 26.72 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.183 1.255 . . . . 0.0 110.989 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.89 138.34 15.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.971 . . . . 0.0 109.878 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 tttp -79.43 118.44 21.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.09 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.85 136.7 34.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.951 -1.093 . . . . 0.0 109.513 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -128.31 102.7 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.676 HE21 ' N ' ' A' ' 120' ' ' SER . 24.9 tp60 -60.55 131.67 51.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.112 -0.993 . . . . 0.0 108.665 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.676 ' N ' HE21 ' A' ' 119' ' ' GLN . 9.5 m -146.82 179.27 7.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 110.462 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -124.93 166.55 16.1 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 122' ' ' LEU . 53.8 mt -51.73 -28.5 15.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.798 -1.189 . . . . 0.0 110.227 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 t -54.18 -49.89 68.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.753 -1.217 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -67.33 -41.1 85.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -60.92 -40.08 91.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.987 -1.071 . . . . 0.0 109.146 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 130' ' ' GLY . 31.0 ttt85 -56.53 -41.46 76.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 108.912 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.53 -35.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.144 -0.973 . . . . 0.0 108.556 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -90.73 -49.62 6.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.179 -0.951 . . . . 0.0 110.822 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.0 mt -109.4 39.69 2.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.349 -0.844 . . . . 0.0 109.901 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -64.81 38.8 0.1 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.527 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -152.89 -58.16 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.796 -1.414 . . . . 0.0 109.612 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.2 m -99.06 35.49 1.89 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.096 -1.003 . . . . 0.0 109.167 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -67.16 117.79 49.63 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.46 -174.83 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.179 1.919 . . . . 0.0 111.289 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.557 ' C ' HE21 ' A' ' 137' ' ' GLN . 38.2 t0 -108.3 113.56 26.75 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.528 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 97.7 mt -80.31 137.96 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.7 mm-40 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.373 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.14 152.85 82.23 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.273 -1.133 . . . . 0.0 109.119 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.69 -176.89 2.51 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.945 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -165.81 90.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.27 60.34 4.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.55 93.96 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.784 2.323 . . . . 0.0 112.021 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.89 -69.16 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 87.92 1.31 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.766 2.31 . . . . 0.0 111.935 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.2 p -169.17 -39.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.85 -140.55 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.1 -51.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.69 -4.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.149 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -65.53 150.04 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.25 7.69 88.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.52 -9.83 39.91 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 p -175.53 145.14 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -1.191 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.8 -176.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -79.1 -46.0 18.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.2 p -161.2 178.53 9.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.468 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.76 -10.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtm-85 -71.6 131.87 43.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -1.177 . . . . 0.0 109.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.41 97.89 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.111 -0.993 . . . . 0.0 108.942 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.5 92.11 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.543 -0.723 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 -174.35 4.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 92.3 t -75.75 144.4 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.252 -0.905 . . . . 0.0 109.055 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 15.3 m-70 -152.41 145.61 24.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -84.93 97.58 9.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.508 HG11 HD21 ' A' ' 49' ' ' LEU . 4.2 p -92.21 124.75 58.79 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.186 -0.946 . . . . 0.0 108.824 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 112' ' ' THR . 83.2 Cg_exo -46.36 142.04 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.696 1.597 . . . . 0.0 113.338 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -69.26 -33.85 73.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 109.994 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.7 p -64.19 -36.65 84.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.562 -0.712 . . . . 0.0 112.411 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.78 -16.75 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.641 -1.287 . . . . 0.0 111.477 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 HG11 ' A' ' 44' ' ' VAL . 27.6 mt -57.53 122.26 12.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.609 -1.307 . . . . 0.0 109.57 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -85.38 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NH2' ' SG ' ' A' ' 99' ' ' CYS . 41.9 mmm-85 -130.68 83.29 62.27 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.506 -0.746 . . . . 0.0 109.225 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.648 ' O ' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -93.82 22.71 0.51 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.068 2.512 . . . . 0.0 112.136 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.4 mp -138.16 108.48 8.15 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.72 157.26 31.72 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.619 1.546 . . . . 0.0 112.182 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -154.9 126.95 7.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 56' ' ' VAL . 7.4 p -55.0 117.64 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.921 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD21 ' SG ' ' A' ' 99' ' ' CYS . 73.4 mt -90.17 149.84 22.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 62' ' ' VAL . 5.4 t70 -109.57 136.36 20.28 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 94.1 Cg_endo -75.03 -21.26 15.99 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.849 1.7 . . . . 0.0 112.934 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -81.64 -40.5 22.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.886 -1.134 . . . . 0.0 110.13 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.78 -38.12 62.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.107 -0.996 . . . . 0.0 109.239 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 58' ' ' ASP . 39.4 t -55.81 -47.07 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 108.635 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 3.1 mt-30 -65.22 -37.44 87.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 108.943 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.8 t -57.97 -48.27 80.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.322 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 mt -64.26 -43.76 93.86 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.146 -0.971 . . . . 0.0 109.102 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 t -56.25 -31.48 32.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.04 -36.07 61.86 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -61.85 -44.28 97.15 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.322 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.76 -42.98 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.039 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -75.46 -33.74 60.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.274 -0.891 . . . . 0.0 110.72 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -33.24 22.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.941 -1.099 . . . . 0.0 110.594 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.89 93.06 1.35 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.63 -20.09 48.58 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.362 1.375 . . . . 0.0 112.676 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' VAL . 22.7 t70 -85.33 -30.85 23.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.904 -1.122 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.4 m -66.75 9.37 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.881 -1.137 . . . . 0.0 110.093 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.5 p -146.67 100.89 4.0 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.99 159.83 18.29 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.251 1.967 . . . . 0.0 113.793 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.7 173.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.09 171.07 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 81' ' ' VAL . 20.1 t0 -91.51 145.18 24.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.924 -1.11 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 2.2 t -147.04 140.05 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mp -89.47 139.02 30.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.526 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 9.8 t90 -119.76 113.56 20.81 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mt -134.44 145.85 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.455 -0.778 . . . . 0.0 110.117 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.4 tttp -103.45 157.33 17.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.642 -0.661 . . . . 0.0 109.367 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.12 -173.09 37.32 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.13 -5.68 23.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.806 -0.82 . . . . 0.0 110.831 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -129.28 28.02 5.28 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.073 -1.017 . . . . 0.0 110.599 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.22 -13.57 19.92 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.035 -1.04 . . . . 0.0 110.952 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -50.45 107.8 0.41 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.26 135.19 39.65 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.556 -0.967 . . . . 0.0 109.005 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 99.6 m-85 -131.75 133.36 44.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.534 -0.729 . . . . 0.0 109.493 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.91 118.09 34.56 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.394 -0.816 . . . . 0.0 109.793 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -100.86 143.94 30.41 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.575 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -130.86 111.1 11.8 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.415 -0.803 . . . . 0.0 109.5 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.91 73.32 0.82 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 99' ' ' CYS . . . 153.88 -166.03 31.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.34 20.1 0.17 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.511 ' SG ' ' NH2' ' A' ' 51' ' ' ARG . 10.1 t -49.97 -44.51 50.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -1.131 . . . . 0.0 109.863 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -69.95 -44.94 68.52 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.035 -1.04 . . . . 0.0 109.761 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.64 HH21 HG23 ' A' ' 76' ' ' VAL . 45.4 mtt180 -56.78 -32.16 65.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.838 -1.164 . . . . 0.0 108.863 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -62.17 -49.83 74.27 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.62 84.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.9 -51.35 68.52 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -60.99 -43.33 99.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 109' ' ' GLN . 14.5 tt0 -59.7 -48.23 82.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.12 3.02 0.46 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 107' ' ' GLN . 11.1 tp60 54.16 40.14 31.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.349 -0.844 . . . . 0.0 110.455 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.65 149.85 31.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.917 -1.114 . . . . 0.0 108.791 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.498 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.8 tt0 -78.07 -43.96 27.66 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 110.021 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -122.55 178.09 5.14 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.097 -1.002 . . . . 0.0 110.082 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.61 146.11 43.31 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.19 130.89 5.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.393 1.395 . . . . 0.0 111.344 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.75 143.86 23.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -80.39 115.62 20.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.41 -0.806 . . . . 0.0 108.894 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.9 mt -74.99 139.53 42.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 0.0 109.429 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.74 102.12 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 120' ' ' SER . 30.2 tp60 -61.06 133.62 56.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.116 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.64 ' N ' HE21 ' A' ' 119' ' ' GLN . 6.4 m -142.64 179.03 7.22 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.734 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.7 p -113.81 160.51 18.64 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 30.0 tp -54.77 -39.73 68.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -54.14 -48.57 70.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.944 -1.098 . . . . 0.0 109.812 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -55.19 -40.08 70.33 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.231 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.7 tp -59.67 -40.97 89.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.945 -1.097 . . . . 0.0 109.039 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' GLY . 23.2 mmt85 -56.49 -37.06 69.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.076 -1.015 . . . . 0.0 109.259 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -55.48 -35.33 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.38 -49.75 6.35 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.489 -0.757 . . . . 0.0 110.424 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 131' ' ' ALA . 84.6 mt -109.58 42.09 1.55 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.406 -0.809 . . . . 0.0 109.279 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.24 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -157.52 -54.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.812 -1.405 . . . . 0.0 109.767 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.6 p -99.51 33.87 2.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -71.72 117.61 59.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.77 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.0 -174.99 2.45 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.014 1.809 . . . . 0.0 111.424 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.1 t0 -104.89 113.96 27.87 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 98.8 mt -81.28 138.68 35.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.327 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 62.7 mm-40 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.043 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.625 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . -74.84 -37.21 2.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.266 -1.137 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 18' ' ' ALA . 49.9 Cg_exo -56.01 97.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.086 1.857 . . . . 0.0 112.151 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 21' ' ' GLY . 7.2 tm-20 -76.33 146.05 39.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' N ' ' OE2' ' A' ' 20' ' ' GLU . . . 78.86 68.24 1.51 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.22 94.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.782 2.321 . . . . 0.0 112.281 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.53 170.62 28.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.36 -55.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.761 2.307 . . . . 0.0 111.97 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 m -169.99 -77.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.95 -64.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.21 -154.21 51.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.06 -33.97 65.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -1.131 . . . . 0.0 109.449 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.45 -66.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.337 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.9 -167.6 38.04 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 106.73 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 m -68.85 126.18 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -1.129 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.4 mt -50.95 -23.34 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -74.36 117.43 16.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 m -163.56 -25.15 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.14 -77.01 0.18 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' NH1' ' CG ' ' A' ' 119' ' ' GLN . 9.9 tpp180 -79.54 137.59 37.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.13 . . . . 0.0 109.393 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mt -143.65 98.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.23 -0.919 . . . . 0.0 109.018 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.22 113.76 27.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.663 -0.648 . . . . 0.0 109.329 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.34 -173.65 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 46.2 t -76.51 144.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 14.5 m-70 -151.67 145.85 25.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -85.16 97.01 9.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 44' ' ' VAL . 4.7 p -91.24 125.29 58.84 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.169 -0.957 . . . . 0.0 108.8 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HA ' HG22 ' A' ' 112' ' ' THR . 86.1 Cg_exo -45.28 143.57 5.16 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.712 1.608 . . . . 0.0 113.244 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.16 -37.67 75.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.453 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.63 -23.17 65.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.54 -0.725 . . . . 0.0 112.332 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.47 20.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.453 -1.404 . . . . 0.0 110.492 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' A' ' 44' ' ' VAL . 64.7 mt -91.76 127.82 37.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.587 -1.32 . . . . 0.0 109.4 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 50' ' ' ILE . 25.6 mt -94.03 126.95 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -133.69 85.99 40.45 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.454 -0.779 . . . . 0.0 109.921 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' LEU . 41.3 Cg_endo -90.82 20.54 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.055 2.504 . . . . 0.0 112.036 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 52' ' ' PRO . 1.5 mp -136.84 107.79 9.03 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.22 162.77 28.26 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.659 1.573 . . . . 0.0 112.216 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 p -156.39 128.35 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.4 p -56.96 117.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.876 . . . . 0.0 109.862 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.456 HD21 ' SG ' ' A' ' 99' ' ' CYS . 70.6 mt -87.37 149.82 24.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.742 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 14.0 t70 -108.68 137.8 20.12 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.522 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 74.5 Cg_endo -74.15 -24.23 14.95 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.803 1.668 . . . . 0.0 113.194 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.85 -41.46 23.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.937 -1.102 . . . . 0.0 110.588 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -37.53 69.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.099 -1.001 . . . . 0.0 109.677 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 58' ' ' ASP . 55.7 t -57.8 -48.0 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.83 -1.169 . . . . 0.0 109.0 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 59' ' ' PRO . 1.2 mt-30 -60.9 -38.53 86.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.7 t -57.73 -48.09 80.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.44 -44.87 85.93 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.252 -0.905 . . . . 0.0 109.222 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.85 -31.39 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -67.71 -42.4 82.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.96 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.44 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 2.2 m -63.81 -49.06 74.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.527 -0.733 . . . . 0.0 109.521 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt -59.44 -40.34 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.996 -1.065 . . . . 0.0 109.2 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -75.16 -35.55 61.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.387 -0.821 . . . . 0.0 110.16 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -80.86 -35.85 32.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.92 -1.113 . . . . 0.0 109.883 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 68' ' ' THR . 0.7 OUTLIER -159.18 101.59 1.56 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 0.0 108.903 -179.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -22.8 29.73 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.545 1.497 . . . . 0.0 113.443 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -92.67 2.28 56.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.715 -1.24 . . . . 0.0 110.084 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -99.77 10.61 41.04 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.195 -0.941 . . . . 0.0 110.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.86 97.72 42.64 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.332 -0.855 . . . . 0.0 108.835 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -50.15 155.65 4.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.336 2.024 . . . . 0.0 112.221 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.12 167.06 28.32 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.452 2.101 . . . . 0.0 111.698 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -107.45 167.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.34 138.87 34.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.063 -1.023 . . . . 0.0 109.581 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.39 131.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.2 135.86 33.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 108.846 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.524 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 8.9 t90 -115.54 112.31 22.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 mt -133.22 146.27 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.512 ' NZ ' ' OD1' ' A' ' 91' ' ' ASP . 6.6 tttp -104.61 156.42 17.98 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.67 -176.58 41.39 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.46 -5.46 14.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.794 -0.827 . . . . 0.0 110.97 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -128.15 26.05 5.8 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.068 -1.02 . . . . 0.0 110.599 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.414 ' O ' ' OD1' ' A' ' 91' ' ' ASP . . . 81.26 -12.8 36.47 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.18 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 92' ' ' TYR . . . -51.18 108.27 0.54 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.512 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -77.87 135.18 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.63 -0.923 . . . . 0.0 109.231 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 90' ' ' GLY . 97.1 m-85 -132.3 150.18 52.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.553 -0.717 . . . . 0.0 109.504 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.98 125.24 41.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -108.36 143.76 36.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.665 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 t -128.9 108.79 10.71 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.563 -0.711 . . . . 0.0 109.284 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.46 72.65 0.79 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.14 -164.2 29.24 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.56 27.59 0.87 Allowed Glycine 0 N--CA 1.495 2.619 0 O-C-N 121.334 -1.097 . . . . 0.0 110.391 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.456 ' SG ' HD21 ' A' ' 57' ' ' LEU . 9.4 t -56.29 -43.77 79.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -1.183 . . . . 0.0 110.067 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -69.2 -45.01 70.96 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.109 -0.994 . . . . 0.0 110.256 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mtt85 -55.52 -33.16 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.869 -1.144 . . . . 0.0 108.739 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 15.5 t80 -66.0 -42.13 90.13 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.15 -43.21 99.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.77 83.17 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.256 -0.903 . . . . 0.0 109.396 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -67.54 -40.14 85.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.146 -0.971 . . . . 0.0 108.67 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 106' ' ' GLN . 0.7 OUTLIER -56.97 -41.85 79.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.391 -0.818 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 109' ' ' GLN . 32.6 tt0 -63.69 -47.21 82.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.125 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.1 mt -64.57 4.98 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.819 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 107' ' ' GLN . 22.4 mt-30 49.97 19.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.35 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -56.07 156.25 5.66 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.867 -1.145 . . . . 0.0 108.701 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 112' ' ' THR . 6.2 tt0 -80.65 -43.78 19.89 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.546 -0.722 . . . . 0.0 110.473 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 45' ' ' PRO . 17.4 p -125.58 178.05 5.88 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.966 -1.084 . . . . 0.0 110.622 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.76 145.02 41.22 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.22 130.35 5.46 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 121.514 1.476 . . . . 0.0 111.558 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.29 143.77 24.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 109.979 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -79.93 119.09 22.31 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.15 141.78 35.4 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.179 -0.951 . . . . 0.0 109.879 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.38 101.91 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.626 HE21 ' N ' ' A' ' 120' ' ' SER . 30.3 tp60 -61.12 132.58 54.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.095 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.626 ' N ' HE21 ' A' ' 119' ' ' GLN . 7.9 m -143.97 -178.88 6.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -0.929 . . . . 0.0 109.544 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.2 p -119.93 163.7 17.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.682 -0.636 . . . . 0.0 109.399 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.48 -42.85 64.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.4 m -54.27 -49.38 69.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.916 -1.115 . . . . 0.0 109.816 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -54.06 -40.29 67.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.1 -1.0 . . . . 0.0 109.079 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 125' ' ' LEU . 13.0 tp -60.95 -39.01 87.9 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.17 -0.956 . . . . 0.0 108.862 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 130' ' ' GLY . 51.8 ttp85 -55.53 -39.1 70.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 108.902 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.56 -34.53 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -90.34 -49.4 6.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.368 -0.832 . . . . 0.0 110.792 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 131' ' ' ALA . 94.4 mt -113.1 42.73 1.85 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.48 -0.762 . . . . 0.0 110.001 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 126' ' ' ARG . . . -63.8 40.16 0.09 OUTLIER Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.773 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 129' ' ' LEU . . . -153.81 -55.96 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.756 -1.438 . . . . 0.0 109.664 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 m -101.85 35.59 2.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.16 -0.963 . . . . 0.0 109.319 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 119.78 78.31 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.8 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.48 -173.38 1.85 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.978 1.785 . . . . 0.0 111.141 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.583 ' C ' HE21 ' A' ' 137' ' ' GLN . 41.2 t0 -109.66 92.77 4.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.526 ' O ' ' NE2' ' A' ' 137' ' ' GLN . 94.4 mt -61.23 139.89 58.05 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.64 0.733 . . . . 0.0 110.881 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.583 HE21 ' C ' ' A' ' 135' ' ' ASP . 62.3 mm-40 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.075 179.105 . . . . . . . . 1 1 . 1 stop_ save_